Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,A1BG,Alpha-1B-glycoprotein,43812,101,2.59 [0.84-8.02],0.0976993567729677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AAMDC,Mth938 domain-containing protein,42584,98,1.04 [0.72-1.49],0.8472151271823133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AARSD1,Alanyl-tRNA editing protein Aarsd1,50063,116,1.11 [0.83-1.48],0.489442465722448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABCA2,ATP-binding cassette sub-family A member 2,42299,95,1.81 [1.15-2.83],0.0100056139047716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABHD14B,Protein ABHD14B,49756,118,1.16 [0.87-1.54],0.3084559793854464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABL1,Tyrosine-protein kinase ABL1,50063,116,0.99 [0.78-1.27],0.966365224116446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABO,Histo-blood group ABO system transferase,43781,100,0.97 [0.85-1.10],0.6149672300070741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABRAXAS2,BRISC complex subunit Abraxas 2,42299,95,1.05 [0.78-1.42],0.7338693140459871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",49115,114,1.17 [0.96-1.42],0.1095403525556327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",42949,99,0.82 [0.59-1.15],0.2518261825078346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",43744,99,1.02 [0.82-1.26],0.8746250879172345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACAN,Aggrecan core protein,49817,118,1.30 [0.73-2.34],0.3718744873279205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACE,Angiotensin-converting enzyme,43781,100,1.94 [0.99-3.81],0.0529955612451407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACE2,Angiotensin-converting enzyme 2,49383,114,1.42 [1.07-1.88],0.0141615484879484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACHE,Acetylcholinesterase,42800,100,1.48 [0.86-2.53],0.1532168550883377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACOT13,Acyl-coenzyme A thioesterase 13,43557,98,0.99 [0.84-1.17],0.893228964680228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,50298,118,0.96 [0.69-1.34],0.8162024376394599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP1,Low molecular weight phosphotyrosine protein phosphatase,42481,99,1.05 [0.69-1.60],0.802989941531522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP5,Tartrate-resistant acid phosphatase type 5,50521,115,1.26 [0.77-2.06],0.3639242700810823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP6,Lysophosphatidic acid phosphatase type 6,50655,120,0.76 [0.62-0.93],0.0076152563351977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACRBP,Acrosin-binding protein,43536,100,0.99 [0.61-1.62],0.9836718081756748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACRV1,Acrosomal protein SP-10,42481,99,1.20 [0.98-1.48],0.0825090323640318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACSL1,Long-chain-fatty-acid--CoA ligase 1,42299,95,1.36 [0.88-2.09],0.1671845964677888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTA2,"Actin, aortic smooth muscle",49383,114,1.55 [1.18-2.05],0.0018529994308326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTN2,Alpha-actinin-2,42299,95,1.04 [0.75-1.45],0.8086489669604393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTN4,Alpha-actinin-4,49349,116,0.96 [0.57-1.62],0.8735835295828975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACVRL1,Serine/threonine-protein kinase receptor R3,49831,118,1.57 [0.84-2.92],0.1557027074652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY1,Aminoacylase-1,50298,118,1.37 [1.06-1.76],0.0153692166599854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,42299,95,1.33 [0.97-1.84],0.0791974771874227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACYP1,Acylphosphatase-1,42636,100,1.11 [0.84-1.48],0.4609900135383586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA,Adenosine deaminase,50851,119,1.55 [1.04-2.31],0.0305305364653602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA2,Adenosine deaminase 2,50008,119,1.93 [1.37-2.72],0.0001793321903415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,42481,99,1.30 [0.77-2.21],0.3312227399734258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,49383,114,1.58 [0.93-2.70],0.0917282233435528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,49913,118,1.02 [0.65-1.59],0.9402536488016828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,50851,119,1.06 [0.67-1.69],0.8083944607562059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,50662,120,0.93 [0.54-1.62],0.8081097346208465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,43557,98,1.60 [0.88-2.91],0.1251992361260416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,42481,99,1.15 [0.64-2.07],0.6473985361089476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,50919,116,0.48 [0.25-0.92],0.0283659741961389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,50063,116,1.28 [0.86-1.90],0.2270473460242268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,49383,114,0.89 [0.50-1.56],0.6779258400700567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,42481,99,1.14 [0.67-1.94],0.636776885165913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,50453,117,1.21 [0.84-1.74],0.3042678187095807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL2,ADAMTS-like protein 2,43751,100,1.99 [1.19-3.33],0.0083007450772385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL4,ADAMTS-like protein 4,42584,98,1.17 [0.52-2.67],0.7012687722089745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL5,ADAMTS-like protein 5,43744,99,0.74 [0.45-1.19],0.2151318888243541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,49115,114,1.19 [0.82-1.73],0.3487276342318435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADD1,Alpha-adducin,42800,100,1.00 [0.76-1.31],0.987235544872291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRB3,Adhesion G protein-coupled receptor B3,49831,118,0.88 [0.54-1.43],0.597116161308664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRD1,Adhesion G-protein coupled receptor D1,42800,100,1.52 [0.96-2.42],0.0755469577844312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE1,Adhesion G protein-coupled receptor E1,43557,98,1.37 [0.98-1.90],0.0618346146169103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE2,Adhesion G protein-coupled receptor E2,50517,120,1.09 [0.62-1.93],0.7568913468752403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE5,Adhesion G protein-coupled receptor E5,50674,116,1.11 [0.65-1.89],0.6969772225159641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRF5,Adhesion G protein-coupled receptor F5,43744,99,1.70 [0.86-3.33],0.1256043165084089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRG1,Adhesion G-protein coupled receptor G1,50063,116,1.08 [0.88-1.32],0.4707029463578444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRG2,Adhesion G-protein coupled receptor G2,50298,118,0.64 [0.37-1.09],0.102517582379504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRV1,Adhesion G-protein coupled receptor V1,42326,94,1.10 [0.85-1.43],0.4853696691291731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH1B,All-trans-retinol dehydrogenase,42800,100,1.41 [1.13-1.77],0.0027246140139978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,49383,114,1.27 [1.05-1.55],0.0138165542016553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADIPOQ,Adiponectin,43812,101,1.00 [0.76-1.32],0.9731520815784775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADM,Pro-adrenomedullin,50729,120,1.29 [0.70-2.35],0.4127666516727556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADRA2A,Alpha-2A adrenergic receptor,42299,95,0.64 [0.43-0.95],0.0282456399935892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFAP1,Actin filament-associated protein 1,42800,100,1.06 [0.84-1.33],0.6454530859870811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFM,Afamin,43812,101,1.54 [0.59-4.00],0.376221974227977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AFP,Alpha-fetoprotein,49749,118,1.10 [0.86-1.40],0.435198219292161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGBL2,Cytosolic carboxypeptidase 2,42326,94,1.02 [0.82-1.28],0.839742650378763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGER,Advanced glycosylation end product-specific receptor,50187,120,0.76 [0.52-1.12],0.1692196067289357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGR2,Anterior gradient protein 2 homolog,48723,114,1.06 [0.90-1.25],0.5010077965272834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGR3,Anterior gradient protein 3,49031,113,1.13 [0.86-1.48],0.3683579462598885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGRN,Agrin,50517,120,1.37 [0.88-2.13],0.1600447532755137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGRP,Agouti-related protein,50851,119,1.31 [0.96-1.78],0.0848947132291235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGT,Angiotensinogen,43781,100,1.55 [0.73-3.26],0.2522851564856427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGXT,Serine--pyruvate aminotransferase,50298,118,1.33 [1.09-1.61],0.0044631884765717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHCY,Adenosylhomocysteinase,50298,118,1.05 [0.82-1.33],0.7168279974997416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHNAK,Neuroblast differentiation-associated protein AHNAK,42584,98,0.85 [0.46-1.58],0.6023037330449807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHNAK2,Protein AHNAK2,42584,98,0.72 [0.36-1.43],0.3462164444228167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,43536,100,1.05 [0.80-1.38],0.7092003961400559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSG,Alpha-2-HS-glycoprotein,43781,100,1.04 [0.52-2.11],0.9077134593492452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AHSP,Alpha-hemoglobin-stabilizing protein,50233,118,1.04 [0.87-1.26],0.6440488181655304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIDA,"Axin interactor, dorsalization-associated protein",42549,97,0.85 [0.64-1.12],0.2476962833243757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIF1,Allograft inflammatory factor 1,49115,114,0.89 [0.65-1.22],0.4716101822434316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIF1L,Allograft inflammatory factor 1-like,42584,98,1.02 [0.72-1.44],0.93100933668191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",49979,116,1.14 [0.98-1.32],0.0939355692133741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AK1,Adenylate kinase isoenzyme 1,50298,118,1.22 [0.96-1.55],0.1115315504098631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AK2,"Adenylate kinase 2, mitochondrial",43641,99,0.95 [0.79-1.14],0.5822543039987726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKAP12,A-kinase anchor protein 12,42800,100,1.50 [0.69-3.24],0.3029149604229508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1B1,Aldo-keto reductase family 1 member B1,49115,114,0.96 [0.77-1.20],0.7385948924388697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1B10,Aldo-keto reductase family 1 member B10,42549,97,0.97 [0.70-1.35],0.8782716769343191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR1C4,Aldo-keto reductase family 1 member C4,49383,114,1.12 [0.85-1.48],0.4285123905238865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKR7L,Aflatoxin B1 aldehyde reductase member 4,42481,99,1.14 [0.88-1.49],0.3170939504357399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT1S1,Proline-rich AKT1 substrate 1,49125,114,1.16 [0.90-1.49],0.2574506175422381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT2,RAC-beta serine/threonine-protein kinase,43667,97,1.00 [0.86-1.16],0.9980350617030164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AKT3,RAC-gamma serine/threonine-protein kinase,48882,114,1.07 [0.80-1.43],0.661072093778222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALCAM,CD166 antigen,50919,116,0.97 [0.42-2.25],0.9458142779128532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH1A1,Retinal dehydrogenase 1,50317,118,1.34 [1.01-1.76],0.0392058899998586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH2,"Aldehyde dehydrogenase, mitochondrial",43536,100,1.09 [0.78-1.53],0.6244760039412659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",50141,119,1.18 [0.96-1.46],0.1169738210000545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",43667,97,1.23 [0.83-1.81],0.3009542292781922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALMS1,Alstrom syndrome protein 1,42949,99,0.78 [0.47-1.27],0.3098306424763105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALPI,Intestinal-type alkaline phosphatase,42481,99,1.02 [0.87-1.19],0.8300307110120786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALPP,"Alkaline phosphatase, placental type",50063,116,1.12 [0.96-1.30],0.1524122635040994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMBN,Ameloblastin,49349,116,0.52 [0.25-1.04],0.0657713621098255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMBP,Protein AMBP,50656,119,0.98 [0.44-2.18],0.9637441472315996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,43751,100,0.99 [0.47-2.06],0.9711462582511272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMFR,E3 ubiquitin-protein ligase AMFR,49125,114,1.09 [0.85-1.40],0.4914790523104559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMIGO1,Amphoterin-induced protein 1,42549,97,1.17 [0.83-1.64],0.3623123035171945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMIGO2,Amphoterin-induced protein 2,50063,116,2.10 [1.05-4.22],0.0366075857131812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMN,Protein amnionless,49349,116,0.95 [0.67-1.35],0.781290823178691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMOT,Angiomotin,42800,100,1.28 [0.79-2.07],0.3195680557703478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMOTL2,Angiomotin-like protein 2,43375,100,0.76 [0.47-1.22],0.2513255415738274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMPD3,AMP deaminase 3,43641,99,1.06 [0.81-1.37],0.6793913417384371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,41014,94,1.01 [0.69-1.48],0.9670943109677924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY2A,Pancreatic alpha-amylase,48366,110,0.94 [0.66-1.33],0.7171918960822619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMY2B,Alpha-amylase 2B,46883,108,0.95 [0.67-1.36],0.7879113880775006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANG,Angiogenin,50171,119,1.43 [0.91-2.26],0.1190202413300744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPT1,Angiopoietin-1,50115,118,0.99 [0.82-1.20],0.9007449667347728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPT2,Angiopoietin-2,50729,120,1.48 [0.98-2.23],0.0606614871272268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL1,Angiopoietin-related protein 1,49563,113,1.42 [0.80-2.51],0.2318562253189512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL2,Angiopoietin-related protein 2,50354,120,1.40 [0.94-2.09],0.0945054483877783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL3,Angiopoietin-related protein 3,50336,119,0.99 [0.63-1.56],0.9674181595454034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL4,Angiopoietin-related protein 4,50436,120,1.76 [1.25-2.50],0.0013751713172275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL7,Angiopoietin-related protein 7,50729,120,1.30 [0.84-2.01],0.2448493937795539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANK2,Ankyrin-2,42299,95,0.96 [0.72-1.28],0.7884074337481208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,42481,99,0.96 [0.75-1.22],0.7151674078741284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKRA2,Ankyrin repeat family A protein 2,42186,96,1.04 [0.73-1.47],0.8441176685116825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKRD54,Ankyrin repeat domain-containing protein 54,49115,114,1.22 [0.96-1.57],0.1076879628430444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,42584,98,1.16 [0.75-1.81],0.5035533317254686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANPEP,Aminopeptidase N,50418,119,1.82 [1.06-3.11],0.0298585968253034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA1,Annexin A1,42558,99,1.02 [0.66-1.56],0.9382973888548538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA10,Annexin A10,49125,114,1.29 [1.09-1.53],0.0030997391881198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA11,Annexin A11,50145,117,1.11 [0.86-1.42],0.4348986924077359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA2,Annexin A2,41940,97,1.13 [0.88-1.47],0.3409533529538057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA3,Annexin A3,50662,120,1.05 [0.84-1.32],0.6575490981262879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA4,Annexin A4,50058,118,0.97 [0.77-1.21],0.7702269283522352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA5,Annexin A5,48962,114,0.94 [0.54-1.63],0.8141476831010861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AOC1,Amiloride-sensitive amine oxidase [copper-containing],49349,116,0.79 [0.55-1.12],0.1813118074758778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AOC3,Membrane primary amine oxidase,50498,119,1.23 [0.72-2.10],0.4551518954305867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP1G2,AP-1 complex subunit gamma-like 2,43536,100,0.99 [0.78-1.26],0.9346574949308334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP2B1,AP-2 complex subunit beta,42549,97,0.78 [0.50-1.20],0.2597010934987612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP3B1,AP-3 complex subunit beta-1,43557,98,0.92 [0.72-1.19],0.5361042174821498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AP3S2,AP-3 complex subunit sigma-2,43641,99,0.91 [0.60-1.37],0.6377195879400741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,50063,116,1.02 [0.71-1.45],0.930090451887028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APCS,Serum amyloid P-component,43420,101,0.66 [0.38-1.14],0.1400900566965084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,50571,120,1.20 [0.93-1.55],0.1682876408972431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APLP1,Amyloid-like protein 1,50298,118,0.78 [0.57-1.07],0.1244035679489748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA1,Apolipoprotein A-I,43812,101,0.65 [0.30-1.40],0.2719995112232105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA2,Apolipoprotein A-II,43781,100,1.40 [0.96-2.05],0.0826069023542172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOA4,Apolipoprotein A-IV,43812,101,1.14 [0.69-1.91],0.6058234325531827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOB,Apolipoprotein B-100,43781,100,1.40 [0.59-3.31],0.4448897810432476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOBR,Apolipoprotein B receptor,42584,98,1.03 [0.65-1.62],0.9127909202455814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOC1,Apolipoprotein C-I,43730,101,1.01 [0.61-1.68],0.9557982617093176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOD,Apolipoprotein D,41845,98,1.14 [0.75-1.75],0.530568537584028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOE,Apolipoprotein E,43812,101,1.21 [1.00-1.48],0.054651300504186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOF,Apolipoprotein F,43781,100,0.62 [0.38-0.99],0.046249383423771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOH,Beta-2-glycoprotein 1,50317,118,0.89 [0.56-1.40],0.6068869827695893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOL1,Apolipoprotein L1,43781,100,0.87 [0.62-1.21],0.4097683270351161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOM,Apolipoprotein M,50417,119,0.65 [0.37-1.14],0.129791782695518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APP,Amyloid-beta precursor protein,50240,118,1.07 [0.84-1.36],0.5941800046889301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APPL2,DCC-interacting protein 13-beta,42800,100,1.01 [0.85-1.20],0.8809080530404023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APRT,Adenine phosphoribosyltransferase,49830,118,1.08 [0.77-1.51],0.6712506033180794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARAF,Serine/threonine-protein kinase A-Raf,42949,99,1.04 [0.78-1.37],0.7968764468029055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AREG,Amphiregulin,50063,116,1.27 [0.89-1.82],0.1940737955294611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARF6,ADP-ribosylation factor 6,43557,98,1.01 [0.85-1.21],0.8900060284532101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARFIP1,Arfaptin-1,43667,97,1.03 [0.78-1.36],0.8459321576052103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARG1,Arginase-1,49995,119,1.05 [0.78-1.42],0.7478910850883276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARG2,"Arginase-2, mitochondrial",43536,100,1.26 [0.85-1.86],0.2507484154307587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP1,Rho GTPase-activating protein 1,49115,114,1.05 [0.73-1.50],0.8036649440059438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP25,Rho GTPase-activating protein 25,49115,114,1.20 [0.93-1.55],0.1571317461529792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP30,Rho GTPase-activating protein 30,42949,99,0.64 [0.33-1.23],0.1791482256755736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP45,Rho GTPase-activating protein 45,42800,100,1.04 [0.82-1.31],0.7503485536775186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGAP5,Rho GTPase-activating protein 5,42186,96,1.01 [0.78-1.30],0.95365390965072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF1,Rho guanine nucleotide exchange factor 1,43641,99,1.06 [0.85-1.31],0.6159567150909746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF10,Rho guanine nucleotide exchange factor 10,43667,97,0.98 [0.80-1.21],0.8818580530591276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF12,Rho guanine nucleotide exchange factor 12,50225,119,1.08 [0.92-1.27],0.3335297955308937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF5,Rho guanine nucleotide exchange factor 5,42326,94,1.33 [1.07-1.66],0.0103737201852023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARID3A,AT-rich interactive domain-containing protein 3A,42326,94,0.79 [0.46-1.34],0.3757537553614002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARID4B,AT-rich interactive domain-containing protein 4B,49125,114,0.88 [0.57-1.35],0.5663386450171041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARL13B,ADP-ribosylation factor-like protein 13B,42299,95,0.98 [0.73-1.31],0.8837670134691432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,42299,95,0.76 [0.46-1.27],0.2986682509093359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARMCX2,Armadillo repeat-containing X-linked protein 2,42326,94,0.90 [0.63-1.29],0.5764743921113141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARNT,Aryl hydrocarbon receptor nuclear translocator,49349,116,0.59 [0.35-0.98],0.0435983223697162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,42299,95,1.04 [0.72-1.49],0.8416133453678968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARSA,Arylsulfatase A,50317,118,1.34 [0.96-1.86],0.0851340453330132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARSB,Arylsulfatase B,50063,116,0.96 [0.72-1.30],0.8058317822522624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ART3,Ecto-ADP-ribosyltransferase 3,50498,119,1.00 [0.63-1.58],0.9947586747136388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ART5,Ecto-ADP-ribosyltransferase 5,42326,94,1.04 [0.77-1.41],0.7891694630067798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARTN,Artemin,49349,116,0.86 [0.57-1.30],0.4737177766887162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASAH1,Acid ceramidase,43347,100,1.21 [0.83-1.76],0.3254470516440984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASAH2,Neutral ceramidase,49913,118,1.19 [0.86-1.65],0.2810698175115592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASGR1,Asialoglycoprotein receptor 1,49913,118,1.29 [0.77-2.19],0.3358619667789635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASGR2,Asialoglycoprotein receptor 2,43781,100,1.40 [0.70-2.82],0.3418359826740906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASPN,Asporin,43744,99,1.04 [0.52-2.07],0.9163946714828162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASPSCR1,Tether containing UBX domain for GLUT4,43667,97,0.95 [0.71-1.27],0.739220474446787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASRGL1,Isoaspartyl peptidase/L-asparaginase,42584,98,0.98 [0.81-1.19],0.8170420927799378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ASS1,Argininosuccinate synthase,42299,95,1.05 [0.82-1.35],0.7060519003328309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATF2,Cyclic AMP-dependent transcription factor ATF-2,49125,114,1.05 [0.83-1.32],0.7086886536992174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATF4,Cyclic AMP-dependent transcription factor ATF-4,42186,96,1.18 [0.68-2.04],0.5630093594384634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATG16L1,Autophagy-related protein 16-1,43557,98,1.02 [0.81-1.28],0.856198332943546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATG4A,Cysteine protease ATG4A,49115,114,1.15 [0.88-1.50],0.3136144437023898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATOX1,Copper transport protein ATOX1,50453,117,1.25 [0.99-1.58],0.0624035465342621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,42299,95,1.07 [0.72-1.59],0.7320768569783682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,42299,95,0.97 [0.52-1.80],0.9273528564409148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,42299,95,0.65 [0.35-1.19],0.1582299511492524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B4,Protein ATP1B4,42186,96,1.30 [0.86-1.95],0.2164956008467146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP2B4,Plasma membrane calcium-transporting ATPase 4,42299,95,0.93 [0.66-1.32],0.6988369771826946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5F1D,"ATP synthase subunit delta, mitochondrial",42299,95,0.93 [0.62-1.40],0.7427496777669367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5IF1,"ATPase inhibitor, mitochondrial",50517,120,0.99 [0.85-1.14],0.870074469475148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP5PO,"ATP synthase subunit O, mitochondrial",49125,114,0.78 [0.51-1.18],0.2395771537553593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6AP2,Renin receptor,49115,114,0.80 [0.51-1.26],0.3381012480227817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1D,V-type proton ATPase subunit D,50063,116,0.76 [0.39-1.49],0.4270393125405196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1F,V-type proton ATPase subunit F,49042,114,0.85 [0.65-1.10],0.2093080548412318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1G1,V-type proton ATPase subunit G 1,42584,98,0.90 [0.68-1.18],0.4381729017052395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP6V1G2,V-type proton ATPase subunit G 2,42299,95,0.85 [0.68-1.06],0.1532688845078884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATRAID,All-trans retinoic acid-induced differentiation factor,43557,98,1.39 [0.89-2.17],0.1433030765403611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATRN,"Attractin, Isoform 2",43812,101,2.49 [0.84-7.35],0.0983854941003347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN10,Ataxin-10,49125,114,1.09 [0.87-1.38],0.4483629876210731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN2,Ataxin-2,42326,94,1.13 [0.97-1.32],0.1079207044643913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN2L,Ataxin-2-like protein,43667,97,1.07 [0.71-1.59],0.7520803460616527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN3,Ataxin-3,43641,99,1.00 [0.74-1.36],0.9851291202380869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AXIN1,Axin-1,50225,119,1.05 [0.89-1.25],0.5386113932281535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AXL,Tyrosine-protein kinase receptor UFO,50498,119,1.39 [0.78-2.48],0.2587801100386309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AZI2,5-azacytidine-induced protein 2,43667,97,0.97 [0.68-1.38],0.869254171500142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AZU1,Azurocidin,48775,114,0.94 [0.76-1.18],0.6121550366881032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B2M,Beta-2-microglobulin,43812,101,1.42 [1.00-2.02],0.0481965604023639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,42299,95,0.71 [0.26-1.95],0.5016555247647874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",42584,98,1.32 [0.78-2.24],0.3007451852137095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B4GALT1,"Beta-1,4-galactosyltransferase 1",50517,120,1.27 [0.71-2.26],0.4172081401418304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B4GAT1,"Beta-1,4-glucuronyltransferase 1",50317,118,0.75 [0.39-1.47],0.4023963167699426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BABAM1,BRISC and BRCA1-A complex member 1,42481,99,1.12 [0.59-2.15],0.7224832923352495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BACH1,Transcription regulator protein BACH1,50225,119,1.20 [0.97-1.49],0.0953769088153046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG3,BAG family molecular chaperone regulator 3,49831,118,0.88 [0.60-1.30],0.5159430057161369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG4,BAG family molecular chaperone regulator 4,42481,99,0.87 [0.58-1.31],0.5042661480955042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAG6,Large proline-rich protein BAG6,49383,114,1.16 [0.73-1.82],0.530556690929898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,49115,114,1.35 [1.07-1.71],0.0131262502608294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAMBI,BMP and activin membrane-bound inhibitor homolog,49115,114,1.55 [0.93-2.60],0.0931431752715634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BANK1,B-cell scaffold protein with ankyrin repeats,50225,119,1.05 [0.90-1.23],0.5034631559381899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAP18,Chromatin complexes subunit BAP18,43641,99,1.07 [0.83-1.39],0.5991146298442537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BATF,Basic leucine zipper transcriptional factor ATF-like,42549,97,1.18 [0.98-1.42],0.0751053097083616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAX,Apoptosis regulator BAX,49041,114,1.01 [0.84-1.22],0.9251063123147036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAM,Basal cell adhesion molecule,50317,118,1.36 [0.71-2.60],0.3594232451796884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAN,Brevican core protein,49913,118,0.78 [0.49-1.24],0.2944466892964723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",43744,99,1.47 [0.84-2.57],0.1826627037904535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",42326,94,1.02 [0.71-1.47],0.9063902012150512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCHE,Cholinesterase,42972,97,1.16 [0.57-2.38],0.6758786470892191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2,Apoptosis regulator Bcl-2,43557,98,1.21 [0.91-1.62],0.1924155150532767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L1,Bcl-2-like protein 1,43641,99,0.99 [0.81-1.20],0.9023194963135184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",50225,119,1.30 [0.87-1.95],0.2008122022936123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL2L15,Bcl-2-like protein 15,42481,99,0.80 [0.56-1.16],0.2419431953548549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL7A,B-cell CLL/lymphoma 7 protein family member A,42186,96,1.19 [0.92-1.55],0.1933560865961092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCL7B,B-cell CLL/lymphoma 7 protein family member B,43536,100,0.70 [0.42-1.17],0.1713807989722662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCR,Breakpoint cluster region protein,50225,119,1.13 [0.94-1.35],0.1847292458139383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BDNF,Brain-derived neurotrophic factor,43751,100,1.09 [0.86-1.37],0.472982392337869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BECN1,Beclin-1,42584,98,0.89 [0.64-1.24],0.4867576091779232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BEX3,Protein BEX3,42186,96,1.18 [0.82-1.68],0.3749846813939039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BGLAP,Osteocalcin,43751,100,1.12 [0.91-1.38],0.289860108169842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BGN,Biglycan,49033,113,0.96 [0.83-1.10],0.5378654538844463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BHLHE40,Class E basic helix-loop-helix protein 40,42326,94,0.87 [0.65-1.17],0.3640891452300749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,42299,95,0.90 [0.42-1.95],0.7964383561923676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BID,BH3-interacting domain death agonist,50225,119,0.93 [0.73-1.19],0.5593258554065896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BIN2,Bridging integrator 2,50317,118,0.95 [0.80-1.14],0.6005335422095133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BIRC2,Baculoviral IAP repeat-containing protein 2,49115,114,0.99 [0.76-1.29],0.9352500851617742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLMH,Bleomycin hydrolase,50919,116,1.29 [0.79-2.12],0.3066204246370941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLNK,B-cell linker protein,42481,99,0.90 [0.55-1.50],0.6939496762594894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,42326,94,0.94 [0.71-1.25],0.6860555968769815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,43641,99,0.76 [0.46-1.26],0.2851012261114893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BLVRB,Flavin reductase,50317,118,1.08 [0.85-1.37],0.5180638510693053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP10,Bone morphogenetic protein 10,42800,100,1.43 [0.72-2.84],0.3056244829688015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP4,Bone morphogenetic protein 4,49831,118,0.82 [0.57-1.18],0.2826719986144363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMP6,Bone morphogenetic protein 6,49305,114,1.21 [0.80-1.82],0.363395388867318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMPER,BMP-binding endothelial regulator protein,42800,100,2.09 [1.09-4.02],0.0271194174639044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,43744,99,1.03 [0.59-1.82],0.9067795551196436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,42481,99,1.11 [0.73-1.70],0.6172136547421931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOC,Brother of CDO,49383,114,0.76 [0.37-1.54],0.4430058651640577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOLA1,BolA-like protein 1,42326,94,1.17 [0.84-1.64],0.3478377355360204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BOLA2_BOLA2B,BolA-like protein 2,42584,98,0.91 [0.64-1.30],0.6066288875863355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFA2,BPI fold-containing family A member 2,41080,96,0.94 [0.79-1.13],0.5302359792271225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFB1,BPI fold-containing family B member 1,50188,116,0.89 [0.69-1.16],0.3857070683665494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BPIFB2,BPI fold-containing family B member 2,43660,99,1.13 [0.86-1.50],0.3757753519198969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRAP,BRCA1-associated protein,43151,97,1.02 [0.85-1.22],0.8666726791923501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD1,Bromodomain-containing protein 1,42949,99,0.69 [0.34-1.42],0.3143386905991901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD2,Bromodomain-containing protein 2,42326,94,1.17 [0.69-1.99],0.563315465879296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRD3,Bromodomain-containing protein 3,42299,95,0.68 [0.41-1.12],0.1304816287393252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRDT,Bromodomain testis-specific protein,42299,95,0.87 [0.51-1.50],0.6247783887946909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRK1,Protein BRICK1,49125,114,0.99 [0.68-1.43],0.9491732026060022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRME1,Break repair meiotic recombinase recruitment factor 1,42326,94,1.24 [0.84-1.82],0.2835833086893135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BRSK2,Serine/threonine-protein kinase BRSK2,43667,97,1.08 [0.65-1.79],0.766671943211355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BSG,Basigin,50768,117,1.65 [0.75-3.65],0.2160725567021974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BSND,Barttin,42186,96,1.14 [0.67-1.93],0.6329463259098973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,50746,120,0.88 [0.64-1.20],0.4047894121639239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST2,Bone marrow stromal antigen 2,50746,120,1.71 [1.38-2.13],1.3129617659202622e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTC,Probetacellulin,49115,114,0.99 [0.79-1.24],0.912901214067258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTD,Biotinidase,43812,101,1.67 [0.65-4.30],0.2876114604286992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTLA,B- and T-lymphocyte attenuator,42186,96,1.10 [0.91-1.33],0.3320577221314242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN1A1,Butyrophilin subfamily 1 member A1,43452,100,1.09 [0.69-1.72],0.7125000714738827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN2A1,Butyrophilin subfamily 2 member A1,50517,120,1.08 [0.59-1.97],0.8089756714917014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN3A2,Butyrophilin subfamily 3 member A2,50225,119,1.54 [1.06-2.24],0.0232963568773434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTNL10,Butyrophilin-like protein 10,42186,96,0.71 [0.39-1.30],0.2705722637099617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C19orf12,Protein C19orf12,49125,114,1.17 [0.93-1.47],0.1919269771889755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1GALT1C1,C1GALT1-specific chaperone 1,42299,95,1.14 [0.64-2.04],0.6518834329005334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QA,Complement C1q subcomponent subunit A,50603,117,2.03 [1.01-4.10],0.0469796980607445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",43667,97,0.88 [0.64-1.22],0.4586978959498011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QL2,Complement C1q-like protein 2,42481,99,1.14 [0.75-1.73],0.5506037757982062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,50498,119,1.69 [1.21-2.37],0.0022114258470094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,42800,100,1.98 [1.19-3.29],0.0086706863156013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,43667,97,1.22 [0.69-2.14],0.4931196969986965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,42723,100,0.76 [0.53-1.10],0.14351219867201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1R,Complement C1r subcomponent,43812,101,0.92 [0.32-2.65],0.8801774297703947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1RL,Complement C1r subcomponent-like protein,43735,101,1.36 [0.51-3.59],0.5414108605624833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1S,Complement C1s subcomponent,43812,101,0.82 [0.33-2.01],0.6645340718707571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2,Complement C2,50417,119,1.16 [0.56-2.43],0.686830743728471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2CD2L,Phospholipid transfer protein C2CD2L,49042,114,1.25 [0.89-1.75],0.2048629747176645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C2orf69,UPF0565 protein C2orf69,42549,97,1.07 [0.78-1.45],0.6818609741914643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C3,Complement C3,41569,97,0.93 [0.59-1.47],0.7668302878716772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C4BPB,C4b-binding protein beta chain,50453,117,1.24 [0.83-1.85],0.3004313182306781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C5,Complement C5,43812,101,2.29 [0.76-6.86],0.1396259983979913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C7,Complement component C7,42767,97,1.27 [0.68-2.36],0.4515098142382107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C7orf50,Uncharacterized protein C7orf50,43641,99,0.92 [0.39-2.20],0.8586211143020996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C8B,Complement component C8 beta chain,43812,101,1.15 [0.62-2.14],0.6540588608476372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C9,Complement component C9,43781,100,1.17 [0.81-1.67],0.399911312590342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C9orf40,Uncharacterized protein C9orf40,43557,98,1.01 [0.80-1.28],0.9015627326314494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA1,Carbonic anhydrase 1,49190,117,1.03 [0.79-1.35],0.8087585953558561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA11,Carbonic anhydrase-related protein 11,49115,114,0.57 [0.28-1.15],0.1175213854599369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA12,Carbonic anhydrase 12,50063,116,0.97 [0.58-1.62],0.9170564362198348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA13,Carbonic anhydrase 13,49742,116,1.05 [0.89-1.23],0.5742122272268297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA14,Carbonic anhydrase 14,50729,120,0.77 [0.49-1.21],0.2587608839947166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA2,Carbonic anhydrase 2,50149,118,1.12 [0.89-1.40],0.3349862549139132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA3,Carbonic anhydrase 3,50836,116,1.09 [0.84-1.42],0.5118922281604592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA4,Carbonic anhydrase 4,50919,116,0.78 [0.40-1.53],0.4660192406890853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA5A,"Carbonic anhydrase 5A, mitochondrial",49383,114,1.13 [0.95-1.34],0.1763083109003633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA6,Carbonic anhydrase 6,50159,118,0.83 [0.64-1.07],0.1551325766480555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA7,Carbonic anhydrase 7,42949,99,1.01 [0.58-1.77],0.9663603415893722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA8,Carbonic anhydrase-related protein,42481,99,0.51 [0.19-1.34],0.1731008685029111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA9,Carbonic anhydrase 9,50729,120,1.53 [1.13-2.08],0.0055650107549813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CABP2,Calcium-binding protein 2,42549,97,0.92 [0.67-1.27],0.6103818112030329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,42326,94,1.10 [0.61-1.96],0.7578237610735671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,42299,95,0.89 [0.61-1.31],0.5682345144371926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,42326,94,0.85 [0.59-1.22],0.3668582271451409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,43667,97,1.03 [0.82-1.29],0.8039587864326088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CACYBP,Calcyclin-binding protein,42720,100,1.02 [0.84-1.23],0.8515794758310111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CADPS,Calcium-dependent secretion activator 1,42549,97,0.78 [0.45-1.34],0.3629051733543033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALB1,Calbindin,50063,116,0.93 [0.65-1.33],0.6821249429189891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALB2,Calretinin,49125,114,0.77 [0.42-1.38],0.3763932787094379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCA,Calcitonin,49830,118,1.24 [0.98-1.56],0.0718513074704374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCB,Calcitonin gene-related peptide 2,43641,99,1.04 [0.64-1.68],0.8766357483790937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,50571,120,1.05 [0.89-1.22],0.5751596353190274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,42584,98,0.95 [0.74-1.23],0.7158412202357948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CALY,Neuron-specific vesicular protein calcyon,42299,95,0.96 [0.56-1.65],0.8838140470263848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,49115,114,1.11 [0.77-1.60],0.5875365453569836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,42549,97,0.77 [0.52-1.16],0.2128541510766363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,43667,97,0.94 [0.79-1.13],0.5388161030188274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CANT1,Soluble calcium-activated nucleotidase 1,50146,118,1.87 [0.85-4.11],0.1180052832699683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPG,Macrophage-capping protein,49923,118,0.99 [0.75-1.30],0.9492954659993116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPN3,Calpain-3,43536,100,0.67 [0.37-1.22],0.1901228500876402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAPS,Calcyphosin,43641,99,0.90 [0.71-1.14],0.381127252959657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CARHSP1,Calcium-regulated heat-stable protein 1,49125,114,0.99 [0.72-1.37],0.9659797882476387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASC3,Protein CASC3,42549,97,0.73 [0.45-1.20],0.2191944076902082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP1,Caspase-1,49125,114,0.93 [0.72-1.18],0.542792628281316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP10,Caspase-10,49125,114,1.09 [0.87-1.38],0.4553153430099044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP2,Caspase-2,50225,119,1.02 [0.81-1.30],0.840508024566563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP3,Caspase-3,50919,116,1.04 [0.86-1.25],0.6839112187577732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP4,Caspase-4,42949,99,0.97 [0.86-1.09],0.6428739978342908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP7,Caspase-7,43641,99,1.05 [0.84-1.32],0.6573514876237657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP8,Caspase-8,50582,119,1.04 [0.80-1.34],0.7902236829478952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASP9,Caspase-9,42481,99,0.92 [0.67-1.27],0.6113727479610991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CASQ2,Calsequestrin-2,42299,95,0.99 [0.66-1.51],0.9797452405533412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CAT,Catalase,43133,100,1.09 [0.78-1.54],0.6038412013918248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLIF,Cobalamin binding intrinsic factor,50223,118,1.08 [0.87-1.33],0.5027185533559195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLN1,Cerebellin-1,42326,94,1.17 [0.99-1.37],0.0584616892408039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLN4,Cerebellin-4,50729,120,0.75 [0.45-1.23],0.2546583143152037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBS,Cystathionine beta-synthase,42584,98,1.17 [0.82-1.66],0.3942600666113818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBX2,Chromobox protein homolog 2,42299,95,0.68 [0.36-1.28],0.230129875668843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,49913,118,1.05 [0.85-1.31],0.6415964999850252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCAR2,Cell cycle and apoptosis regulator protein 2,43641,99,0.94 [0.65-1.38],0.7663681278416208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC134,Coiled-coil domain-containing protein 134,43536,100,0.81 [0.54-1.22],0.3088318087929637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC28A,Coiled-coil domain-containing protein 28A,42549,97,1.30 [0.68-2.50],0.4289043808930545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC50,Coiled-coil domain-containing protein 50,43667,97,1.01 [0.79-1.30],0.9196603035528949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCDC80,Coiled-coil domain-containing protein 80,50298,118,1.20 [0.78-1.86],0.4044733431332178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,42584,98,0.82 [0.60-1.12],0.2144447093918314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL11,Eotaxin,50851,119,1.22 [0.79-1.87],0.370184377211524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL13,C-C motif chemokine 13,50766,119,1.08 [0.85-1.36],0.5357676176538846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL14,C-C motif chemokine 14,50171,119,1.29 [0.89-1.88],0.1769631323575053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL15,C-C motif chemokine 15,50919,116,1.15 [0.80-1.64],0.453237252217497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL16,C-C motif chemokine 16,50919,116,1.00 [0.74-1.35],0.9961535263341328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL17,C-C motif chemokine 17,50188,120,1.02 [0.85-1.21],0.8466337966843467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL18,C-C motif chemokine 18,49614,119,1.10 [0.88-1.36],0.4032888184429353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL19,C-C motif chemokine 19,50746,120,0.90 [0.78-1.04],0.1588859961407079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL2,C-C motif chemokine 2,49831,118,1.05 [0.78-1.42],0.7474111132951151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL20,C-C motif chemokine 20,50851,119,1.01 [0.85-1.21],0.8975477666511352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL21,C-C motif chemokine 21,50517,120,0.91 [0.61-1.36],0.6451355141468708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL22,C-C motif chemokine 22,49781,119,1.17 [0.87-1.58],0.2978401176412288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL23,C-C motif chemokine 23,50517,120,1.32 [0.91-1.92],0.1399807086472444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL24,C-C motif chemokine 24,50436,120,0.92 [0.76-1.12],0.4291219001539631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL25,C-C motif chemokine 25,50851,119,1.35 [0.97-1.87],0.0709734129645137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL26,C-C motif chemokine 26,50225,119,0.94 [0.78-1.13],0.495391838460037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL27,C-C motif chemokine 27,50298,118,1.06 [0.81-1.39],0.6606032416932976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL28,C-C motif chemokine 28,50059,118,1.25 [0.98-1.61],0.0775350933671841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL3,C-C motif chemokine 3,50225,119,0.97 [0.75-1.24],0.8048104198125122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL4,C-C motif chemokine 4,50353,120,0.79 [0.59-1.05],0.1085238707093308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL5,C-C motif chemokine 5,50498,119,0.98 [0.84-1.15],0.7907764045179217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL7,C-C motif chemokine 7,50225,119,1.13 [0.87-1.46],0.3565470376549076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL8,C-C motif chemokine 8,50656,119,1.05 [0.80-1.36],0.7429385282503191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN1,CCN family member 1,49980,115,1.14 [0.91-1.42],0.2549178637123807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN2,CCN family member 2,50267,119,1.21 [0.91-1.60],0.1923362300175103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN3,CCN family member 3,50834,115,1.46 [0.93-2.31],0.1011943590798644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN4,CCN family member 4,50729,120,1.52 [1.06-2.19],0.0235090559773653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN5,CCN family member 5,50317,118,1.06 [0.70-1.62],0.774314238599528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCND2,G1/S-specific cyclin-D2,42949,99,0.83 [0.51-1.34],0.4452043990717604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCNE1,G1/S-specific cyclin-E1,42481,99,0.79 [0.57-1.09],0.1477687935243555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCS,Copper chaperone for superoxide dismutase,49913,118,0.99 [0.71-1.40],0.976791391900897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCT5,T-complex protein 1 subunit epsilon,49115,114,1.06 [0.73-1.52],0.7702844902880202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD101,Immunoglobulin superfamily member 2,43557,98,1.06 [0.67-1.68],0.8086108314958839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD109,CD109 antigen,50317,118,0.96 [0.59-1.56],0.8668636078599252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD14,Monocyte differentiation antigen CD14,49284,117,1.59 [1.09-2.32],0.0157978145208317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD160,CD160 antigen,50851,119,1.14 [0.82-1.58],0.4517804241301666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD163,Scavenger receptor cysteine-rich type 1 protein M130,50498,119,1.44 [1.01-2.06],0.0458955723748877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD164,Sialomucin core protein 24,50317,118,1.29 [0.79-2.10],0.3098824673277716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD164L2,CD164 sialomucin-like 2 protein,42549,97,1.11 [0.66-1.88],0.6933854147952103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD177,CD177 antigen,50233,118,1.11 [0.97-1.27],0.1458965361104263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD1C,T-cell surface glycoprotein CD1c,50453,117,0.83 [0.43-1.59],0.5769066221701887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2,T-cell surface antigen CD2,42299,95,1.46 [1.03-2.06],0.032676931479174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD200,OX-2 membrane glycoprotein,50225,119,0.80 [0.43-1.49],0.4882894267196407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD200R1,Cell surface glycoprotein CD200 receptor 1,50057,119,0.87 [0.55-1.38],0.5578782860653393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD207,C-type lectin domain family 4 member K,49194,113,0.85 [0.55-1.31],0.4594202847773072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD209,CD209 antigen,50433,115,0.62 [0.41-0.95],0.0293335486896193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD22,B-cell receptor CD22,50851,119,1.07 [0.73-1.56],0.7340659911523807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD226,CD226 antigen,42481,99,1.06 [0.67-1.68],0.7959475323647232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD244,Natural killer cell receptor 2B4,50851,119,1.63 [0.91-2.89],0.0978873557313378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD248,Endosialin,43751,100,1.19 [0.75-1.90],0.4641179871164838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD27,CD27 antigen,50453,117,1.40 [0.97-2.02],0.0688712380673348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD274,Programmed cell death 1 ligand 1,49913,118,1.53 [1.00-2.36],0.0503137831909923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD276,CD276 antigen,50268,120,1.33 [0.85-2.10],0.2138023809085316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD28,T-cell-specific surface glycoprotein CD28,49115,114,1.37 [0.92-2.05],0.1199769155593984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2AP,CD2-associated protein,50298,118,1.18 [0.92-1.51],0.2040785545333556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300A,CMRF35-like molecule 8,42800,100,1.88 [1.03-3.42],0.0405979627957083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300C,CMRF35-like molecule 6,50746,120,1.13 [0.72-1.76],0.5982054546268246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300E,CMRF35-like molecule 2,50565,120,1.39 [0.96-2.01],0.0829558130153064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300LF,CMRF35-like molecule 1,50729,120,1.15 [0.88-1.49],0.309995459806329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300LG,CMRF35-like molecule 9,50317,118,0.73 [0.47-1.13],0.1592241168890139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD302,CD302 antigen,50063,116,1.74 [1.07-2.83],0.0267544958116017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD33,Myeloid cell surface antigen CD33,50453,117,1.09 [0.88-1.35],0.4170608826369468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD34,Hematopoietic progenitor cell antigen CD34,50585,120,0.34 [0.17-0.66],0.0014685950587678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD36,Platelet glycoprotein 4,42481,99,1.05 [0.70-1.59],0.811561100280324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,50063,116,1.84 [1.13-3.00],0.0136665278072933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3D,T-cell surface glycoprotein CD3 delta chain,42326,94,1.12 [0.66-1.89],0.6750391781763547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3E,T-cell surface glycoprotein CD3 epsilon chain,42949,99,1.34 [0.90-2.01],0.1493382061175777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3G,T-cell surface glycoprotein CD3 gamma chain,42481,99,0.65 [0.46-0.93],0.0170583063932838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD4,T-cell surface glycoprotein CD4,50143,118,1.16 [0.69-1.93],0.5829281241282351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD40,Tumor necrosis factor receptor superfamily member 5,50272,120,1.08 [0.78-1.48],0.656092228642702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD40LG,CD40 ligand,50851,119,1.05 [0.85-1.28],0.6711459600941362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD46,Membrane cofactor protein,50006,119,1.43 [0.83-2.44],0.1955987388237319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD48,CD48 antigen,50436,120,1.48 [0.88-2.50],0.1384255042946409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD5,T-cell surface glycoprotein CD5,50656,119,0.92 [0.57-1.47],0.7278134258516464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD55,Complement decay-accelerating factor,48534,115,1.19 [0.64-2.20],0.5831094277294251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD58,Lymphocyte function-associated antigen 3,50183,120,0.68 [0.28-1.66],0.3936493944871465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD59,CD59 glycoprotein,48487,113,1.84 [0.99-3.45],0.0556453361722501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD5L,CD5 antigen-like,43570,101,1.60 [1.08-2.35],0.0179075255846806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD6,T-cell differentiation antigen CD6,50768,117,0.84 [0.62-1.15],0.2770173204328104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD63,CD63 antigen,49831,118,1.09 [0.79-1.49],0.6170332902466255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD69,Early activation antigen CD69,50054,118,1.01 [0.84-1.21],0.9503376115618016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD7,T-cell antigen CD7,42402,99,0.85 [0.54-1.35],0.5005527597812258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD70,CD70 antigen,50225,119,1.21 [0.83-1.77],0.3099063345657736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD72,B-cell differentiation antigen CD72,42800,100,1.60 [1.06-2.41],0.0244421990982043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD74,HLA class II histocompatibility antigen gamma chain,50746,120,1.59 [1.03-2.46],0.0368598935133992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD79B,B-cell antigen receptor complex-associated protein beta chain,50851,119,1.36 [0.98-1.89],0.0686464704565152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD80,T-lymphocyte activation antigen CD80,43744,99,2.04 [1.25-3.33],0.0042846508726322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD82,CD82 antigen,42949,99,0.71 [0.40-1.25],0.234417372974159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD83,CD83 antigen,50225,119,1.22 [0.77-1.94],0.3893332839658155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD84,SLAM family member 5,50225,119,1.23 [0.74-2.04],0.4339083083406593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD86,T-lymphocyte activation antigen CD86,43557,98,1.96 [1.06-3.61],0.0311094274670666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD8A,T-cell surface glycoprotein CD8 alpha chain,50746,120,0.90 [0.66-1.24],0.5221548886778461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD93,Complement component C1q receptor,48411,116,1.09 [0.64-1.85],0.7448775133875079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD99,CD99 antigen,50317,118,0.86 [0.37-1.99],0.7300842590062633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD99L2,CD99 antigen-like protein 2,50317,118,1.08 [0.55-2.10],0.8229749463666269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDA,Cytidine deaminase,43659,99,1.38 [0.96-1.97],0.0796047454726305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDAN1,Codanin-1,43641,99,0.86 [0.36-2.05],0.7381336333094128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC123,Cell division cycle protein 123 homolog,42186,96,1.13 [0.86-1.48],0.3930206327925775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC25A,M-phase inducer phosphatase 1,42186,96,0.98 [0.59-1.63],0.9288084518255988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC26,Anaphase-promoting complex subunit CDC26,43476,98,0.95 [0.72-1.26],0.7339827530741452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC27,Cell division cycle protein 27 homolog,49115,114,0.98 [0.75-1.30],0.9120160001166656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC37,Hsp90 co-chaperone Cdc37,50453,117,1.04 [0.86-1.26],0.7023823371856666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDC42BPB,Serine/threonine-protein kinase MRCK beta,43557,98,0.98 [0.81-1.19],0.8591291859643234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDCP1,CUB domain-containing protein 1,49913,118,1.29 [0.98-1.72],0.0724681157907949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH1,Cadherin-1,48620,116,1.10 [0.74-1.64],0.6330877368442767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH15,Cadherin-15,50663,120,0.95 [0.73-1.24],0.7062980313632895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH17,Cadherin-17,50298,118,1.03 [0.82-1.29],0.8230715827641295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH2,Cadherin-2,50298,118,1.57 [1.01-2.43],0.0443035345190649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH22,Cadherin-22,42949,99,0.74 [0.35-1.53],0.412538988944935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH23,Cadherin-23,43641,99,0.65 [0.30-1.40],0.2693355449478526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH3,Cadherin-3,50746,120,0.86 [0.55-1.34],0.5043665751338153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH4,Cadherin-4,42326,94,1.11 [0.75-1.64],0.5943113514018384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH5,Cadherin-5,50919,116,1.08 [0.63-1.84],0.7828665031009678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH6,Cadherin-6,50298,118,1.12 [0.73-1.71],0.5954607695692542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR1,Cadherin-related family member 1,49125,114,0.92 [0.62-1.37],0.6876920252587642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR2,Cadherin-related family member 2,50063,116,1.13 [0.90-1.43],0.2925038694245874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDHR5,Cadherin-related family member 5,50298,118,0.82 [0.55-1.23],0.3352661358746331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDK1,Cyclin-dependent kinase 1,42186,96,0.96 [0.56-1.64],0.879326314495071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,43667,97,0.82 [0.57-1.17],0.2774311434654926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKL5,Cyclin-dependent kinase-like 5,42326,94,1.00 [0.68-1.46],0.98135863723402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKN1A,Cyclin-dependent kinase inhibitor 1,50063,116,1.01 [0.86-1.17],0.9447666222160724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,50063,116,1.02 [0.86-1.22],0.8092790740387638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDNF,Cerebral dopamine neurotrophic factor,50063,116,1.13 [0.69-1.84],0.6260833913432217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,50352,120,0.75 [0.42-1.36],0.351256295566427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDSN,Corneodesmosin,50693,119,0.88 [0.61-1.28],0.5059049395702067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,50373,117,1.65 [0.83-3.28],0.1543252602006817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,43557,98,0.92 [0.72-1.16],0.473405780135144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,42949,99,0.98 [0.74-1.30],0.9111539773023358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,43557,98,0.74 [0.46-1.21],0.2305251965051045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,42949,99,1.46 [1.05-2.03],0.0227757965911148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,50225,119,1.14 [0.95-1.36],0.1524323726417158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,49115,114,1.05 [0.75-1.48],0.7714735083741722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,48480,113,0.98 [0.75-1.27],0.8747441330584147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,43751,100,1.35 [0.90-2.03],0.1453213948457518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,49383,114,0.98 [0.71-1.36],0.917699686899522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEBPA,CCAAT/enhancer-binding protein alpha,42481,99,0.86 [0.47-1.57],0.6214128162819681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEBPB,CCAAT/enhancer-binding protein beta,49383,114,1.14 [0.75-1.73],0.5390974941044488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELA2A,Chymotrypsin-like elastase family member 2A,43751,100,0.93 [0.69-1.25],0.6370874074806019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELA3A,Chymotrypsin-like elastase family member 3A,50835,116,1.07 [0.81-1.40],0.644694319670315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,42800,100,0.96 [0.50-1.84],0.9008109759047298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEMIP2,Cell surface hyaluronidase,42481,99,1.07 [0.61-1.88],0.820484662420423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEND1,Cell cycle exit and neuronal differentiation protein 1,42326,94,0.96 [0.68-1.36],0.8255328827716173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CENPF,Centromere protein F,42949,99,0.98 [0.69-1.38],0.8920637107877115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CENPJ,Centromere protein J,42949,99,0.86 [0.64-1.16],0.3334212749991646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP112,Centrosomal protein of 112 kDa,42299,95,1.20 [0.83-1.73],0.331170079808009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP152,Centrosomal protein of 152 kDa,42186,96,1.04 [0.66-1.64],0.8545063600636768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP164,Centrosomal protein of 164 kDa,49349,116,1.25 [1.04-1.50],0.0157543719263611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP170,Centrosomal protein of 170 kDa,42584,98,0.86 [0.66-1.12],0.2534917555317545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP20,Centrosomal protein 20,49115,114,1.09 [0.87-1.35],0.4603816316744903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP290,Centrosomal protein of 290 kDa,42949,99,0.92 [0.63-1.36],0.6831453192705548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP350,Centrosome-associated protein 350,42186,96,1.05 [0.63-1.77],0.8424076026437367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP43,Centrosomal protein 43,48993,113,1.16 [0.91-1.47],0.224765597891931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP85,Centrosomal protein of 85 kDa,49115,114,0.98 [0.76-1.28],0.9090861242539132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CERT,Ceramide transfer protein,49125,114,1.15 [0.87-1.50],0.3252563055244951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES1,Liver carboxylesterase 1,50421,116,1.23 [1.02-1.48],0.0293389010033193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES2,Cocaine esterase,50063,116,0.93 [0.69-1.26],0.6496938407369446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES3,Carboxylesterase 3,50063,116,0.96 [0.76-1.23],0.7618221709447848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CETN2,Centrin-2,49125,114,0.99 [0.77-1.26],0.905507660544294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CETN3,Centrin-3,43557,98,0.93 [0.73-1.20],0.5891080840467358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFB,Complement factor B,43008,100,1.27 [0.71-2.28],0.4191906639869428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFC1,Cryptic protein,49115,114,0.99 [0.68-1.42],0.9418141133372024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFD,Complement factor D,43812,101,1.32 [0.57-3.05],0.5176577850396502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFH,Complement factor H,41254,97,0.79 [0.34-1.84],0.5843448087607916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR2,Complement factor H-related protein 2,43492,101,0.93 [0.67-1.29],0.6624585028903206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR4,Complement factor H-related protein 4,43729,101,0.95 [0.73-1.22],0.6674289497677444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFHR5,Complement factor H-related protein 5,43207,97,0.72 [0.47-1.09],0.1156450017567588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFI,Complement factor I,43812,101,1.74 [0.67-4.48],0.2548095112710539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CFP,Properdin,43812,101,1.00 [0.43-2.37],0.9927305673587072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGA,Glycoprotein hormones alpha chain,50317,118,1.00 [0.79-1.27],0.969921432200874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,43781,100,1.31 [0.88-1.95],0.1777217708714259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGN,Cingulin,42549,97,1.40 [0.95-2.05],0.087463708955886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGREF1,Cell growth regulator with EF hand domain protein 1,50298,118,1.01 [0.70-1.48],0.9426387361664132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,49115,114,1.29 [1.00-1.65],0.0456314119339224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHAD,Chondroadherin,42800,100,1.03 [0.71-1.49],0.8889204331457209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",43641,99,1.58 [1.07-2.35],0.0229519146671033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHCHD6,MICOS complex subunit MIC25,43536,100,1.52 [0.88-2.62],0.1322464588741948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHEK2,Serine/threonine-protein kinase Chk2,49383,114,0.82 [0.49-1.38],0.4569691828785684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHGA,Chromogranin-A,43751,100,1.17 [0.97-1.41],0.1003004599330551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHGB,Secretogranin-1,50583,120,1.00 [0.68-1.48],0.998230532182538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHI3L1,Chitinase-3-like protein 1,49187,115,0.99 [0.81-1.21],0.9393287834859084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHIT1,Chitotriosidase-1,50509,116,1.16 [1.01-1.34],0.0320397180335777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHL1,Neural cell adhesion molecule L1-like protein,50420,119,0.66 [0.38-1.15],0.1398139817830624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHM,Rab proteins geranylgeranyltransferase component A 1,42549,97,0.88 [0.63-1.22],0.4350821129881235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHMP1A,Charged multivesicular body protein 1a,49913,118,1.05 [0.85-1.29],0.6508775458014924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHMP6,Charged multivesicular body protein 6,43744,99,0.98 [0.70-1.38],0.9216334481920526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHP1,Calcineurin B homologous protein 1,42326,94,1.01 [0.77-1.32],0.9503205760788542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRDL1,Chordin-like protein 1,50436,120,1.17 [0.70-1.94],0.5485550984889191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRDL2,Chordin-like protein 2,50298,118,0.86 [0.62-1.20],0.3767098860874937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHRM1,Muscarinic acetylcholine receptor M1,42549,97,0.69 [0.37-1.28],0.2387332289550313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIAPIN1,Anamorsin,50453,117,1.14 [0.88-1.48],0.3112373173447051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CILP,Cartilage intermediate layer protein 1,43751,100,0.99 [0.70-1.40],0.9487840869966688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CINP,Cyclin-dependent kinase 2-interacting protein,42949,99,0.87 [0.54-1.39],0.5495470149825317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIRBP,Cold-inducible RNA-binding protein,43557,98,0.99 [0.81-1.21],0.9398657504316557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CIT,Citron Rho-interacting kinase,42549,97,0.98 [0.64-1.50],0.920672376682669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKAP4,Cytoskeleton-associated protein 4,50606,117,1.66 [1.00-2.76],0.0518423718925299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKB,Creatine kinase B-type,43751,100,1.01 [0.73-1.40],0.9337363348278458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",50103,120,1.36 [1.06-1.74],0.0146788544514612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLASP1,CLIP-associating protein 1,42186,96,0.81 [0.59-1.11],0.1905953161336944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLC,Galectin-10,50221,118,0.81 [0.63-1.05],0.1119560282038892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC10A,C-type lectin domain family 10 member A,49913,118,0.96 [0.61-1.50],0.860966754448956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC11A,C-type lectin domain family 11 member A,50234,118,1.17 [0.84-1.64],0.3595073385827522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC12A,C-type lectin domain family 12 member A,42481,99,0.72 [0.27-1.96],0.5250782783338503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC14A,C-type lectin domain family 14 member A,50317,118,1.24 [0.75-2.04],0.3963584195197154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC1A,C-type lectin domain family 1 member A,49383,114,1.04 [0.63-1.71],0.877614833633309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC1B,C-type lectin domain family 1 member B,50746,120,1.07 [0.91-1.27],0.402288833530652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC2L,C-type lectin domain family 2 member L,42549,97,0.76 [0.47-1.24],0.2723215720862656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC3B,Tetranectin,42778,100,0.70 [0.28-1.74],0.4414208201066053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4A,C-type lectin domain family 4 member A,50225,119,0.57 [0.37-0.86],0.0070123690294707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4C,C-type lectin domain family 4 member C,50225,119,0.95 [0.68-1.33],0.7772108089246984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4D,C-type lectin domain family 4 member D,50225,119,1.09 [0.85-1.40],0.502762629385836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4G,C-type lectin domain family 4 member G,50225,119,1.10 [0.68-1.78],0.7041208732379376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4M,C-type lectin domain family 4 member M,43675,100,0.75 [0.50-1.10],0.1390737663466676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC5A,C-type lectin domain family 5 member A,50135,118,0.95 [0.55-1.64],0.8597895180531556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC6A,C-type lectin domain family 6 member A,49115,114,1.41 [1.02-1.95],0.0374067945418727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC7A,C-type lectin domain family 7 member A,50851,119,1.29 [0.94-1.77],0.1171204464403285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLGN,Calmegin,42549,97,1.47 [1.04-2.06],0.0284295008857816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLIC5,Chloride intracellular channel protein 5,42549,97,0.81 [0.42-1.56],0.5281129259082215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLINT1,Clathrin interactor 1,42186,96,0.92 [0.59-1.44],0.717944606093817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLIP2,CAP-Gly domain-containing linker protein 2,50225,119,1.02 [0.88-1.18],0.7832607556100786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLMP,CXADR-like membrane protein,50729,120,0.77 [0.37-1.61],0.4808859890085337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLNS1A,Methylosome subunit pICln,42549,97,1.15 [0.66-1.99],0.6256034724309031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",49830,118,1.09 [0.92-1.29],0.3317791898361485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLPS,Colipase,50233,118,1.02 [0.82-1.28],0.831300962098389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSPN,Claspin,49042,114,0.74 [0.42-1.31],0.3042448396427947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN1,Calsyntenin-1,49125,114,1.02 [0.74-1.40],0.9073381841248132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN2,Calsyntenin-2,50851,119,1.25 [0.85-1.85],0.2558742341346997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLSTN3,Calsyntenin-3,43641,99,1.45 [0.80-2.61],0.2163024274394412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLTA,Clathrin light chain A,49383,114,1.21 [0.87-1.67],0.2574872415025053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLU,Clusterin,43812,101,1.38 [0.89-2.13],0.1498830832044825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLUL1,Clusterin-like protein 1,50215,118,1.05 [0.74-1.50],0.7702588565382044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CMC1,COX assembly mitochondrial protein homolog,43744,99,0.96 [0.78-1.19],0.739741574545433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CMIP,C-Maf-inducing protein,43536,100,1.02 [0.81-1.28],0.8780822492433005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNDP1,Beta-Ala-His dipeptidase,50498,119,1.10 [0.77-1.56],0.609672071253383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNGB3,Cyclic nucleotide-gated cation channel beta-3,42326,94,1.04 [0.73-1.47],0.8251665653215345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",42505,98,1.00 [0.79-1.28],0.972245222190412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNPY2,Protein canopy homolog 2,49383,114,1.07 [0.83-1.38],0.6205308262475602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNPY4,Protein canopy homolog 4,50063,116,1.07 [0.86-1.33],0.5290660077108928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNST,Consortin,50298,118,1.02 [0.88-1.19],0.7532453072403555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTF,Ciliary neurotrophic factor,42326,94,1.51 [0.89-2.57],0.1256219481384329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN1,Contactin-1,50919,116,0.54 [0.31-0.92],0.0246188833916894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN2,Contactin-2,50729,120,0.99 [0.69-1.42],0.9525684340337476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN3,Contactin-3,50317,118,0.92 [0.55-1.52],0.7387779636573584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN4,Contactin-4,50317,118,0.92 [0.47-1.82],0.814309288389457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN5,Contactin-5,50425,120,0.64 [0.41-0.99],0.0459249783803575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTNAP2,Contactin-associated protein-like 2,50225,119,1.32 [0.91-1.92],0.14381905242885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTNAP4,Contactin-associated protein-like 4,42549,97,0.93 [0.75-1.15],0.5156410778907174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COCH,Cochlin,43744,99,1.35 [0.92-1.98],0.1270253329860729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL15A1,Collagen alpha-1(XV) chain,43751,100,1.07 [0.53-2.16],0.8471958955290935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL18A1,Collagen alpha-1(XVIII) chain,50512,115,2.28 [1.16-4.51],0.0172729216828281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL1A1,Collagen alpha-1(I) chain,50919,116,1.32 [0.69-2.52],0.4024168121112442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL24A1,Collagen alpha-1(XXIV) chain,43557,98,0.93 [0.67-1.28],0.6479074393303126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL28A1,Collagen alpha-1(XXVIII) chain,42549,97,1.03 [0.80-1.32],0.825341720161453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL2A1,Collagen alpha-1(II) chain,42584,98,1.08 [0.85-1.37],0.5500848044526097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL3A1,Collagen alpha-1(III) chain,43751,100,1.45 [0.65-3.24],0.3609139308439554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL4A1,Collagen alpha-1(IV) chain,50298,118,1.42 [0.95-2.13],0.0846592214424782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL4A4,Collagen alpha-4(IV) chain,42878,99,0.78 [0.57-1.08],0.1302588257955605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL5A1,Collagen alpha-1(V) chain,42800,100,1.62 [1.05-2.49],0.0284561143340992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL6A3,Collagen alpha-3(VI) chain,50919,116,1.38 [0.89-2.14],0.151994891512527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL9A1,Collagen alpha-1(IX) chain,50225,119,1.25 [0.90-1.74],0.1751597884303355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL9A2,Collagen alpha-2(IX) chain,42949,99,0.68 [0.40-1.14],0.143186371960603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COLEC12,Collectin-12,50268,120,1.33 [0.73-2.41],0.3472535566288017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMMD1,COMM domain-containing protein 1,42584,98,0.90 [0.65-1.24],0.5217796167038121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMMD9,COMM domain-containing protein 9,43536,100,0.77 [0.45-1.31],0.3341000892022195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMP,Cartilage oligomeric matrix protein,49764,119,1.29 [0.79-2.10],0.302708827029305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COMT,Catechol O-methyltransferase,48850,114,1.11 [0.91-1.35],0.3191764359770935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COPB2,Coatomer subunit beta',42299,95,0.81 [0.50-1.31],0.3879923045940839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COPE,Coatomer subunit epsilon,49125,114,0.87 [0.60-1.28],0.4903173623239266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",42584,98,1.36 [0.93-1.98],0.1133575034512456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CORO1A,Coronin-1A,49284,113,0.96 [0.80-1.16],0.695989854709784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CORO6,Coronin-6,42326,94,0.97 [0.57-1.66],0.9219100554234226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",50063,116,1.13 [0.90-1.42],0.2909215792149405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COX6B1,Cytochrome c oxidase subunit 6B1,43744,99,0.87 [0.48-1.58],0.6439870092469572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA1,Carboxypeptidase A1,50919,116,1.04 [0.81-1.35],0.7393800629326073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA2,Carboxypeptidase A2,50579,118,0.98 [0.77-1.25],0.8855165590369067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPA4,Carboxypeptidase A4,41946,99,0.87 [0.56-1.36],0.5511351516580021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPB1,Carboxypeptidase B,50919,116,1.10 [0.85-1.43],0.4657571956644042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPB2,Carboxypeptidase B2,43730,101,0.67 [0.29-1.54],0.3450705081000185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPE,Carboxypeptidase E,50337,118,0.82 [0.56-1.22],0.3394881751066578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPLX2,Complexin-2,42186,96,0.72 [0.36-1.41],0.3347967525799051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPM,Carboxypeptidase M,50501,120,1.10 [0.70-1.72],0.6879827906388469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",42481,99,1.64 [1.00-2.69],0.0484809602876291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPPED1,Serine/threonine-protein phosphatase CPPED1,50746,120,0.92 [0.72-1.18],0.5248185514975791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPQ,Carboxypeptidase Q,43672,100,1.20 [0.72-2.01],0.4876248754610125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPTP,Ceramide-1-phosphate transfer protein,42299,95,1.07 [0.65-1.74],0.7940394992203206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPVL,Probable serine carboxypeptidase CPVL,50645,120,1.59 [1.06-2.41],0.0268160621155115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPXM1,Probable carboxypeptidase X1,50453,117,1.09 [0.87-1.38],0.4422621314467229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPXM2,Inactive carboxypeptidase-like protein X2,43744,99,1.71 [0.87-3.36],0.116354865568988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CR1,Complement receptor type 1,43614,100,1.56 [0.93-2.61],0.0947205017505772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CR2,Complement receptor type 2,50498,119,1.05 [0.75-1.48],0.7612136495909911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,49115,114,0.98 [0.81-1.20],0.851761872196801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRADD,Death domain-containing protein CRADD,49830,118,0.97 [0.78-1.21],0.8160180457944565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREB3,Cyclic AMP-responsive element-binding protein 3,42186,96,1.26 [0.94-1.68],0.124949504310563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREBZF,CREB/ATF bZIP transcription factor,42186,96,1.81 [0.98-3.35],0.0593545119795323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREG1,Protein CREG1,49642,117,1.02 [0.67-1.54],0.9412184613258991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRELD1,Protein disulfide isomerase CRELD1,42800,100,1.31 [0.78-2.17],0.3066717355956608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRELD2,Protein disulfide isomerase CRELD2,50436,120,1.29 [0.95-1.74],0.10252402953836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRH,Corticoliberin,49031,114,0.73 [0.60-0.89],0.0019324384170957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRHBP,Corticotropin-releasing factor-binding protein,50268,120,1.21 [0.68-2.14],0.5163499687677038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRHR1,Corticotropin-releasing factor receptor 1,49383,114,0.78 [0.58-1.07],0.1250821140449873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIM1,Cysteine-rich motor neuron 1 protein,50517,120,2.28 [1.07-4.88],0.0335451792156483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIP2,Cysteine-rich protein 2,49913,118,1.64 [1.19-2.27],0.0027756359860339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRISP2,Cysteine-rich secretory protein 2,50729,120,1.15 [0.87-1.53],0.3311003200880177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRISP3,Cysteine-rich secretory protein 3,43373,98,1.05 [0.52-2.13],0.8827294797335752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRKL,Crk-like protein,50351,120,1.03 [0.88-1.20],0.7450253200943714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRLF1,Cytokine receptor-like factor 1,50517,120,1.43 [0.76-2.70],0.2671758435007867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRNN,Cornulin,48856,118,0.74 [0.59-0.94],0.0118521293229674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAC1,Cartilage acidic protein 1,50919,116,0.90 [0.53-1.55],0.7138308291078133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAM,Cytotoxic and regulatory T-cell molecule,49913,118,1.28 [0.93-1.75],0.129211997820409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAP,Cartilage-associated protein,42549,97,0.51 [0.29-0.88],0.0153880514044786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRX,Cone-rod homeobox protein,49383,114,0.93 [0.79-1.11],0.4279579522913831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYBB1,Beta-crystallin B1,43744,99,0.91 [0.67-1.22],0.5140056257972403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYBB2,Beta-crystallin B2,43641,99,1.04 [0.82-1.32],0.7564164321200265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYGD,Gamma-crystallin D,43641,99,0.85 [0.70-1.04],0.113040273937133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYM,Ketimine reductase mu-crystallin,42326,94,0.87 [0.65-1.16],0.3342656290900518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRYZL1,Quinone oxidoreductase-like protein 1,42584,98,0.94 [0.76-1.16],0.540349897218781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSDE1,Cold shock domain-containing protein E1,42299,95,0.83 [0.68-1.02],0.0754985206852359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1,Macrophage colony-stimulating factor 1,50517,120,1.18 [0.66-2.12],0.5818976633586961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1R,Macrophage colony-stimulating factor 1 receptor,43781,100,2.03 [1.37-3.01],0.0004255072568478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2,Granulocyte-macrophage colony-stimulating factor,42299,95,0.74 [0.42-1.33],0.3148892261725881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,49913,118,1.14 [0.88-1.47],0.314607093736112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF2RB,Cytokine receptor common subunit beta,42481,99,0.75 [0.48-1.16],0.1985364066367592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF3,Granulocyte colony-stimulating factor,49349,116,0.93 [0.66-1.30],0.6546716215456072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF3R,Granulocyte colony-stimulating factor receptor,42481,99,0.83 [0.44-1.59],0.5798561979892345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSH1,Chorionic somatomammotropin hormone 1,43781,100,1.27 [0.73-2.20],0.4010278119961359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSNK1D,Casein kinase I isoform delta,42481,99,0.96 [0.70-1.31],0.7774603996726228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSNK2A1,Casein kinase II subunit alpha,43667,97,0.66 [0.42-1.03],0.0645552647929673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSPG4,Chondroitin sulfate proteoglycan 4,43751,100,2.20 [1.26-3.84],0.0055648244547808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSPG5,Chondroitin sulfate proteoglycan 5,42326,94,0.90 [0.59-1.38],0.629343302665514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSRP3,Cysteine and glycine-rich protein 3,42299,95,1.04 [0.85-1.27],0.7028953380636356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST1,Cystatin-SN,37984,90,0.93 [0.76-1.14],0.508076909872778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST3,Cystatin-C,50413,119,1.92 [1.15-3.20],0.012707761755587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST5,Cystatin-D,49360,115,0.93 [0.69-1.25],0.6424729097358748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST6,Cystatin-M,48979,112,0.89 [0.63-1.25],0.4868742344222768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST7,Cystatin-F,50353,120,1.09 [0.94-1.27],0.2693851775962689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSTB,Cystatin-B,49615,114,1.32 [0.91-1.91],0.1434560344262207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTAG1A_CTAG1B,Cancer/testis antigen 1,42867,99,1.09 [0.75-1.59],0.6567627075479753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTBS,Di-N-acetylchitobiase,43139,98,1.13 [0.55-2.32],0.748530306114742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTF1,Cardiotrophin-1,49383,114,1.06 [0.87-1.29],0.5642148262822246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTHRC1,Collagen triple helix repeat-containing protein 1,43751,100,0.97 [0.49-1.91],0.9343058683820528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTLA4,Cytotoxic T-lymphocyte protein 4,43751,100,1.24 [0.70-2.20],0.4567438021723677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTNNA1,Catenin alpha-1,42326,94,1.18 [0.72-1.92],0.5124075070905709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRB1,Chymotrypsinogen B,50317,118,0.96 [0.72-1.28],0.7714635833497386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRC,Chymotrypsin-C,50271,120,0.97 [0.75-1.24],0.7839191641391081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTRL,Chymotrypsin-like protease CTRL-1,43641,99,1.03 [0.78-1.35],0.844049565702647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSB,Cathepsin B,50349,115,0.97 [0.71-1.32],0.8280474665520374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSC,Dipeptidyl peptidase 1,50179,119,1.19 [0.83-1.71],0.3373770075537116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSD,Cathepsin D,47015,108,1.42 [0.98-2.04],0.0604782596110893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSE,Cathepsin E,42800,100,1.02 [0.71-1.46],0.9098354977869142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSF,Cathepsin F,50453,117,0.64 [0.43-0.96],0.0330398100483459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSH,Pro-cathepsin H,49219,113,1.03 [0.82-1.28],0.826590908527359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSL,Cathepsin L1,50298,118,2.24 [1.21-4.15],0.0104315521468118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSO,Cathepsin O,50851,119,2.13 [1.32-3.44],0.0019462383924802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSS,Cathepsin S,39528,94,1.54 [0.68-3.50],0.3015299955716228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSV,Cathepsin L2,50562,120,0.68 [0.46-1.02],0.060982927853731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSZ,Cathepsin Z,50335,119,1.55 [0.94-2.55],0.0867600224204608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CUZD1,CUB and zona pellucida-like domain-containing protein 1,42549,97,1.11 [0.71-1.73],0.6443154750643083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CWC15,Spliceosome-associated protein CWC15 homolog,43312,98,0.89 [0.63-1.27],0.5281219865060522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CX3CL1,Fractalkine,49913,118,1.28 [0.80-2.06],0.307137276243217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXADR,Coxsackievirus and adenovirus receptor,50225,119,1.34 [1.00-1.80],0.047793282612701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL1,Growth-regulated alpha protein,50191,120,1.00 [0.85-1.18],0.9758780665820292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL10,C-X-C motif chemokine 10,50517,120,1.16 [0.92-1.45],0.2027815604848603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL11,C-X-C motif chemokine 11,50746,120,1.10 [0.91-1.33],0.3050292854786691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL12,Stromal cell-derived factor 1,49349,116,1.07 [0.71-1.62],0.7379175527510908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL13,C-X-C motif chemokine 13,50746,120,1.16 [0.93-1.45],0.1883289812626354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL14,C-X-C motif chemokine 14,49349,116,1.03 [0.79-1.36],0.8090207575887025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL16,C-X-C motif chemokine 16,50837,116,0.76 [0.38-1.53],0.4407488983037618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL17,C-X-C motif chemokine 17,50851,119,1.45 [1.03-2.04],0.0331431909440213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL3,C-X-C motif chemokine 3,50272,120,0.98 [0.82-1.15],0.7751365047171441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL5,C-X-C motif chemokine 5,50134,117,1.06 [0.92-1.22],0.4189258884712307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL6,C-X-C motif chemokine 6,50851,119,1.17 [0.95-1.44],0.1413872636823439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL8,Interleukin-8,49909,119,1.05 [0.84-1.31],0.6658889650079616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL9,C-X-C motif chemokine 9,50517,120,1.16 [0.92-1.45],0.2047818283386282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5A,Cytochrome b5,42186,96,1.34 [1.11-1.61],0.002091138657287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5R2,NADH-cytochrome b5 reductase 2,43070,98,0.88 [0.62-1.23],0.452642563367066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",42299,95,1.03 [0.82-1.28],0.8295835765817434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYTH3,Cytohesin-3,42186,96,0.92 [0.69-1.23],0.5785392001143856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYTL1,Cytokine-like protein 1,43751,100,0.73 [0.34-1.57],0.4183675433630348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAAM1,Disheveled-associated activator of morphogenesis 1,42800,100,0.98 [0.78-1.24],0.8807329864717891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAB2,Disabled homolog 2,50729,120,1.05 [0.91-1.21],0.5348671842512891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAG1,Dystroglycan,50517,120,1.07 [0.76-1.51],0.687078260496981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAND5,DAN domain family member 5,42481,99,0.72 [0.52-1.00],0.0523405021789506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAPK2,Death-associated protein kinase 2,42481,99,0.88 [0.61-1.27],0.4991314403691897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,50225,119,1.04 [0.90-1.19],0.6185378031277577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DARS1,"Aspartate--tRNA ligase, cytoplasmic",49830,118,1.05 [0.84-1.32],0.6684066436246321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBH,Dopamine beta-hydroxylase,43696,100,1.05 [0.88-1.26],0.590570331530437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBI,Acyl-CoA-binding protein,50077,118,1.08 [0.88-1.33],0.4716776551484158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBN1,Drebrin,42481,99,0.79 [0.53-1.19],0.2552714749500548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DBNL,Drebrin-like protein,50517,120,1.03 [0.86-1.22],0.7681286545554763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",50453,117,1.56 [0.99-2.45],0.0566470672054142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCC,Netrin receptor DCC,42549,97,0.55 [0.20-1.52],0.2476255126736335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCDC2C,Doublecortin domain-containing protein 2C,42186,96,1.10 [0.82-1.47],0.5371800484954552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCLRE1C,Protein artemis,42186,96,0.66 [0.34-1.30],0.232920706221687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCN,Decorin,49383,114,1.04 [0.51-2.12],0.9176558044076544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTD,Deoxycytidylate deaminase,42800,100,1.01 [0.83-1.24],0.910897510075716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN1,Dynactin subunit 1,50729,120,1.14 [0.89-1.46],0.2837099861108219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN2,Dynactin subunit 2,50063,116,0.90 [0.75-1.08],0.2552638911793816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTN6,Dynactin subunit 6,49125,114,1.03 [0.82-1.29],0.8096250969539567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTPP1,dCTP pyrophosphatase 1,50298,118,1.63 [0.99-2.68],0.0570625353039471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCUN1D1,DCN1-like protein 1,42326,94,0.93 [0.70-1.25],0.6436414769867976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCUN1D2,DCN1-like protein 2,42186,96,1.12 [0.90-1.40],0.3151202251064996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCXR,L-xylulose reductase,50453,117,1.44 [1.08-1.93],0.0128261706938531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDA1,DET1- and DDB1-associated protein 1,42299,95,0.66 [0.37-1.20],0.1727379655064756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",50063,116,1.22 [0.86-1.74],0.2715319773430679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDC,Aromatic-L-amino-acid decarboxylase,50223,118,1.12 [0.80-1.56],0.514147465071209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDHD2,Phospholipase DDHD2,43667,97,0.89 [0.66-1.19],0.4313860491250196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDI2,Protein DDI1 homolog 2,42800,100,1.03 [0.81-1.31],0.8129680211851311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDR1,Epithelial discoidin domain-containing receptor 1,50746,120,0.95 [0.47-1.94],0.8966682158657711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDT,D-dopachrome decarboxylase,43751,100,1.06 [0.68-1.65],0.7907194673882918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX1,ATP-dependent RNA helicase DDX1,43557,98,0.93 [0.62-1.40],0.7266617884797607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX25,ATP-dependent RNA helicase DDX25,42549,97,0.99 [0.58-1.69],0.9796341378383964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX39A,ATP-dependent RNA helicase DDX39A,42481,99,1.01 [0.45-2.30],0.9759705148867082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX4,Probable ATP-dependent RNA helicase DDX4,42481,99,0.99 [0.69-1.42],0.94524839854927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX53,Probable ATP-dependent RNA helicase DDX53,42549,97,0.65 [0.37-1.15],0.1384426067861185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DDX58,Antiviral innate immune response receptor RIG-I,49115,114,1.15 [0.89-1.49],0.2808215567543297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",50225,119,1.00 [0.85-1.19],0.95656574939306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFA1_DEFA1B,Neutrophil defensin 1,49275,117,1.11 [0.83-1.48],0.4714468916512331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB103A_DEFB103B,Beta-defensin 103,42157,98,0.97 [0.60-1.56],0.9042405239536347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB104A_DEFB104B,Beta-defensin 104,42326,94,0.89 [0.60-1.31],0.5569526399606395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB116,Beta-defensin 116,42326,94,1.13 [0.90-1.43],0.2896436013444355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB118,Beta-defensin 118,42326,94,1.04 [0.75-1.45],0.8198989640623728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DEFB4A_DEFB4B,Beta-defensin 4A,49576,116,1.03 [0.92-1.15],0.6198967032268161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DENND2B,DENN domain-containing protein 2B,42299,95,0.81 [0.51-1.31],0.3990718644979925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DENR,Density-regulated protein,42481,99,0.95 [0.67-1.34],0.7667020577090856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DFFA,DNA fragmentation factor subunit alpha,50851,119,1.09 [0.86-1.39],0.4567862755104573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGCR6,Protein DGCR6,42326,94,1.14 [0.75-1.73],0.550294016151164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGKA,Diacylglycerol kinase alpha,42481,99,0.97 [0.68-1.39],0.8649928731492083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DGKZ,Diacylglycerol kinase zeta,49349,116,1.40 [0.91-2.16],0.1295494560510966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHODH,Dihydroorotate dehydrogenase,42299,95,0.90 [0.57-1.41],0.6358085132546034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHPS,Deoxyhypusine synthase,43536,100,1.21 [0.80-1.83],0.3735422763517132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,43641,99,1.06 [0.71-1.58],0.7664644400383778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIABLO,"Diablo homolog, mitochondrial",50135,118,0.99 [0.85-1.14],0.844705871694166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIPK1C,Divergent protein kinase domain 1C,42549,97,1.03 [0.65-1.65],0.8895582429593288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DIPK2B,Divergent protein kinase domain 2B,42800,100,1.47 [0.78-2.76],0.2323101349633353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK1,Dickkopf-related protein 1,50746,120,1.05 [0.80-1.38],0.7135274825287927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK3,Dickkopf-related protein 3,50919,116,1.46 [0.85-2.50],0.166137796715811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK4,Dickkopf-related protein 4,49831,118,1.42 [1.04-1.94],0.0271404566627512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKKL1,Dickkopf-like protein 1,50063,116,1.03 [0.85-1.25],0.741023356091721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLG4,Disks large homolog 4,43641,99,0.88 [0.67-1.17],0.3891205032376718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLGAP5,Disks large-associated protein 5,43667,97,0.87 [0.57-1.35],0.5413956226330024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLK1,Protein delta homolog 1,50919,116,0.90 [0.67-1.20],0.4616019858098481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLL1,Delta-like protein 1,50453,117,1.61 [0.96-2.71],0.0697354037167484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLL4,Delta-like protein 4,42584,98,1.06 [0.88-1.27],0.5733763514017787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DMD,Dystrophin,42584,98,0.92 [0.61-1.38],0.6763000008268942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DMP1,Dentin matrix acidic phosphoprotein 1,42584,98,0.98 [0.71-1.35],0.9104653286537424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA1,DnaJ homolog subfamily A member 1,42186,96,1.01 [0.66-1.53],0.9789481325076166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA2,DnaJ homolog subfamily A member 2,50689,119,1.04 [0.85-1.27],0.6939836950670624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJA4,DnaJ homolog subfamily A member 4,43641,99,1.04 [0.80-1.35],0.7813540710120277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB1,DnaJ homolog subfamily B member 1,50063,116,1.06 [0.88-1.28],0.5267242305544395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB14,DnaJ homolog subfamily B member 14,43557,98,1.09 [0.82-1.47],0.545744461724754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB2,DnaJ homolog subfamily B member 2,42800,100,1.02 [0.72-1.45],0.9063711511269166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB6,DnaJ homolog subfamily B member 6,42397,100,1.01 [0.81-1.27],0.915591852264915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB8,DnaJ homolog subfamily B member 8,49383,114,1.23 [0.97-1.57],0.0878689840836303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC21,DnaJ homolog subfamily C member 21,43641,99,0.76 [0.44-1.29],0.3024198826852378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC6,Putative tyrosine-protein phosphatase auxilin,42584,98,0.95 [0.75-1.20],0.6688657848851797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJC9,DnaJ homolog subfamily C member 9,43557,98,1.05 [0.82-1.35],0.7000492028556422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNER,Delta and Notch-like epidermal growth factor-related receptor,50186,120,0.67 [0.36-1.25],0.2074021533221004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNLZ,DNL-type zinc finger protein,42326,94,0.98 [0.77-1.23],0.845942418835343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNM1,Dynamin-1,43557,98,1.04 [0.88-1.23],0.643511669635525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNM3,Dynamin-3,43667,97,0.87 [0.60-1.26],0.4628041506222026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNMBP,Dynamin-binding protein,49913,118,1.00 [0.77-1.31],0.9834987563248994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNPEP,Aspartyl aminopeptidase,43641,99,1.20 [0.85-1.68],0.3039804055132161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,50432,120,1.20 [0.89-1.63],0.2385064485037312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOC2B,Double C2-like domain-containing protein beta,42549,97,0.85 [0.47-1.55],0.5928680163198298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOCK9,Dedicator of cytokinesis protein 9,42326,94,1.05 [0.89-1.23],0.570377326105854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOK1,Docking protein 1,43641,99,1.03 [0.89-1.18],0.731798419078701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DOK2,Docking protein 2,50298,118,0.99 [0.86-1.13],0.8532507582961055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPEP1,Dipeptidase 1,49830,118,0.81 [0.59-1.13],0.2111880629058352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPEP2,Dipeptidase 2,50063,116,0.84 [0.49-1.47],0.5501545472668898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP10,Inactive dipeptidyl peptidase 10,50225,119,0.93 [0.59-1.46],0.7423244947415921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP4,Dipeptidyl peptidase 4,49363,116,1.39 [0.78-2.47],0.26143905380379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP6,Dipeptidyl aminopeptidase-like protein 6,50063,116,0.99 [0.61-1.60],0.9559916785893942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP7,Dipeptidyl peptidase 2,49890,118,1.10 [0.85-1.43],0.4772133129752557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPT,Dermatopontin,50919,116,1.40 [0.73-2.68],0.3091147068724027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPY30,Protein dpy-30 homolog,50571,120,1.35 [1.07-1.70],0.0122299245576298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DRAXIN,Draxin,49913,118,1.05 [0.72-1.54],0.7840008188415755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DRG2,Developmentally-regulated GTP-binding protein 2,50063,116,0.91 [0.68-1.22],0.5348849490854786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSC2,Desmocollin-2,49757,115,1.17 [0.74-1.87],0.5034822925956742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSCAM,Down syndrome cell adhesion molecule,43667,97,1.94 [1.16-3.24],0.0117597374252925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG2,Desmoglein-2,50317,118,0.68 [0.37-1.23],0.2023534403402338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG3,Desmoglein-3,50561,120,0.75 [0.47-1.19],0.2141199345390393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSG4,Desmoglein-4,49902,116,0.91 [0.66-1.26],0.5761324104548664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTD1,D-aminoacyl-tRNA deacylase 1,42800,100,0.96 [0.77-1.20],0.7181273655925388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTNB,Dystrobrevin beta,43455,100,1.17 [0.76-1.80],0.4829980040254613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTX2,Probable E3 ubiquitin-protein ligase DTX2,42549,97,1.03 [0.76-1.41],0.8407626543904337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTX3,Probable E3 ubiquitin-protein ligase DTX3,50063,116,1.51 [0.81-2.84],0.1981617045878319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTYMK,Thymidylate kinase,43744,99,0.98 [0.74-1.30],0.8933012502611208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUOX2,Dual oxidase 2,49383,114,1.18 [0.97-1.43],0.0984141267905259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP13,Dual specificity protein phosphatase 13 isoform A,43536,100,1.28 [0.84-1.95],0.2550209127096962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP29,Dual specificity phosphatase 29,42549,97,1.12 [0.86-1.46],0.3959293902303973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUSP3,Dual specificity protein phosphatase 3,49125,114,1.01 [0.83-1.22],0.9386014151366738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",43557,98,1.07 [0.89-1.29],0.4577449130434391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DXO,Decapping and exoribonuclease protein,43641,99,1.09 [0.72-1.67],0.6724409562318969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,43536,100,0.90 [0.58-1.40],0.6400566567903121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNLT1,Dynein light chain Tctex-type 1,42549,97,0.85 [0.65-1.11],0.2259820735340672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DYNLT3,Dynein light chain Tctex-type 3,43536,100,0.93 [0.60-1.44],0.7461145610866877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,49913,118,1.00 [0.84-1.19],0.9852599643132894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EBI3_IL27,Interleukin-27,50655,120,1.38 [0.83-2.30],0.2136365125737859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECE1,Endothelin-converting enzyme 1,49125,114,0.97 [0.60-1.54],0.8848448485644529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",43744,99,1.43 [1.15-1.77],0.0012460560733347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHS1,"Enoyl-CoA hydratase, mitochondrial",42584,98,1.10 [0.90-1.34],0.3600710455026589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECI2,Enoyl-CoA delta isomerase 2,42299,95,1.07 [0.79-1.46],0.6476625285211051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECM1,Extracellular matrix protein 1,42609,97,0.85 [0.51-1.42],0.541338275617541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECSCR,Endothelial cell-specific chemotaxis regulator,42326,94,0.86 [0.55-1.35],0.5233866056912608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDA2R,Tumor necrosis factor receptor superfamily member 27,50729,120,1.39 [0.92-2.09],0.1130578031114331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDAR,Tumor necrosis factor receptor superfamily member EDAR,50225,119,0.95 [0.79-1.13],0.5690546215197678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDDM3B,Epididymal secretory protein E3-beta,43536,100,1.16 [0.82-1.64],0.3973806559605084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,42299,95,0.94 [0.54-1.65],0.8375062652132538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDF1,Endothelial differentiation-related factor 1,43667,97,0.95 [0.71-1.27],0.7174956312340858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,49383,114,1.35 [0.86-2.11],0.19281889014186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDN1,Endothelin-1,42584,98,1.85 [0.98-3.48],0.0570473806826446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EDNRB,Endothelin receptor type B,42481,99,0.82 [0.49-1.36],0.4341273623084045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EEF1D,Elongation factor 1-delta,43744,99,0.98 [0.80-1.21],0.8666747610472485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFCAB14,EF-hand calcium-binding domain-containing protein 14,43557,98,1.15 [0.61-2.17],0.6571289422319633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFCAB2,Dynein regulatory complex protein 8,42949,99,0.91 [0.52-1.60],0.7534917153185685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,50416,119,1.49 [0.90-2.47],0.1175079210742105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFHD1,EF-hand domain-containing protein D1,43667,97,1.12 [0.66-1.91],0.6684152047127192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNA1,Ephrin-A1,50235,118,1.49 [0.86-2.56],0.1508817743485774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNA4,Ephrin-A4,49831,118,1.47 [0.90-2.40],0.1209978207986769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNB2,Ephrin-B2,42549,97,1.27 [0.98-1.66],0.074865402492638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGF,Pro-epidermal growth factor,50190,120,1.01 [0.87-1.18],0.85615462846566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFL7,Epidermal growth factor-like protein 7,49115,114,1.30 [0.88-1.92],0.1956128183842626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFLAM,Pikachurin,43557,98,1.83 [1.10-3.03],0.0198798145684259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFR,Epidermal growth factor receptor,50919,116,0.53 [0.31-0.90],0.0196850690111186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGLN1,Egl nine homolog 1,50225,119,1.09 [0.83-1.42],0.5425722030413538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EHBP1,EH domain-binding protein 1,43744,99,0.95 [0.74-1.23],0.7101362866383907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EHD3,EH domain-containing protein 3,42584,98,1.00 [0.85-1.18],0.9865806280860868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",43641,99,0.80 [0.53-1.19],0.2713254764207783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",43396,97,1.12 [0.95-1.34],0.1819780983127159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,42299,95,1.00 [0.74-1.35],0.9971800811225872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,42584,98,0.73 [0.44-1.23],0.2408768828394859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4B,Eukaryotic translation initiation factor 4B,49913,118,1.11 [0.83-1.48],0.4697751591283969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4E,Eukaryotic translation initiation factor 4E,42481,99,0.98 [0.79-1.22],0.8631618388179163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,50298,118,1.17 [0.92-1.48],0.207463226574421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,50851,119,1.03 [0.88-1.22],0.6835985194037233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,43667,97,0.91 [0.67-1.23],0.5229891263873263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF5,Eukaryotic translation initiation factor 5,42299,95,0.74 [0.45-1.23],0.2472969250388322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EIF5A,Eukaryotic translation initiation factor 5A-1,49349,116,1.09 [0.65-1.85],0.740317650305333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELAC1,Zinc phosphodiesterase ELAC protein 1,43667,97,0.92 [0.73-1.15],0.4468790531539975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELAVL4,ELAV-like protein 4,42326,94,1.09 [0.87-1.36],0.4353586584884927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELN,Elastin,43744,99,1.66 [0.99-2.81],0.0566265300731098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELOA,Elongin-A,50063,116,1.17 [0.91-1.50],0.2313923836393188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ELOB,Elongin-B,42299,95,0.88 [0.51-1.52],0.6547256115992013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENAH,Protein enabled homolog,49349,116,1.31 [0.95-1.81],0.101743308656207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENDOU,Poly(U)-specific endoribonuclease,40381,90,0.86 [0.58-1.27],0.4461740110299342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENG,Endoglin,50919,116,1.02 [0.39-2.65],0.9666445370420068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO1,Alpha-enolase,50248,117,1.04 [0.84-1.28],0.7159383693877063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO2,Gamma-enolase,50746,120,0.97 [0.76-1.24],0.7888517199234863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENO3,Beta-enolase,42584,98,1.22 [0.90-1.64],0.206139549381692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENOPH1,Enolase-phosphatase E1,43536,100,0.86 [0.57-1.31],0.4862975644070605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,42299,95,0.97 [0.47-2.00],0.9370622570825776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPEP,Glutamyl aminopeptidase,42299,95,1.08 [0.71-1.63],0.7262532360670648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,50919,116,1.06 [0.57-1.95],0.8615678753515431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,50517,120,0.99 [0.68-1.45],0.965009331980662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,42584,98,0.71 [0.42-1.20],0.1967791733712956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,48742,115,1.11 [0.91-1.35],0.3046520749521667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENSA,Alpha-endosulfine,43536,100,1.17 [0.84-1.63],0.3406444340970038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,49115,114,1.29 [0.88-1.88],0.1923275281095437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,49383,114,0.69 [0.33-1.44],0.319492159417901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,49383,114,1.11 [0.59-2.08],0.7420499484332838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ENTR1,Endosome-associated-trafficking regulator 1,42584,98,1.05 [0.76-1.46],0.7630139837976748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EP300,Histone acetyltransferase p300,42481,99,1.05 [0.57-1.91],0.8831197381736752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPB41L5,Band 4.1-like protein 5,42549,97,0.85 [0.60-1.20],0.3506845832456743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPCAM,Epithelial cell adhesion molecule,50269,120,1.01 [0.86-1.19],0.9084664348895044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPGN,Epigen,43536,100,1.20 [0.86-1.68],0.2848821538230667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA1,Ephrin type-A receptor 1,50432,120,0.97 [0.60-1.57],0.8951673548486252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA10,Ephrin type-A receptor 10,49125,114,0.90 [0.68-1.19],0.4656108152742046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA2,Ephrin type-A receptor 2,48473,114,1.11 [0.66-1.89],0.6887639544570742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA4,Ephrin type-A receptor 4,42800,100,0.85 [0.44-1.65],0.6408626399581725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHB4,Ephrin type-B receptor 4,50919,116,1.74 [0.95-3.18],0.0738601005722496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHB6,Ephrin type-B receptor 6,49830,118,0.91 [0.55-1.52],0.723250388632784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHX2,Bifunctional epoxide hydrolase 2,49383,114,1.08 [0.84-1.39],0.5561319337042637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPN1,Epsin-1,42949,99,0.98 [0.62-1.55],0.93064795960609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPO,Erythropoietin,50225,119,1.23 [1.03-1.48],0.0258657230038964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPPK1,Epiplakin,42584,98,0.96 [0.74-1.24],0.7365604043696076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,50645,120,1.23 [0.73-2.06],0.4364234481224346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB2,Receptor tyrosine-protein kinase erbB-2,50453,117,1.46 [0.74-2.87],0.2715862379633804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB3,Receptor tyrosine-protein kinase erbB-3,50103,120,0.73 [0.32-1.69],0.4661633827290129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBB4,Receptor tyrosine-protein kinase erbB-4,50453,117,0.81 [0.41-1.59],0.5422113803446673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERBIN,Erbin,50063,116,1.02 [0.87-1.20],0.8162757577476578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERC2,ERC protein 2,42549,97,1.09 [0.86-1.38],0.4957076409898528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERCC1,DNA excision repair protein ERCC-1,42186,96,1.00 [0.55-1.82],0.9942756595603351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EREG,Proepiregulin,49830,118,1.06 [0.87-1.29],0.5761168991604562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERI1,3'-5' exoribonuclease 1,42949,99,0.70 [0.38-1.28],0.2429708257505202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERMAP,Erythroid membrane-associated protein,42481,99,1.50 [1.00-2.26],0.0522912774719597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,43536,100,0.86 [0.51-1.45],0.5765020797762905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERP29,Endoplasmic reticulum resident protein 29,42800,100,1.00 [0.85-1.17],0.9795612651288398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERP44,Endoplasmic reticulum resident protein 44,49980,115,1.31 [0.70-2.47],0.3962393365167465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,42299,95,0.97 [0.62-1.53],0.9007941669609224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESAM,Endothelial cell-selective adhesion molecule,50919,116,1.37 [0.84-2.24],0.2105004522762252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESM1,Endothelial cell-specific molecule 1,50268,120,1.66 [1.05-2.62],0.0286794184477417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESPL1,Separin,42186,96,1.01 [0.71-1.43],0.9645786000355332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESR1,Estrogen receptor,42481,99,0.76 [0.50-1.17],0.2129262883596374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESYT2,Extended synaptotagmin-2,43641,99,0.95 [0.75-1.20],0.666153192023009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVI2B,Protein EVI2B,42186,96,1.01 [0.62-1.64],0.9813935965632904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVI5,Ecotropic viral integration site 5 protein homolog,42481,99,1.07 [0.86-1.32],0.5461188624092458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EVPL,Envoplakin,42949,99,0.96 [0.53-1.73],0.8986226242463947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EXOSC10,Exosome component 10,42299,95,0.84 [0.56-1.24],0.3745941316100523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EXTL1,Exostosin-like 1,42299,95,1.10 [0.75-1.61],0.6326297083003496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EZR,Ezrin,50746,120,1.18 [0.62-2.26],0.6062281315626992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F10,Coagulation factor X,43781,100,0.61 [0.31-1.19],0.1467338926256259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F11,Coagulation factor XI,43174,99,0.96 [0.51-1.80],0.8912579493374786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F11R,Junctional adhesion molecule A,50317,118,1.15 [0.87-1.53],0.3220352104114916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F12,Coagulation factor XII,43812,101,0.79 [0.51-1.21],0.2809736706219004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F13B,Coagulation factor XIII B chain,43570,101,0.77 [0.37-1.60],0.4754069103089673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F2,Prothrombin,43812,101,0.61 [0.17-2.14],0.4363328200271621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F2R,Proteinase-activated receptor 1,50436,120,1.14 [0.86-1.51],0.3648034930613867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F3,Tissue factor,50420,119,0.71 [0.39-1.30],0.2696715461883437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F7,Coagulation factor VII,50415,119,0.83 [0.49-1.40],0.4826850770109415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F9,Coagulation factor IX,50417,119,1.38 [0.57-3.34],0.4806559452107012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP1,"Fatty acid-binding protein, liver",50268,120,1.15 [0.98-1.36],0.0840672718279024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP2,"Fatty acid-binding protein, intestinal",50298,118,1.08 [0.88-1.32],0.4633687292629697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP3,"Fatty acid-binding protein, heart",43744,99,1.24 [0.88-1.75],0.2206652720704174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP4,"Fatty acid-binding protein, adipocyte",50919,116,1.34 [0.98-1.82],0.068156410594864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP5,Fatty acid-binding protein 5,50581,120,1.05 [0.83-1.32],0.7049584457921702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP6,Gastrotropin,49307,113,1.12 [0.85-1.48],0.4279726865612995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP9,Fatty acid-binding protein 9,50225,119,0.94 [0.71-1.26],0.6951095062036003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FADD,FAS-associated death domain protein,50298,118,0.99 [0.80-1.23],0.9350003132581796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM13A,Protein FAM13A,43557,98,1.02 [0.77-1.36],0.8907676601706058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM171A2,Protein FAM171A2,43667,97,0.95 [0.83-1.08],0.4320826284179565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM171B,Protein FAM171B,43536,100,0.51 [0.22-1.21],0.1250550828115362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM172A,Cotranscriptional regulator FAM172A,42584,98,0.89 [0.65-1.23],0.4946070297845518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM20A,Pseudokinase FAM20A,43744,99,1.76 [0.95-3.26],0.0702826418439206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3B,Protein FAM3B,50063,116,1.12 [0.71-1.76],0.6190921281912858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3C,Protein FAM3C,50223,118,1.11 [0.65-1.90],0.6982867155023349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3D,Protein FAM3D,43557,98,1.13 [0.90-1.41],0.3016922016923057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAP,Prolyl endopeptidase FAP,50919,116,1.05 [0.58-1.91],0.8724508354166775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FARSA,Phenylalanine--tRNA ligase alpha subunit,42549,97,0.87 [0.65-1.18],0.3818961670917705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAS,Tumor necrosis factor receptor superfamily member 6,50754,116,1.31 [0.88-1.93],0.1829763916524544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FASLG,Tumor necrosis factor ligand superfamily member 6,50851,119,1.07 [0.69-1.65],0.7703184240371239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBLN2,Fibulin-2,43751,100,1.70 [0.97-2.97],0.0633396963355195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBN2,Fibrillin-2,42549,97,0.91 [0.66-1.27],0.5821573724546663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FBP1,"Fructose-1,6-bisphosphatase 1",50298,118,1.07 [0.86-1.33],0.5378072359641907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,43744,99,1.26 [0.98-1.63],0.072721937786368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCAR,Immunoglobulin alpha Fc receptor,50225,119,1.20 [0.86-1.66],0.2816713867349717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,43667,97,0.85 [0.38-1.91],0.6981693522274168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCER2,Low affinity immunoglobulin epsilon Fc receptor,50317,118,0.74 [0.53-1.03],0.0703902788536841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,50088,119,1.18 [0.87-1.60],0.2811275210049347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,49115,114,1.16 [0.89-1.52],0.2703213504622372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,50336,119,1.07 [0.77-1.49],0.6810338410243351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCN1,Ficolin-1,43696,100,1.35 [0.93-1.95],0.1152017320674973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCN2,Ficolin-2,50095,119,1.15 [0.77-1.71],0.5078306187348347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL1,Fc receptor-like protein 1,50298,118,1.05 [0.74-1.50],0.7887710274727091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL2,Fc receptor-like protein 2,50611,117,1.42 [1.08-1.88],0.0131548469876439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL3,Fc receptor-like protein 3,49349,116,1.21 [0.90-1.62],0.2028646125645679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL5,Fc receptor-like protein 5,50317,118,1.10 [0.84-1.45],0.4962196803779315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL6,Fc receptor-like protein 6,50225,119,1.01 [0.80-1.27],0.957407429488274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRLB,Fc receptor-like B,49115,114,1.22 [0.97-1.52],0.084201430044158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FDX1,"Adrenodoxin, mitochondrial",42299,95,1.04 [0.76-1.42],0.8099660041921295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FDX2,"Ferredoxin-2, mitochondrial",42299,95,0.92 [0.64-1.33],0.6588801177712638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FEN1,Flap endonuclease 1,49115,114,1.09 [0.87-1.36],0.4396260390750913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FES,Tyrosine-protein kinase Fes/Fps,49115,114,1.01 [0.72-1.44],0.9373624196059804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FETUB,Fetuin-B,50417,119,1.46 [0.86-2.46],0.1578873482495509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGA,Fibrinogen alpha chain,42776,100,1.28 [0.70-2.37],0.4241464656068677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",43667,97,1.00 [0.78-1.27],0.9838480860292674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF12,Fibroblast growth factor 12,42481,99,0.66 [0.35-1.23],0.187529599791782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF16,Fibroblast growth factor 16,42481,99,1.10 [0.75-1.63],0.6221468300916808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF19,Fibroblast growth factor 19,50517,120,1.06 [0.86-1.30],0.6036634054561327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF2,Fibroblast growth factor 2,50225,119,0.97 [0.76-1.23],0.7892946088128838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF20,Fibroblast growth factor 20,42481,99,0.70 [0.40-1.21],0.205007974976808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF21,Fibroblast growth factor 21,50655,120,1.12 [0.98-1.27],0.0931904031313638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF23,Fibroblast growth factor 23,50646,120,1.50 [1.22-1.85],0.0001046864636503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF3,Fibroblast growth factor 3,42481,99,0.92 [0.47-1.80],0.8176029974305958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF5,Fibroblast growth factor 5,49349,116,1.06 [0.65-1.73],0.8111162901673425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF6,Fibroblast growth factor 6,42481,99,0.86 [0.51-1.46],0.5857545907593876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF7,Fibroblast growth factor 7,42186,96,1.19 [0.98-1.44],0.0787041630928354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF9,Fibroblast growth factor 9,42110,96,1.12 [0.69-1.80],0.6538222428411733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP1,Fibroblast growth factor-binding protein 1,50453,117,0.53 [0.33-0.84],0.0077737538102126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP2,Fibroblast growth factor-binding protein 2,43751,100,0.84 [0.57-1.22],0.3567740362914608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP3,Fibroblast growth factor-binding protein 3,43641,99,1.34 [0.80-2.24],0.2643197176298654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR2,Fibroblast growth factor receptor 2,50453,117,2.25 [1.12-4.50],0.0219746588672996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR4,Fibroblast growth factor receptor 4,42800,100,0.84 [0.59-1.21],0.3565984110782619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGL1,Fibrinogen-like protein 1,43781,100,1.56 [1.18-2.07],0.0016702183704518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGR,Tyrosine-protein kinase Fgr,49125,114,1.09 [0.85-1.40],0.4992429705902769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FH,"Fumarate hydratase, mitochondrial",42326,94,0.99 [0.77-1.26],0.913516945090288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FHIP2A,FHF complex subunit HOOK interacting protein 2A,42299,95,0.64 [0.40-1.03],0.0689056009074913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FHIT,Bis(5'-adenosyl)-triphosphatase,49125,114,1.00 [0.80-1.26],0.9687157615964066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FIS1,Mitochondrial fission 1 protein,50268,120,1.03 [0.84-1.27],0.778386424704034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,43667,97,0.97 [0.80-1.18],0.7821297551502132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,50452,116,1.01 [0.87-1.17],0.8890501984831896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,49913,118,1.05 [0.72-1.52],0.8150716650112647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,49913,118,1.05 [0.88-1.25],0.5797097975441547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,49042,114,0.76 [0.51-1.14],0.189055634505009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FKBPL,FK506-binding protein-like,43557,98,0.98 [0.70-1.36],0.8823267906577862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLI1,Friend leukemia integration 1 transcription factor,49115,114,1.01 [0.87-1.18],0.8641549649782528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,49913,118,2.26 [1.36-3.75],0.0016347526564251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT1,Vascular endothelial growth factor receptor 1,49981,115,1.40 [0.75-2.64],0.2920093286540339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT3,Receptor-type tyrosine-protein kinase FLT3,49115,114,0.74 [0.42-1.31],0.3041607055917799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT3LG,Fms-related tyrosine kinase 3 ligand,50851,119,1.20 [0.75-1.92],0.4475790250416444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLT4,Vascular endothelial growth factor receptor 3,50453,117,1.02 [0.63-1.66],0.9323686349286614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FMNL1,Formin-like protein 1,49125,114,1.11 [0.89-1.39],0.3447323431193939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FMR1,Synaptic functional regulator FMR1,49115,114,0.69 [0.43-1.12],0.1317757545050499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FN1,Fibronectin,43812,101,0.55 [0.27-1.11],0.0959997443692119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FNDC1,Fibronectin type III domain-containing protein 1,43641,99,1.17 [0.77-1.76],0.4639118841714729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,43536,100,0.90 [0.51-1.58],0.7064614466387047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLH1,Glutamate carboxypeptidase 2,42481,99,0.88 [0.69-1.12],0.2879872271971579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR1,Folate receptor alpha,50223,117,1.11 [0.64-1.94],0.7139421812412885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR2,Folate receptor beta,50746,120,1.21 [0.70-2.08],0.4910145634334389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOLR3,Folate receptor gamma,50291,117,0.96 [0.88-1.05],0.3993675422972562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOS,Proto-oncogene c-Fos,42110,96,0.87 [0.50-1.51],0.6179470744383948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOSB,Protein fosB,49125,114,0.77 [0.47-1.26],0.2926742710368221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXJ3,Forkhead box protein J3,42481,99,0.78 [0.49-1.25],0.3022188834569734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXO1,Forkhead box protein O1,50225,119,1.09 [0.91-1.32],0.3487120079394953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FOXO3,Forkhead box protein O3,49115,114,0.89 [0.74-1.07],0.2210295546468662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRMD4B,FERM domain-containing protein 4B,42299,95,0.97 [0.73-1.29],0.8464032960131821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRMD7,FERM domain-containing protein 7,42549,97,0.75 [0.42-1.33],0.3256433277497009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FRZB,Secreted frizzled-related protein 3,49750,118,0.88 [0.48-1.63],0.6924499574299527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSHB,Follitropin subunit beta,42584,98,1.30 [0.93-1.80],0.1195967981498747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FST,Follistatin,50436,120,1.32 [0.97-1.80],0.0776739497045061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSTL1,Follistatin-related protein 1,42584,98,1.60 [0.70-3.68],0.2673719608525708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSTL3,Follistatin-related protein 3,50191,119,1.09 [0.66-1.80],0.7481398819477921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FTCD,Formimidoyltransferase-cyclodeaminase,43560,99,1.26 [1.02-1.56],0.0314738973272164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUCA1,Tissue alpha-L-fucosidase,50605,115,1.15 [0.93-1.42],0.2076668097485154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUOM,Fucose mutarotase,42800,100,1.64 [1.24-2.15],0.0004400704042158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FURIN,Furin,50453,117,1.35 [0.83-2.21],0.2264177251686303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUS,RNA-binding protein FUS,49033,114,1.32 [0.90-1.93],0.1571544912624968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",42868,98,0.99 [0.73-1.35],0.9695998617294144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,50746,120,0.92 [0.66-1.30],0.6428679037544623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUT8,"Alpha-(1,6)-fucosyltransferase",49913,118,1.09 [0.83-1.44],0.5201940067906117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FXN,"Frataxin, mitochondrial",50729,120,1.07 [0.86-1.34],0.5148130043120484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FXYD5,FXYD domain-containing ion transport regulator 5,49349,116,0.94 [0.72-1.22],0.634863907615399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FYB1,FYN-binding protein 1,50233,118,1.03 [0.86-1.22],0.7780309727891365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FZD10,Frizzled-10,42549,97,0.98 [0.69-1.38],0.8957714446385865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FZD8,Frizzled-8,42326,94,1.44 [1.03-2.00],0.0317547046754312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABARAP,Gamma-aminobutyric acid receptor-associated protein,43536,100,1.22 [0.86-1.71],0.2604786171414731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,42949,99,0.95 [0.70-1.30],0.7663543477638861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,42326,94,0.76 [0.52-1.11],0.1594982754224865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAD1,Glutamate decarboxylase 1,42186,96,0.98 [0.46-2.08],0.9603715852936532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAD2,Glutamate decarboxylase 2,42481,99,0.93 [0.60-1.45],0.7556467312176345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,42949,99,0.94 [0.61-1.44],0.7642666878723148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,42584,98,0.78 [0.53-1.15],0.2100418996700934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAGE2A,G antigen 2A,42186,96,1.12 [0.85-1.46],0.4232960390048418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAL,Galanin peptides,50517,120,0.87 [0.68-1.11],0.2679679906215761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,50063,116,1.89 [1.07-3.33],0.0287324308861681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,50729,120,1.31 [0.72-2.40],0.3770757246443466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,49349,116,1.26 [0.86-1.83],0.2317404931133086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,43744,99,0.59 [0.30-1.18],0.1394827841754185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT7,N-acetylgalactosaminyltransferase 7,50063,116,1.14 [0.52-2.50],0.7489207466597956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAMT,Guanidinoacetate N-methyltransferase,42299,95,0.89 [0.49-1.60],0.6955820780632593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,41864,98,1.50 [0.78-2.90],0.2257060933453765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GART,Trifunctional purine biosynthetic protein adenosine-3,43667,97,0.79 [0.36-1.76],0.5704621276025152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAS2,Growth arrest-specific protein 2,42949,99,1.16 [0.84-1.60],0.3678343710315398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAS6,Growth arrest-specific protein 6,50590,116,1.09 [0.57-2.09],0.7904514999802718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GASK1A,Golgi-associated kinase 1A,42299,95,1.02 [0.64-1.62],0.9241951618655118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAST,Gastrin,43641,99,1.19 [1.06-1.35],0.0039930604302846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,42186,96,1.44 [0.71-2.94],0.3101248631629834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",42584,98,1.00 [0.77-1.28],0.9760088218207515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBA,Lysosomal acid glucosylceramidase,42549,97,1.13 [0.80-1.61],0.479439143291774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP1,Guanylate-binding protein 1,43562,99,1.40 [1.07-1.84],0.013674745228596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP2,Guanylate-binding protein 2,49349,116,1.09 [0.83-1.43],0.5334713532304758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP4,Guanylate-binding protein 4,49125,114,1.22 [0.88-1.68],0.2342915498974989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP6,Guanylate-binding protein 6,42299,95,0.82 [0.49-1.36],0.4363845770957451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GC,Vitamin D-binding protein,43812,101,0.62 [0.29-1.31],0.2086011933937119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCC1,GRIP and coiled-coil domain-containing protein 1,43641,99,1.00 [0.84-1.20],0.9792526215314328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCG,Pro-glucagon,49115,114,1.12 [0.98-1.27],0.0998374134540637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,41749,99,1.23 [0.87-1.75],0.247413905588005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCLM,Glutamate--cysteine ligase regulatory subunit,42299,95,0.77 [0.47-1.26],0.3011548776390795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",50063,116,0.89 [0.55-1.44],0.6437626333451328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF15,Growth/differentiation factor 15,50919,116,1.84 [1.41-2.39],5.248787802398368e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF2,Growth/differentiation factor 2,50298,118,0.72 [0.46-1.14],0.1648500188582721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDNF,Glial cell line-derived neurotrophic factor,49125,114,1.46 [0.98-2.18],0.0597789186166253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GET3,ATPase GET3,43744,99,0.79 [0.53-1.17],0.2402972741723875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFAP,Glial fibrillary acidic protein,49034,113,1.37 [0.98-1.92],0.0676572041759753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFER,FAD-linked sulfhydryl oxidase ALR,49115,114,1.10 [0.85-1.42],0.488264841715628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,49115,114,0.99 [0.87-1.14],0.939993181482259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA1,GDNF family receptor alpha-1,50655,120,1.21 [0.69-2.10],0.5117432848884806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA2,GDNF family receptor alpha-2,50063,116,1.17 [0.54-2.54],0.6964487784488221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRA3,GDNF family receptor alpha-3,49756,117,1.31 [0.74-2.33],0.3595263242215919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFRAL,GDNF family receptor alpha-like,42347,96,1.01 [0.74-1.38],0.9609902733273128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGA1,ADP-ribosylation factor-binding protein GGA1,49125,114,0.99 [0.77-1.28],0.940364488943238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGACT,Gamma-glutamylaminecyclotransferase,43744,99,1.10 [0.84-1.43],0.498607567303081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGCT,Gamma-glutamylcyclotransferase,43664,99,0.85 [0.56-1.28],0.4317460506341144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGH,Gamma-glutamyl hydrolase,49450,116,1.28 [0.80-2.03],0.3001347794898981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT1,Glutathione hydrolase 1 proenzyme,50235,118,1.65 [1.26-2.17],0.0002816761920754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT5,Glutathione hydrolase 5 proenzyme,49913,118,1.14 [0.57-2.31],0.7083805551299522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GH1,Somatotropin,50223,118,1.03 [0.94-1.13],0.5090068971435089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GH2,Growth hormone variant,49115,114,1.09 [1.00-1.19],0.0487743899850555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHR,Growth hormone receptor,42800,100,1.00 [0.51-1.95],0.9943760017870966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHRHR,Growth hormone-releasing hormone receptor,49125,114,0.83 [0.58-1.18],0.2941512146397284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GHRL,Appetite-regulating hormone,50298,118,1.02 [0.84-1.24],0.8125735338692478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GID8,Glucose-induced degradation protein 8 homolog,43667,97,0.87 [0.46-1.65],0.6666042463649592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIGYF2,GRB10-interacting GYF protein 2,43667,97,0.85 [0.65-1.11],0.2250952762128207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP7,GTPase IMAP family member 7,42800,100,1.22 [0.71-2.08],0.4709791938966314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP8,GTPase IMAP family member 8,42186,96,1.56 [1.20-2.02],0.0008117246238132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIP,Gastric inhibitory polypeptide,42584,98,1.16 [0.83-1.63],0.3762252719273219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPC2,PDZ domain-containing protein GIPC2,43641,99,1.70 [0.97-2.98],0.0628392731986377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPC3,PDZ domain-containing protein GIPC3,43557,98,1.00 [0.82-1.21],0.973026716079442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPR,Gastric inhibitory polypeptide receptor,42481,99,0.95 [0.62-1.47],0.8260585325401284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIT1,ARF GTPase-activating protein GIT1,42481,99,1.00 [0.82-1.23],0.9769652920247222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GJA8,Gap junction alpha-8 protein,42186,96,0.96 [0.69-1.34],0.8105659463455065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GKN1,Gastrokine-1,48185,109,0.83 [0.45-1.53],0.5459761874636955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLA,Alpha-galactosidase A,42720,100,1.29 [0.78-2.14],0.328807627699117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLB1,Beta-galactosidase,49913,118,1.06 [0.72-1.56],0.7760349559376825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLI2,Zinc finger protein GLI2,42481,99,0.88 [0.47-1.67],0.6986595040253035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLO1,Lactoylglutathione lyase,49383,114,1.24 [0.94-1.63],0.1299620095498698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLOD4,Glyoxalase domain-containing protein 4,50187,120,1.13 [0.71-1.78],0.6032263288425166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLP1R,Glucagon-like peptide 1 receptor,42326,94,0.91 [0.52-1.58],0.7379158270020645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLRX,Glutaredoxin-1,49976,117,1.11 [0.84-1.46],0.4713912098387121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",42800,100,1.07 [0.87-1.33],0.5126897564111665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,49125,114,1.11 [0.81-1.52],0.5161186525808656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GLYR1,Putative oxidoreductase GLYR1,43536,100,1.16 [0.86-1.55],0.3257717952514697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GM2A,Ganglioside GM2 activator,42687,98,1.22 [0.78-1.90],0.3790420860170995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMFG,Glia maturation factor gamma,43744,99,0.96 [0.74-1.26],0.790161121641135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMPR,GMP reductase 1,50851,119,1.16 [0.83-1.61],0.3808445306938006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GMPR2,GMP reductase 2,42800,100,1.05 [0.78-1.39],0.7602336699964942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNAS,Neuroendocrine secretory protein 55,43667,97,1.20 [0.98-1.45],0.0713441816749267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,49115,114,1.04 [0.81-1.34],0.7630083249643475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,42549,97,0.94 [0.63-1.42],0.7782812863277605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNLY,Granulysin,50317,118,1.26 [0.93-1.70],0.1306684133598429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNPDA1,Glucosamine-6-phosphate isomerase 1,42584,98,1.22 [0.76-1.96],0.4041803911726138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNPDA2,Glucosamine-6-phosphate isomerase 2,42800,100,0.82 [0.48-1.39],0.4658442953403009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOLGA3,Golgin subfamily A member 3,43667,97,0.94 [0.73-1.22],0.6555577626524729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOLM2,Protein GOLM2,50746,120,1.36 [0.74-2.49],0.3274148599930635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,50225,119,1.03 [0.88-1.21],0.6836192402032251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GORASP2,Golgi reassembly-stacking protein 2,43557,98,0.88 [0.58-1.33],0.5343296976233076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GOT1,"Aspartate aminotransferase, cytoplasmic",43751,100,1.33 [0.87-2.02],0.1885283196714981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP1BA,Platelet glycoprotein Ib alpha chain,50090,119,1.04 [0.64-1.69],0.8878864182313142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP1BB,Platelet glycoprotein Ib beta chain,42299,95,1.01 [0.75-1.34],0.969551725308736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,48754,114,0.99 [0.81-1.21],0.9404294250701168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP5,Platelet glycoprotein V,42800,100,1.13 [0.67-1.92],0.6481637416209916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GP6,Platelet glycoprotein VI,50233,118,1.04 [0.87-1.25],0.663841370780624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPA33,Cell surface A33 antigen,50063,116,1.01 [0.89-1.13],0.925258727869014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPC1,Glypican-1,50729,120,1.05 [0.61-1.81],0.8550948437584087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPC5,Glypican-5,49913,118,0.89 [0.66-1.19],0.4286921612016028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPD1,Glycerol-3-phosphate dehydrogenase,43536,100,1.55 [1.13-2.14],0.0068895304072146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPHA2,Glycoprotein hormone alpha-2,43557,98,0.85 [0.53-1.37],0.498965949579042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPI,Glucose-6-phosphate isomerase,43781,100,1.10 [0.74-1.63],0.6454581547549045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,43557,98,0.89 [0.69-1.14],0.3611315459539602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPKOW,G-patch domain and KOW motifs-containing protein,49125,114,1.08 [0.63-1.84],0.7899704633686686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPNMB,Transmembrane glycoprotein NMB,48929,117,1.74 [0.99-3.06],0.0552116469127775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR101,Probable G-protein coupled receptor 101,42326,94,1.22 [0.93-1.59],0.148739029920626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR158,Probable G-protein coupled receptor 158,43667,97,0.80 [0.44-1.45],0.4558478887312857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR15L,Protein GPR15L,43557,98,1.16 [0.86-1.57],0.338606777826119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR37,Prosaposin receptor GPR37,49383,114,1.28 [0.99-1.64],0.0557160818235681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPRC5C,G-protein coupled receptor family C group 5 member C,43536,100,1.62 [1.30-2.02],2.1325309043914185e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRAP2,GRB2-related adapter protein 2,50298,118,1.03 [0.91-1.17],0.6367430963719483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,43744,99,0.91 [0.67-1.24],0.5562586833823834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRIK2,"Glutamate receptor ionotropic, kainate 2",43667,97,0.82 [0.50-1.35],0.4441658113978688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",42326,94,1.10 [0.80-1.52],0.5648643553236368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRK5,G protein-coupled receptor kinase 5,49383,114,0.88 [0.62-1.25],0.4770084501362739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRN,Progranulin,50072,117,1.86 [0.99-3.49],0.0541015626981131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRP,Gastrin-releasing peptide,42584,98,1.17 [0.82-1.66],0.396543999938033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRPEL1,"GrpE protein homolog 1, mitochondrial",50063,116,1.54 [1.23-1.93],0.0001814610745785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRSF1,G-rich sequence factor 1,41955,96,0.87 [0.68-1.13],0.2957689287936427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSAP,Gamma-secretase-activating protein,49115,114,0.92 [0.74-1.14],0.4457291251611647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSN,Gelsolin,43617,99,0.74 [0.29-1.93],0.5408345408073287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSR,"Glutathione reductase, mitochondrial",43530,99,2.49 [1.12-5.52],0.0250959417017575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTA1,Glutathione S-transferase A1,50221,118,1.14 [0.95-1.38],0.163497164740642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTA3,Glutathione S-transferase A3,49115,114,1.06 [0.85-1.31],0.6024113948154048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTM4,Glutathione S-transferase Mu 4,42299,95,1.02 [0.79-1.33],0.8678540536210685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTP1,Glutathione S-transferase P,48811,112,0.76 [0.58-0.99],0.0425022220411453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTT2B,Glutathione S-transferase theta-2B,43641,99,1.01 [0.93-1.10],0.7732648749816402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,42949,99,1.19 [0.96-1.48],0.1087495460462165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GTPBP2,GTP-binding protein 2,42549,97,1.01 [0.79-1.28],0.9523295057508282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUCA2A,Guanylin,50071,117,1.21 [0.76-1.94],0.4194095259687391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUCY2C,Heat-stable enterotoxin receptor,42949,99,1.02 [0.81-1.30],0.836464975787288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUK1,Guanylate kinase,42299,95,1.04 [0.63-1.72],0.8843150896825758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GUSB,Beta-glucuronidase,50521,115,1.23 [0.95-1.60],0.1176030381907004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GYS1,"Glycogen [starch] synthase, muscle",49383,114,1.01 [0.84-1.20],0.9534959357689086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMA,Granzyme A,50851,119,1.65 [1.08-2.53],0.0197781277062365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMB,Granzyme B,50225,119,1.13 [0.90-1.40],0.2967490117594334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMH,Granzyme H,49383,114,1.15 [0.96-1.38],0.1268618896015644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,H2AP,Huntingtin-interacting protein M,42186,96,0.85 [0.54-1.35],0.5026125640927127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",42299,95,1.12 [0.87-1.44],0.3922826479081328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",50582,119,1.14 [0.92-1.42],0.2218682987454896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAO1,Hydroxyacid oxidase 1,50729,120,1.20 [1.06-1.35],0.0029223382404397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HARS1,"Histidine--tRNA ligase, cytoplasmic",50317,118,1.05 [0.85-1.29],0.6761209577887488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAVCR1,Hepatitis A virus cellular receptor 1,50656,119,1.12 [0.87-1.44],0.3619518638548588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAVCR2,Hepatitis A virus cellular receptor 2,50317,118,1.42 [0.91-2.20],0.1230835936154301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBEGF,Proheparin-binding EGF-like growth factor,50582,119,0.98 [0.79-1.22],0.8836611289460821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBQ1,Hemoglobin subunit theta-1,50729,120,1.06 [0.82-1.36],0.6547706298323386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HBZ,Hemoglobin subunit zeta,43744,99,1.01 [0.85-1.20],0.9130894740584028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HCG22,Protein PBMUCL2,42299,95,0.84 [0.54-1.30],0.4273656901238659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HCLS1,Hematopoietic lineage cell-specific protein,50851,119,1.08 [0.81-1.45],0.5849678082080806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDAC8,Histone deacetylase 8,42481,99,0.70 [0.44-1.09],0.1119981713791088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDAC9,Histone deacetylase 9,42326,94,0.76 [0.51-1.12],0.1646326071061924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDDC2,5'-deoxynucleotidase HDDC2,43557,98,1.00 [0.65-1.54],0.9988018958747368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDGF,Hepatoma-derived growth factor,50655,120,1.02 [0.86-1.21],0.8378891101310515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HDGFL2,Hepatoma-derived growth factor-related protein 2,43641,99,0.96 [0.71-1.31],0.8045318383539645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEBP1,Heme-binding protein 1,49383,114,1.02 [0.75-1.39],0.8849645269112679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEG1,Protein HEG homolog 1,42800,100,3.20 [1.62-6.30],0.0007772033770708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEPACAM2,HEPACAM family member 2,43641,99,0.86 [0.55-1.36],0.5245131008838207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEPH,Hephaestin,43744,99,1.22 [0.59-2.55],0.5889183918734597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEXIM1,Protein HEXIM1,50225,119,1.04 [0.85-1.27],0.6841671509163518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGF,Hepatocyte growth factor,50851,119,1.30 [0.83-2.04],0.2558371433391417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGFAC,Hepatocyte growth factor activator,43369,99,1.05 [0.52-2.10],0.8975993218118562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,49115,114,1.07 [0.87-1.33],0.5041070272159165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HHEX,Hematopoietically-expressed homeobox protein HHEX,43641,99,1.00 [0.78-1.28],0.9782567840533553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIF1A,Hypoxia-inducible factor 1-alpha,42481,99,0.80 [0.55-1.16],0.2379568722600165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIP1,Huntingtin-interacting protein 1,42299,95,0.71 [0.36-1.40],0.3214018109342151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIP1R,Huntingtin-interacting protein 1-related protein,43559,99,1.44 [1.09-1.90],0.0097631049991589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HJV,Hemojuvelin,43667,97,1.44 [1.02-2.02],0.0372775691513378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HK2,Hexokinase-2,49383,114,0.76 [0.41-1.39],0.3692537420119416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",43667,97,1.05 [0.58-1.89],0.8771122073600565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",50069,117,1.91 [1.29-2.83],0.0012860152831128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",50225,119,1.60 [0.96-2.68],0.0735799146127567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMBS,Porphobilinogen deaminase,50729,120,1.09 [0.75-1.58],0.6540109281787392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMCN2,Hemicentin-2,42721,99,1.16 [0.83-1.63],0.3878271464055507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",42584,98,0.87 [0.58-1.32],0.5204570629763088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",42299,95,1.08 [0.71-1.66],0.7147264396411246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMMR,Hyaluronan mediated motility receptor,42106,96,0.98 [0.65-1.48],0.9137278716141438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMOX1,Heme oxygenase 1,49730,116,1.11 [0.80-1.55],0.5300071604928193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HMOX2,Heme oxygenase 2,49125,114,1.29 [0.94-1.76],0.1117777633697319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNF1A,Hepatocyte nuclear factor 1-alpha,42549,97,0.92 [0.67-1.24],0.5717671600319617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNMT,Histamine N-methyltransferase,49678,118,1.31 [0.93-1.84],0.1245486342536151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,49227,114,1.01 [0.81-1.25],0.9466442834879464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,43667,97,0.87 [0.58-1.33],0.5280605658657933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPCAL1,Hippocalcin-like protein 1,50851,119,1.11 [0.89-1.39],0.3416822941212742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPGDS,Hematopoietic prostaglandin D synthase,49115,114,0.85 [0.54-1.33],0.4685191977508884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HPSE,Heparanase,43174,100,1.05 [0.85-1.28],0.6566063292917546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRAS,GTPase Hras,42868,98,1.08 [0.91-1.29],0.3898695011771572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,42584,98,1.21 [0.74-1.99],0.4513181861481135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HRG,Histidine-rich glycoprotein,43570,101,0.76 [0.46-1.24],0.2709267851000406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS1BP3,HCLS1-binding protein 3,42584,98,1.03 [0.83-1.28],0.8151778083461841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,50063,116,0.98 [0.64-1.51],0.9292267791901004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,50729,120,1.47 [0.98-2.21],0.0626002939703182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,42481,99,0.98 [0.56-1.70],0.9287405519752836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSBP1,Heat shock factor-binding protein 1,42584,98,1.09 [0.89-1.33],0.4253041084996654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,50225,119,0.80 [0.53-1.19],0.2696655114971735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,43641,99,1.29 [0.95-1.74],0.1056457876520789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD17B3,Testosterone 17-beta-dehydrogenase 3,42299,95,1.09 [0.74-1.61],0.6749891673242474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,42584,98,0.71 [0.46-1.08],0.1092649014496779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSP90B1,Endoplasmin,48883,114,1.12 [0.90-1.39],0.2988310406745342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPA1A,Heat shock 70 kDa protein 1A,50432,120,1.10 [0.88-1.37],0.3963879228489515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPA2,Heat shock-related 70 kDa protein 2,43536,100,1.23 [0.73-2.05],0.4398669825646534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPB1,Heat shock protein beta-1,49494,116,1.05 [0.83-1.34],0.6650270677677204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPB6,Heat shock protein beta-6,50729,120,1.25 [0.83-1.86],0.2829551816857074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,49924,119,1.84 [1.07-3.16],0.0277802844061162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTR1A,5-hydroxytryptamine receptor 1A,42326,94,0.98 [0.75-1.28],0.8724168984002092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTR1B,5-hydroxytryptamine receptor 1B,42326,94,0.86 [0.52-1.41],0.5455911655751585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HTRA2,"Serine protease HTRA2, mitochondrial",50453,117,1.24 [0.95-1.60],0.1117224171816348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HYAL1,Hyaluronidase-1,50019,119,0.68 [0.33-1.37],0.2773524784532094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HYOU1,Hypoxia up-regulated protein 1,50919,116,0.90 [0.44-1.84],0.7754130444575926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICA1,Islet cell autoantigen 1,49349,116,1.02 [0.83-1.25],0.8763952380302247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM1,Intercellular adhesion molecule 1,50088,119,1.55 [0.91-2.66],0.1101489126884632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM2,Intercellular adhesion molecule 2,50919,116,1.09 [0.65-1.82],0.7374496477336128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM3,Intercellular adhesion molecule 3,50919,116,1.19 [0.64-2.18],0.5840253847543218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM4,Intercellular adhesion molecule 4,50225,119,1.07 [0.79-1.46],0.6626681304284366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICAM5,Intercellular adhesion molecule 5,50298,118,0.86 [0.61-1.22],0.396563176847397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ICOSLG,ICOS ligand,50063,116,0.72 [0.31-1.69],0.4521476282416633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ID4,DNA-binding protein inhibitor ID-4,42949,99,0.99 [0.63-1.55],0.9705912269037972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDI2,Isopentenyl-diphosphate delta-isomerase 2,49125,114,0.77 [0.53-1.12],0.1780279701259567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDO1,"Indoleamine 2,3-dioxygenase 1",42584,98,0.92 [0.67-1.25],0.5818846874721467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDS,Iduronate 2-sulfatase,50851,119,2.59 [0.40-16.76],0.3180782725956579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IDUA,Alpha-L-iduronidase,50729,120,0.91 [0.65-1.28],0.583875748301924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,42500,97,1.89 [1.24-2.87],0.0029479009785398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,42949,99,1.14 [0.80-1.63],0.455738295969087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,42949,99,1.13 [0.70-1.85],0.6117970535519127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNAR1,Interferon alpha/beta receptor 1,43557,98,0.84 [0.39-1.83],0.6604945883939681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNG,Interferon gamma,49349,116,1.01 [0.88-1.17],0.8723079403234262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNGR1,Interferon gamma receptor 1,50517,120,1.37 [0.65-2.88],0.408411538690474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNGR2,Interferon gamma receptor 2,49913,118,1.17 [0.87-1.58],0.3059556815651083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNL1,Interferon lambda-1,49125,114,1.13 [0.79-1.62],0.5079411045736308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNL2,Interferon lambda-2,42326,94,1.06 [0.79-1.44],0.6880661595611366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNLR1,Interferon lambda receptor 1,50225,119,1.14 [0.75-1.74],0.545814897854703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFNW1,Interferon omega-1,42299,95,1.25 [0.80-1.94],0.3294733499392851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFT20,Intraflagellar transport protein 20 homolog,42549,97,0.76 [0.47-1.24],0.2764712765121654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGBP1,Immunoglobulin-binding protein 1,43667,97,0.92 [0.67-1.26],0.5979554157374811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,42326,94,1.19 [0.86-1.65],0.2816445073446812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,43751,100,0.57 [0.29-1.09],0.0904625864689354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF1R,Insulin-like growth factor 1 receptor,50063,116,0.88 [0.41-1.92],0.7566442747916603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,42299,95,0.83 [0.51-1.35],0.4478471264730743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGF2R,Cation-independent mannose-6-phosphate receptor,50317,118,0.92 [0.46-1.85],0.8221193206875881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP1,Insulin-like growth factor-binding protein 1,50836,116,1.07 [0.94-1.22],0.3245774454794654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP2,Insulin-like growth factor-binding protein 2,50839,116,0.99 [0.76-1.30],0.9482164683433632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP3,Insulin-like growth factor-binding protein 3,50498,119,0.62 [0.38-1.00],0.051439876981955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP4,Insulin-like growth factor-binding protein 4,49674,116,1.00 [0.69-1.47],0.981578422405448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP6,Insulin-like growth factor-binding protein 6,50092,119,1.06 [0.63-1.80],0.8181702076005398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP7,Insulin-like growth factor-binding protein 7,50919,116,1.71 [1.11-2.62],0.013992816074454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBPL1,Insulin-like growth factor-binding protein-like 1,50298,118,1.55 [0.98-2.45],0.0596589960060458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFL4,Insulin growth factor-like family member 4,42481,99,1.01 [0.79-1.31],0.9189542042595013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGHMBP2,DNA-binding protein SMUBP-2,42299,95,0.92 [0.64-1.34],0.6672067352523676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGLC2,Immunoglobulin lambda constant 2,43734,101,1.44 [0.84-2.46],0.1828177292060472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGLON5,IgLON family member 5,42186,96,1.07 [0.89-1.29],0.4737248010154831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF21,Immunoglobulin superfamily member 21,42584,98,0.86 [0.51-1.44],0.5568127825998818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF3,Immunoglobulin superfamily member 3,50063,116,1.44 [0.97-2.16],0.0714162181450915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF8,Immunoglobulin superfamily member 8,50298,118,1.44 [0.87-2.40],0.157025397607201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF9,Protein turtle homolog A,43744,99,1.16 [0.93-1.45],0.1878955172856342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IKBKG,NF-kappa-B essential modulator,50225,119,1.10 [0.92-1.32],0.2986453952840719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IKZF2,Zinc finger protein Helios,49115,114,0.91 [0.74-1.13],0.4112555264314659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10,Interleukin-10,49349,116,1.10 [0.91-1.32],0.3223260771572968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10RA,Interleukin-10 receptor subunit alpha,49349,116,0.73 [0.50-1.06],0.0993150273525568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL10RB,Interleukin-10 receptor subunit beta,50517,120,1.26 [0.74-2.14],0.4015521552498313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL11,Interleukin-11,49349,116,0.89 [0.66-1.18],0.4103977197876292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12A_IL12B,Interleukin-12,50063,116,1.00 [0.81-1.24],0.9915804225797228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12B,Interleukin-12 subunit beta,50851,119,1.00 [0.75-1.34],0.9924687623276258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB1,Interleukin-12 receptor subunit beta-1,49349,116,1.60 [1.06-2.42],0.0264568409193197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB2,Interleukin-12 receptor subunit beta-2,42481,99,1.00 [0.62-1.60],0.9880529782194744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13,Interleukin-13,49349,116,1.03 [0.74-1.43],0.846380767807192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13RA1,Interleukin-13 receptor subunit alpha-1,49671,116,1.29 [0.62-2.66],0.4923108591488049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL13RA2,Interleukin-13 receptor subunit alpha-2,42326,94,0.93 [0.47-1.85],0.8363255294312042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL15,Interleukin-15,50225,119,1.37 [0.86-2.20],0.1887328334828669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL15RA,Interleukin-15 receptor subunit alpha,49349,116,1.42 [0.89-2.27],0.136450452694376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL16,Pro-interleukin-16,50851,119,1.16 [0.81-1.65],0.4275085523602541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17A,Interleukin-17A,49275,114,0.96 [0.65-1.42],0.8511282226177656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17C,Interleukin-17C,49349,116,1.04 [0.83-1.30],0.7408107058506943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17D,Interleukin-17D,49349,116,1.35 [0.94-1.93],0.1024720480798648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17F,Interleukin-17F,49349,116,0.88 [0.69-1.13],0.3196771504119362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17RA,Interleukin-17 receptor A,50317,118,1.20 [0.84-1.72],0.3135006814562615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL17RB,Interleukin-17 receptor B,49591,117,1.11 [0.82-1.51],0.5126386913199665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18,Interleukin-18,50101,120,1.10 [0.79-1.55],0.567454670698802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18BP,Interleukin-18-binding protein,50498,119,1.61 [0.99-2.60],0.0546151980322584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18R1,Interleukin-18 receptor 1,50851,119,1.94 [1.22-3.10],0.005379589350563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18RAP,Interleukin-18 receptor accessory protein,49596,118,0.98 [0.89-1.08],0.7025726420887536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL19,Interleukin-19,49044,117,1.05 [0.84-1.32],0.6574151662965884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1A,Interleukin-1 alpha,49349,116,1.04 [0.79-1.35],0.7942941370077826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1B,Interleukin-1 beta,49111,115,0.98 [0.73-1.31],0.8867984095139615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1R1,Interleukin-1 receptor type 1,50235,118,1.64 [0.82-3.29],0.1624685588970818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1R2,Interleukin-1 receptor type 2,50185,120,1.18 [0.53-2.64],0.6811859982247098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RAP,Interleukin-1 receptor accessory protein,50317,118,0.56 [0.38-0.83],0.0038997320383906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RL1,Interleukin-1 receptor-like 1,50754,116,1.37 [0.96-1.95],0.0871616850063903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RL2,Interleukin-1 receptor-like 2,49349,116,0.89 [0.58-1.35],0.5771133486159983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RN,Interleukin-1 receptor antagonist protein,50183,120,1.02 [0.76-1.37],0.892493865808802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2,Interleukin-2,49349,116,1.48 [0.91-2.40],0.111311111732635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20,Interleukin-20,49349,116,0.65 [0.42-0.99],0.0436715438288351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20RA,Interleukin-20 receptor subunit alpha,49349,116,1.29 [0.98-1.70],0.0663409485920626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20RB,Interleukin-20 receptor subunit beta,42481,99,0.95 [0.59-1.51],0.8175662005266977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL21R,Interleukin-21 receptor,42481,99,1.20 [0.91-1.60],0.2030457342240643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL22,Interleukin-22,43536,100,0.93 [0.70-1.24],0.6351713969032025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL22RA1,Interleukin-22 receptor subunit alpha-1,49349,116,0.91 [0.61-1.35],0.6398145526980121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL24,Interleukin-24,49349,116,1.05 [0.76-1.46],0.7538822018695829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL25,Interleukin-25,42036,96,1.04 [0.59-1.84],0.8875718630198264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RA,Interleukin-2 receptor subunit alpha,49942,114,1.20 [0.81-1.78],0.3524481615552545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RB,Interleukin-2 receptor subunit beta,49349,116,1.15 [0.78-1.71],0.4757686867793466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2RG,Cytokine receptor common subunit gamma,43536,100,0.98 [0.57-1.67],0.9346487337678664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL3,Interleukin-3,42186,96,1.23 [0.87-1.74],0.2440790313681492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL31,Interleukin-31,42481,99,0.97 [0.68-1.38],0.8698530839488188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL31RA,Interleukin-31 receptor subunit alpha,42320,99,1.41 [0.87-2.30],0.1661067103177821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL32,Interleukin-32,50225,119,1.36 [0.97-1.92],0.0789259774410557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL33,Interleukin-33,49349,116,1.33 [0.88-2.03],0.1788865288348122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL34,Interleukin-34,49041,114,0.95 [0.59-1.51],0.8134073381557096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL36A,Interleukin-36 alpha,42481,99,0.86 [0.58-1.26],0.4263492089961097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL36G,Interleukin-36 gamma,42316,99,0.92 [0.68-1.24],0.5976322817838942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL3RA,Interleukin-3 receptor subunit alpha,49349,116,1.56 [0.96-2.54],0.0712301375789564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL4,Interleukin-4,49349,116,1.05 [0.87-1.26],0.6308234762101397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL4R,Interleukin-4 receptor subunit alpha,50225,119,1.66 [1.11-2.48],0.0126543950528723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL5,Interleukin-5,49349,116,1.09 [0.99-1.21],0.0877594670307123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL5RA,Interleukin-5 receptor subunit alpha,50225,119,1.30 [0.99-1.70],0.0583705176767369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6,Interleukin-6,50063,116,1.10 [0.91-1.33],0.3399185580100595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6R,Interleukin-6 receptor subunit alpha,50008,119,1.34 [0.84-2.15],0.21804930957947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL6ST,Interleukin-6 receptor subunit beta,50298,118,0.89 [0.35-2.27],0.8014919846351598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL7,Interleukin-7,50225,119,1.13 [0.88-1.45],0.3431888205152938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL7R,Interleukin-7 receptor subunit alpha,50317,118,0.92 [0.68-1.26],0.6089063767801443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL9,Interleukin-9,42949,99,1.01 [0.72-1.42],0.9515630260018922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,49047,114,0.93 [0.69-1.25],0.6388472053047425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMMT,MICOS complex subunit MIC60,43536,100,1.52 [1.09-2.11],0.0134632103178521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPA1,Inositol monophosphatase 1,49913,118,0.94 [0.71-1.23],0.6367632012036755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPACT,Protein IMPACT,43641,99,1.05 [0.75-1.48],0.7695346143357321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMPG1,Interphotoreceptor matrix proteoglycan 1,42326,94,1.00 [0.52-1.95],0.9918321244757428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ING1,Inhibitor of growth protein 1,49042,114,0.97 [0.68-1.39],0.8785144405638651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INHBB,Inhibin beta B chain,42800,100,1.57 [1.12-2.19],0.0080513768477133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INHBC,Inhibin beta C chain,50317,118,1.48 [0.98-2.23],0.0625059687034958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP1,Inositol polyphosphate 1-phosphatase,50063,116,1.12 [0.83-1.51],0.4614550426304675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",42584,98,0.97 [0.69-1.37],0.8847337582246423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",43667,97,0.90 [0.55-1.46],0.6688295915413702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",50063,116,1.07 [0.90-1.26],0.4471476812992216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL3,Insulin-like 3,43641,99,0.98 [0.77-1.24],0.8501087259677684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL4,Early placenta insulin-like peptide,43536,100,1.18 [0.85-1.64],0.3296980103540957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSL5,Insulin-like peptide INSL5,43557,98,1.09 [0.90-1.32],0.3623143882901556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INSR,Insulin receptor,42481,99,1.31 [0.42-4.06],0.6433533773528246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IPCEF1,Interactor protein for cytohesin exchange factors 1,49831,118,1.13 [0.94-1.36],0.1901219227884906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IQGAP2,Ras GTPase-activating-like protein IQGAP2,50063,116,1.14 [0.85-1.52],0.3879597380216776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",49383,114,1.01 [0.84-1.22],0.9288246646699873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAK1,Interleukin-1 receptor-associated kinase 1,49349,116,1.01 [0.79-1.28],0.9585306311297496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IRAK4,Interleukin-1 receptor-associated kinase 4,50225,119,1.08 [0.92-1.26],0.3512579466210128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,48429,111,0.95 [0.61-1.50],0.8415894321333186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISM1,Isthmin-1,50225,119,0.93 [0.62-1.41],0.7453052180088366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ISM2,Isthmin-2,43751,100,1.06 [0.69-1.61],0.8028463423529961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IST1,IST1 homolog,43236,97,1.00 [0.82-1.22],0.9690254944886968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA11,Integrin alpha-11,50225,119,0.57 [0.36-0.91],0.0178438636681335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA2,Integrin alpha-2,42800,100,0.87 [0.50-1.51],0.60936501760292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA5,Integrin alpha-5,50317,118,1.18 [0.62-2.26],0.6179472168778742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA6,Integrin alpha-6,50225,119,0.95 [0.69-1.31],0.7647114537345406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAL,Integrin alpha-L,42481,99,1.04 [0.67-1.63],0.8476370816682407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAM,Integrin alpha-M,50317,118,0.82 [0.49-1.38],0.4537614647173519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAV,Integrin alpha-V,50729,120,0.34 [0.13-0.88],0.0265133885267366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAX,Integrin alpha-X,42949,99,1.04 [0.73-1.48],0.8378998956119181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1,Integrin beta-1,50249,119,1.10 [0.52-2.34],0.810710854621641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1BP1,Integrin beta-1-binding protein 1,49115,114,0.95 [0.63-1.43],0.8025755779961152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1BP2,Integrin beta-1-binding protein 2,49383,114,1.02 [0.88-1.18],0.785273956823954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB2,Integrin beta-2,50013,115,0.72 [0.40-1.29],0.2706127953099734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB5,Integrin beta-5,50453,117,1.48 [0.99-2.21],0.0570674590123548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB6,Integrin beta-6,49349,116,1.18 [0.68-2.04],0.5508348662503351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB7,Integrin beta-7,50729,120,1.16 [0.83-1.63],0.3836906686416941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGBL1,Integrin beta-like protein 1,43751,100,1.79 [1.16-2.77],0.0090770400961105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,43812,101,0.81 [0.29-2.27],0.6919937993129501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,50498,119,1.72 [1.12-2.65],0.0136019718725671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,43812,101,0.74 [0.34-1.59],0.4369722940321034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,43536,100,0.92 [0.59-1.43],0.7027838611082758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITM2A,Integral membrane protein 2A,50225,119,1.10 [0.85-1.44],0.4718145339143694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPA,Inosine triphosphate pyrophosphatase,42299,95,0.81 [0.60-1.09],0.1659846066671405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",42584,98,1.09 [0.83-1.42],0.5437043414270847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",42326,94,0.98 [0.62-1.55],0.9337813966616612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",49125,114,0.83 [0.58-1.19],0.3081668289160833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IZUMO1,Izumo sperm-egg fusion protein 1,42186,96,1.15 [0.80-1.65],0.4609011926721132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JAM2,Junctional adhesion molecule B,50746,120,1.40 [0.78-2.51],0.2612208501653455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JAM3,Junctional adhesion molecule C,42800,100,1.02 [0.70-1.49],0.9139934436245376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JCHAIN,Immunoglobulin J chain,49349,116,1.11 [0.86-1.45],0.4214928396198871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,42186,96,0.70 [0.46-1.05],0.0820619896561908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JPT2,Jupiter microtubule associated homolog 2,43557,98,1.04 [0.84-1.30],0.7130394832571076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,JUN,Transcription factor AP-1,49349,116,0.80 [0.54-1.19],0.2678156117678174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,50063,116,1.21 [0.83-1.76],0.3310514672944696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KAZN,Kazrin,43557,98,1.00 [0.83-1.20],0.9871737325315916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNC4,Potassium voltage-gated channel subfamily C member 4,42326,94,1.07 [0.76-1.50],0.7152344711156309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNH2,Potassium voltage-gated channel subfamily H member 2,42549,97,1.01 [0.78-1.31],0.9395435331181802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNIP4,Kv channel-interacting protein 4,49125,114,0.68 [0.45-1.03],0.0690104763330151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCTD5,BTB/POZ domain-containing protein KCTD5,42819,97,1.09 [0.72-1.65],0.6790330542587096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KDM3A,Lysine-specific demethylase 3A,42481,99,0.93 [0.73-1.19],0.5672451598119651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KDR,Vascular endothelial growth factor receptor 2,50453,117,0.73 [0.39-1.37],0.3332482347717861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KEL,Kell blood group glycoprotein,49125,114,1.34 [0.85-2.12],0.2029891804970833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KHDC3L,KH domain-containing protein 3,42186,96,1.09 [0.84-1.42],0.4946297130410798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KHK,Ketohexokinase,42584,98,1.11 [0.81-1.50],0.5183132274651747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA0319,Dyslexia-associated protein KIAA0319,43641,99,1.19 [0.65-2.18],0.5641752906472195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA1549,UPF0606 protein KIAA1549,42949,99,1.28 [0.99-1.64],0.054962594227758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA1549L,UPF0606 protein KIAA1549L,42949,99,0.75 [0.37-1.53],0.4323134299037579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIAA2013,Uncharacterized protein KIAA2013,43536,100,0.78 [0.50-1.21],0.2700172891054453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF1C,Kinesin-like protein KIF1C,42299,95,0.67 [0.34-1.33],0.2496513585834904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF20B,Kinesin-like protein KIF20B,42326,94,1.07 [0.83-1.37],0.6102100158432964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF22,Kinesin-like protein KIF22,42299,95,1.16 [0.99-1.37],0.072474356881692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIFBP,KIF-binding protein,50063,116,1.01 [0.83-1.23],0.9382908274122034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,43536,100,0.99 [0.80-1.23],0.93692757884529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,49115,114,1.08 [0.88-1.34],0.4451865960271406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,43557,98,0.93 [0.83-1.04],0.209677436410975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,49115,114,1.02 [0.90-1.17],0.7210503911735959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,42186,96,1.12 [0.91-1.36],0.2850797614347251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIRREL1,Kin of IRRE-like protein 1,42326,94,1.06 [0.77-1.46],0.7018490096545175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIRREL2,Kin of IRRE-like protein 2,49125,114,1.11 [0.74-1.67],0.6103428695314075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIT,Mast/stem cell growth factor receptor Kit,50417,119,0.75 [0.44-1.28],0.2845338030659779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KITLG,Kit ligand,50298,118,0.49 [0.33-0.74],0.0006334691938601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLB,Beta-klotho,49125,114,1.02 [0.82-1.27],0.8695143826209627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLF4,Krueppel-like factor 4,42326,94,1.24 [0.80-1.94],0.3345222687226822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLHL41,Kelch-like protein 41,43667,97,0.72 [0.45-1.13],0.1535962157440036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK1,Kallikrein-1,49811,115,0.96 [0.84-1.09],0.5007928539690552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK10,Kallikrein-10,50298,117,1.02 [0.68-1.52],0.9356989790932736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK11,Kallikrein-11,49972,117,1.03 [0.61-1.73],0.9188994348585068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK12,Kallikrein-12,49115,114,0.86 [0.77-0.97],0.0133607409079329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK13,Kallikrein-13,49164,115,0.92 [0.64-1.32],0.6463327803976102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK14,Kallikrein-14,50729,120,0.93 [0.66-1.31],0.6870946744588653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK15,Kallikrein-15,43457,99,1.19 [0.82-1.72],0.3687715631710138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK3,Prostate-specific antigen,43751,100,0.88 [0.73-1.08],0.2188402333513179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK4,Kallikrein-4,50729,120,1.17 [0.92-1.49],0.2070637456794272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK6,Kallikrein-6,50371,117,1.37 [0.81-2.32],0.2379886115411071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK7,Kallikrein-7,41700,97,1.11 [0.68-1.81],0.6684746221662234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK8,Kallikrein-8,48607,113,0.86 [0.54-1.37],0.5302522609640956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLKB1,Plasma kallikrein,42926,99,0.93 [0.43-1.99],0.8462965984321391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRB1,Killer cell lectin-like receptor subfamily B member 1,50851,119,1.59 [1.07-2.36],0.0222372771433861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,42326,94,0.89 [0.62-1.29],0.5471613578285506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRD1,Natural killer cells antigen CD94,50851,119,1.27 [0.91-1.78],0.1629840965961272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRF1,Killer cell lectin-like receptor subfamily F member 1,42481,99,1.32 [0.97-1.78],0.0726805258962651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRK1,NKG2-D type II integral membrane protein,43641,99,1.39 [0.94-2.06],0.1037563941277681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT14,"Keratin, type I cytoskeletal 14",47576,112,0.68 [0.36-1.30],0.2458769410068405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT17,"Keratin, type I cytoskeletal 17",42299,95,1.01 [0.61-1.69],0.9615374768741024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT18,"Keratin, type I cytoskeletal 18",50063,116,1.30 [1.08-1.56],0.0046181675320392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT19,"Keratin, type I cytoskeletal 19",50141,119,1.20 [0.96-1.50],0.1059511515028641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT5,"Keratin, type II cytoskeletal 5",49125,114,0.96 [0.69-1.35],0.8339492418279966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT6C,"Keratin, type II cytoskeletal 6C",42299,95,1.06 [0.63-1.77],0.8345321634787991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT8,"Keratin, type II cytoskeletal 8",42326,94,1.19 [0.97-1.46],0.0882993255370351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KYAT1,Kynurenine--oxoglutarate transaminase 1,50216,118,1.06 [0.80-1.41],0.6882260334767092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KYNU,Kynureninase,50851,119,1.33 [0.94-1.88],0.1037312775125189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,L1CAM,Neural cell adhesion molecule L1,50453,117,0.87 [0.50-1.52],0.6252283177218639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,43744,99,1.02 [0.83-1.27],0.8340328028873296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LACRT,Extracellular glycoprotein lacritin,43454,99,0.86 [0.57-1.32],0.4934863711397654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LACTB2,Endoribonuclease LACTB2,50298,118,1.03 [0.81-1.32],0.8030700124007001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAG3,Lymphocyte activation gene 3 protein,50063,116,1.33 [0.92-1.93],0.1298067327612033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,50268,120,1.38 [1.01-1.88],0.0452220328612272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,49913,118,1.13 [0.96-1.33],0.1288244796064668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMA1,Laminin subunit alpha-1,42299,95,1.19 [0.87-1.63],0.2686481592891764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMA4,Laminin subunit alpha-4,50517,120,1.08 [0.67-1.74],0.7555725516545304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMB1,Laminin subunit beta-1,42584,98,0.97 [0.51-1.85],0.9293757861953998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP1,Lysosome-associated membrane glycoprotein 1,42537,97,0.69 [0.30-1.60],0.3859266237733512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP2,Lysosome-associated membrane glycoprotein 2,48781,109,0.75 [0.32-1.74],0.4974586713308808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP3,Lysosome-associated membrane glycoprotein 3,50768,117,1.35 [1.00-1.82],0.047278845365892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMTOR5,Ragulator complex protein LAMTOR5,43536,100,1.02 [0.64-1.63],0.9392444768722756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAP3,Cytosol aminopeptidase,49349,116,1.03 [0.74-1.45],0.8566530226325983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LARP1,La-related protein 1,43536,100,0.92 [0.67-1.27],0.620119834563766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAT,Linker for activation of T-cells family member 1,50851,119,1.06 [0.86-1.32],0.5642666067940845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAT2,Linker for activation of T-cells family member 2,50063,116,1.03 [0.90-1.17],0.702618452053235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LATS1,Serine/threonine-protein kinase LATS1,42481,99,0.92 [0.73-1.15],0.4518139630074642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAYN,Layilin,49830,118,1.42 [0.92-2.21],0.1145293341230801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LBP,Lipopolysaccharide-binding protein,50498,119,1.33 [1.01-1.74],0.0396437174764808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LBR,Delta(14)-sterol reductase LBR,50746,120,1.12 [0.91-1.39],0.2927195532519087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCAT,Phosphatidylcholine-sterol acyltransferase,43781,100,1.23 [0.51-2.95],0.6512902519798154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCN15,Lipocalin-15,43667,97,0.94 [0.68-1.30],0.7106197159169098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCN2,Neutrophil gelatinase-associated lipocalin,48771,118,1.06 [0.70-1.59],0.7905618293989991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LCP1,Plastin-2,43751,100,0.99 [0.67-1.47],0.971169749784944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LDLR,Low-density lipoprotein receptor,50438,114,1.10 [0.80-1.50],0.5623158733548509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LDLRAP1,Low density lipoprotein receptor adapter protein 1,43667,97,1.02 [0.83-1.24],0.878199243928918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LECT2,Leukocyte cell-derived chemotaxin-2,43744,99,1.47 [1.13-1.92],0.0040949910659969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEFTY2,Left-right determination factor 2,50655,120,1.04 [0.76-1.42],0.8164938511118438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEG1,Protein LEG1 homolog,41342,98,1.18 [0.91-1.53],0.211638231851137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LELP1,Late cornified envelope-like proline-rich protein 1,42326,94,0.93 [0.69-1.24],0.603470988422421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEO1,RNA polymerase-associated protein LEO1,43667,97,1.10 [0.63-1.94],0.7312378740381452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEP,Leptin,50298,118,0.89 [0.70-1.12],0.3111073749582913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEPR,Leptin receptor,50298,118,1.06 [0.63-1.78],0.8264330569602591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LETM1,Mitochondrial proton/calcium exchanger protein,43667,97,1.13 [0.79-1.60],0.5000962398755668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS1,Galectin-1,50298,118,1.19 [0.76-1.88],0.4463153497018379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS3,Galectin-3,50428,115,1.49 [0.87-2.54],0.1491965774258311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS3BP,Galectin-3-binding protein,43812,101,1.32 [0.76-2.31],0.32944179170568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS4,Galectin-4,50268,120,1.33 [1.01-1.75],0.0414368852697387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS7_LGALS7B,Galectin-7,50153,119,1.36 [0.98-1.89],0.0692684225445458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS8,Galectin-8,50746,120,1.09 [0.84-1.41],0.5304384069745467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS9,Galectin-9,50272,120,1.70 [1.06-2.73],0.0283875588339003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGMN,Legumain,50517,120,1.63 [1.06-2.50],0.0260548427560031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LHB,Lutropin subunit beta,49115,114,1.01 [0.84-1.22],0.91102437910791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,50347,120,1.13 [0.87-1.46],0.37165171828015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIF,Leukemia inhibitory factor,49125,114,0.73 [0.50-1.06],0.1008579774392845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIFR,Leukemia inhibitory factor receptor,50225,119,1.87 [0.98-3.54],0.0561418351786278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,50317,118,1.11 [0.72-1.73],0.6363232021646293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,43751,100,1.10 [0.93-1.30],0.265363209690462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,42299,95,1.35 [0.99-1.83],0.0587560648791981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,50223,118,1.06 [0.64-1.74],0.8289076534596875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,43744,99,1.14 [0.88-1.48],0.3056596900564421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,50919,116,1.57 [0.87-2.82],0.134753173253853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,50674,116,1.37 [0.85-2.22],0.1962466683893035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,49349,116,1.72 [1.22-2.44],0.0021449420591481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,50919,116,1.04 [0.82-1.32],0.7432527858118312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIPF,Gastric triacylglycerol lipase,42584,98,0.96 [0.70-1.31],0.8001327728076103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMNB1,Lamin-B1,43475,98,0.90 [0.65-1.24],0.5083263620360486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMNB2,Lamin-B2,43641,99,2.02 [1.12-3.64],0.0186019275783223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMOD1,Leiomodin-1,43667,97,1.27 [0.78-2.09],0.3408530456586703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMOD2,Leiomodin-2,42326,94,1.08 [0.79-1.47],0.6229756544822651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LONP1,"Lon protease homolog, mitochondrial",42584,98,1.07 [0.86-1.34],0.5401427155805485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPA,Apolipoprotein(a),42773,100,0.95 [0.85-1.06],0.3524431846379461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPCAT2,Lysophosphatidylcholine acyltransferase 2,50063,116,1.13 [0.82-1.57],0.4515194956358116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPL,Lipoprotein lipase,50298,118,0.91 [0.65-1.27],0.5752605196859608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPO,Lactoperoxidase,48647,114,1.31 [1.01-1.70],0.0401209658691793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPP,Lipoma-preferred partner,42299,95,1.00 [0.74-1.34],0.9796055832052796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,42299,95,0.94 [0.70-1.26],0.683450584927283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,42549,97,1.18 [0.82-1.70],0.3841603153687262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRG1,Leucine-rich alpha-2-glycoprotein,43812,101,1.45 [0.72-2.93],0.3017492124524584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,50582,119,1.26 [0.80-1.99],0.3132426387038137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,42332,98,0.54 [0.24-1.21],0.132302622219093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP1,Prolow-density lipoprotein receptor-related protein 1,50063,116,0.78 [0.41-1.46],0.4326874860846588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP11,Low-density lipoprotein receptor-related protein 11,50298,118,1.07 [0.69-1.66],0.7597005833314824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP2,Low-density lipoprotein receptor-related protein 2,42549,97,0.93 [0.54-1.61],0.7954414393357377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRP2BP,LRP2-binding protein,42549,97,0.78 [0.57-1.06],0.1100758504996221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,50746,120,1.02 [0.77-1.35],0.8683904225455483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC25,Leucine-rich repeat-containing protein 25,50063,116,1.10 [0.74-1.64],0.6397903014427658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC37A2,Leucine-rich repeat-containing protein 37A2,43557,98,1.16 [0.74-1.82],0.5074185356808083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC38,Leucine-rich repeat-containing protein 38,42549,97,1.41 [1.01-1.97],0.0447891929631278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC59,Leucine-rich repeat-containing protein 59,43744,99,0.91 [0.60-1.37],0.6491738943458044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,43536,100,0.85 [0.56-1.29],0.4453607788444582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRN1,Leucine-rich repeat neuronal protein 1,49349,116,0.91 [0.60-1.37],0.641785459292552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,42549,97,1.00 [0.63-1.60],0.9957445967283932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,43667,97,0.94 [0.45-1.98],0.8731167282865675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSM1,U6 snRNA-associated Sm-like protein LSm1,49115,114,1.03 [0.77-1.37],0.8656937197713609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSM8,U6 snRNA-associated Sm-like protein LSm8,42949,99,1.09 [0.89-1.33],0.4182299934999129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LSP1,Lymphocyte-specific protein 1,50225,119,1.22 [0.83-1.79],0.3219029671141116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTA,Lymphotoxin-alpha,50225,119,1.15 [0.77-1.72],0.5024743542305785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTA4H,Leukotriene A-4 hydrolase,50729,120,1.00 [0.77-1.32],0.977998414920999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTB,Lymphotoxin-beta,43536,100,0.96 [0.54-1.69],0.8802042540577166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP2,Latent-transforming growth factor beta-binding protein 2,50919,116,2.02 [1.25-3.26],0.0041184338987232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP3,Latent-transforming growth factor beta-binding protein 3,49115,114,1.33 [1.04-1.69],0.021351634670644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBR,Tumor necrosis factor receptor superfamily member 3,50019,120,1.14 [0.66-1.98],0.6380979092560313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTO1,Protein LTO1 homolog,49349,116,1.34 [0.98-1.82],0.0645566697039963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LUZP2,Leucine zipper protein 2,43536,100,1.09 [0.72-1.64],0.6901288647928463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LXN,Latexin,49678,117,1.08 [0.86-1.36],0.49030301335474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY6D,Lymphocyte antigen 6D,50019,120,1.14 [0.76-1.72],0.5317897660381039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY75,Lymphocyte antigen 75,50225,119,1.02 [0.67-1.55],0.9123943675999469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY9,T-lymphocyte surface antigen Ly-9,49724,115,1.46 [0.85-2.50],0.1661380679350639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LY96,Lymphocyte antigen 96,49913,118,1.34 [0.88-2.04],0.1768923416318622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYAR,Cell growth-regulating nucleolar protein,49115,114,0.99 [0.73-1.35],0.949693001693568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYN,Tyrosine-protein kinase Lyn,50063,116,1.04 [0.85-1.26],0.7176023718442971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD1,Ly6/PLAUR domain-containing protein 1,49125,114,0.79 [0.56-1.12],0.1859598827645273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD3,Ly6/PLAUR domain-containing protein 3,50052,116,0.77 [0.48-1.25],0.2976079841765465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPD8,Ly6/PLAUR domain-containing protein 8,49115,114,1.04 [0.77-1.41],0.7792322447145847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYPLA2,Acyl-protein thioesterase 2,42326,94,0.95 [0.78-1.16],0.6211023246221987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,42549,97,1.03 [0.86-1.24],0.7442049456150144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,43812,101,0.73 [0.28-1.95],0.5344189679357781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LYZL2,Lysozyme-like protein 2,42186,96,1.13 [0.68-1.91],0.6333816630100232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LZTFL1,Leucine zipper transcription factor-like protein 1,42800,100,1.01 [0.77-1.32],0.949372443190184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,M6PR,Cation-dependent mannose-6-phosphate receptor,42584,98,0.85 [0.50-1.46],0.5613040114712238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,49747,118,1.31 [1.03-1.68],0.0293285752413105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAEA,E3 ubiquitin-protein transferase MAEA,49115,114,0.86 [0.55-1.35],0.5139091132758022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAG,Myelin-associated glycoprotein,42549,97,1.20 [0.80-1.79],0.3855675244165404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAGEA3,Melanoma-associated antigen 3,42949,99,0.97 [0.78-1.20],0.7724438518475963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAGED1,Melanoma-associated antigen D1,49115,114,1.04 [0.73-1.46],0.8437105784594061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAMDC2,MAM domain-containing protein 2,43744,99,1.54 [0.92-2.59],0.1012305381254685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAMDC4,Apical endosomal glycoprotein,43536,100,1.06 [0.76-1.48],0.7313702784972989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",42584,98,1.41 [0.66-3.01],0.3781121903063255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAN2B2,Epididymis-specific alpha-mannosidase,43744,99,0.87 [0.63-1.20],0.387426376071063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",42186,96,1.06 [0.73-1.55],0.7565748119205309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANF,Mesencephalic astrocyte-derived neurotrophic factor,50517,120,1.03 [0.90-1.17],0.7037116066717338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANSC1,MANSC domain-containing protein 1,50453,117,1.02 [0.57-1.84],0.9392288676496776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MANSC4,MANSC domain-containing protein 4,42299,95,1.24 [0.95-1.61],0.1198288040331322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,42326,94,1.37 [0.74-2.52],0.3111375947170857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,42299,95,0.98 [0.72-1.34],0.9024912171970624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2,Microtubule-associated protein 2,43641,99,1.15 [0.78-1.70],0.486341528312875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,43557,98,1.00 [0.74-1.35],0.9925115096786729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,50225,119,0.98 [0.84-1.16],0.8373504935198047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,49115,114,0.92 [0.77-1.09],0.3347115331000703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,49830,118,1.05 [0.91-1.22],0.4935626390698642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPK13,Mitogen-activated protein kinase 13,42186,96,1.19 [0.79-1.79],0.4124606066199152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPK9,Mitogen-activated protein kinase 9,50225,119,1.21 [0.83-1.76],0.317394976071183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPKAPK2,MAP kinase-activated protein kinase 2,42949,99,0.85 [0.65-1.11],0.2386348936976597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPRE3,Microtubule-associated protein RP/EB family member 3,42186,96,1.01 [0.88-1.16],0.9301431820690425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAPT,Microtubule-associated protein tau,49125,114,0.88 [0.65-1.20],0.4299314470120919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MARCO,Macrophage receptor MARCO,50298,118,1.63 [0.88-3.00],0.1202942923562526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MARS1,"Methionine--tRNA ligase, cytoplasmic",42720,100,1.05 [0.84-1.32],0.6440937977468053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MASP1,Mannan-binding lectin serine protease 1,49830,118,1.40 [0.70-2.81],0.3461971369621123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MATN2,Matrilin-2,50352,120,1.98 [1.16-3.38],0.0120216228087934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MATN3,Matrilin-3,49831,118,1.10 [0.67-1.80],0.7021535779098436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAVS,Mitochondrial antiviral-signaling protein,49115,114,1.01 [0.84-1.22],0.8867292731903934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAX,Protein max,49125,114,1.05 [0.90-1.23],0.5566300387458996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MB,Myoglobin,50919,116,1.10 [0.82-1.48],0.513125114286223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MBL2,Mannose-binding protein C,43180,100,1.01 [0.85-1.21],0.8735087423932444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCAM,Cell surface glycoprotein MUC18,50498,119,1.11 [0.69-1.80],0.6675165893073094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",43667,97,0.82 [0.50-1.36],0.4480505045987231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCEMP1,Mast cell-expressed membrane protein 1,42481,99,0.92 [0.74-1.15],0.4586686337454059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCFD2,Multiple coagulation factor deficiency protein 2,50063,118,1.23 [0.85-1.76],0.2689183723717712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MCTS1,Malignant T-cell-amplified sequence 1,43557,98,0.79 [0.36-1.73],0.5570558561439634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,49913,118,1.07 [0.85-1.36],0.5650824350007925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDH1,"Malate dehydrogenase, cytoplasmic",43536,100,1.13 [0.71-1.80],0.6148897973495493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDK,Midkine,50298,116,1.27 [0.96-1.68],0.0914203985839852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDM1,Nuclear protein MDM1,42549,97,0.87 [0.46-1.65],0.6676056202946741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",42584,98,0.99 [0.80-1.22],0.9231590041340254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MED18,Mediator of RNA polymerase II transcription subunit 18,49115,114,1.06 [0.86-1.32],0.5809514455824987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MED21,Mediator of RNA polymerase II transcription subunit 21,42299,95,0.90 [0.58-1.40],0.640364782681625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF10,Multiple epidermal growth factor-like domains protein 10,50268,120,0.94 [0.62-1.41],0.7520825800011879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF11,Multiple epidermal growth factor-like domains protein 11,42299,95,1.18 [0.68-2.06],0.5579193289511338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEGF9,Multiple epidermal growth factor-like domains protein 9,50754,116,0.71 [0.31-1.63],0.4171244057728123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MELTF,Melanotransferrin,43744,99,1.43 [0.78-2.63],0.2513251451059755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MENT,Protein MENT,42800,100,0.57 [0.25-1.29],0.1804222807965743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEP1A,Meprin A subunit alpha,43557,98,1.01 [0.78-1.32],0.9233454846220986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEP1B,Meprin A subunit beta,50298,118,0.96 [0.83-1.09],0.5087887856141384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MEPE,Matrix extracellular phosphoglycoprotein,50268,120,0.86 [0.47-1.59],0.6305176558790793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MERTK,Tyrosine-protein kinase Mer,50851,119,1.17 [0.62-2.21],0.6208722195311109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MESD,LRP chaperone MESD,50317,118,1.02 [0.89-1.16],0.7949851064275675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MET,Hepatocyte growth factor receptor,50442,115,0.92 [0.40-2.10],0.8434571008838295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP1,Methionine aminopeptidase 1,49125,114,0.74 [0.41-1.34],0.318515158947425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",50225,119,1.05 [0.86-1.27],0.6365657947816558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,METAP2,Methionine aminopeptidase 2,50655,120,1.15 [0.86-1.52],0.3499842933449214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP3,Microfibril-associated glycoprotein 3,49383,114,0.85 [0.59-1.23],0.383865745132518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP3L,Microfibrillar-associated protein 3-like,42549,97,0.71 [0.47-1.07],0.1005686554472869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP4,Microfibril-associated glycoprotein 4,42800,100,2.21 [1.24-3.94],0.0070366087457562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP5,Microfibrillar-associated protein 5,50919,116,0.91 [0.61-1.37],0.6613472570790659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFGE8,Lactadherin,50317,118,1.41 [0.99-2.02],0.0563318419236324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MGLL,Monoglyceride lipase,50436,120,1.04 [0.87-1.25],0.6634759192122404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MGMT,Methylated-DNA--protein-cysteine methyltransferase,50225,119,1.02 [0.89-1.17],0.7385498442778287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MIA,Melanoma-derived growth regulatory protein,50453,117,1.10 [0.71-1.70],0.6588725932140012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MICALL2,MICAL-like protein 2,42549,97,0.98 [0.73-1.30],0.877892215106338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,50225,119,1.08 [0.96-1.21],0.2205139684677442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MIF,Macrophage migration inhibitory factor,50233,118,1.04 [0.82-1.32],0.757533722611998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MILR1,Allergin-1,49349,116,1.29 [0.95-1.77],0.1062190522511066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,43536,100,1.04 [0.88-1.25],0.6296597957477437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MINK1,Misshapen-like kinase 1,43641,99,0.97 [0.79-1.19],0.734922753827478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MITD1,MIT domain-containing protein 1,49913,118,1.03 [0.87-1.21],0.7633261507312279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MKI67,Proliferation marker protein Ki-67,42481,99,0.69 [0.38-1.25],0.2165554775869415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MLLT1,Protein ENL,42186,96,0.88 [0.64-1.22],0.4527507200091496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MLN,Promotilin,50225,119,0.97 [0.81-1.16],0.7384760368570904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MME,Neprilysin,50063,116,1.32 [1.09-1.60],0.0040884537741527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP1,Interstitial collagenase,48483,113,1.11 [0.92-1.33],0.2869899127389262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP10,Stromelysin-2,50183,119,0.91 [0.69-1.21],0.5228834605618149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP12,Macrophage metalloelastase,50340,119,1.19 [0.89-1.60],0.2326050502990234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP13,Collagenase 3,49125,114,0.88 [0.53-1.46],0.6131639332551331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP15,Matrix metalloproteinase-15,43744,99,0.75 [0.45-1.25],0.2710628370506821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP3,Stromelysin-1,50317,118,1.13 [0.82-1.57],0.4427050190536686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP7,Matrilysin,49306,114,1.20 [0.85-1.71],0.2952056342008658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP8,Neutrophil collagenase,50662,120,1.06 [0.85-1.32],0.5936093405143403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP9,Matrix metalloproteinase-9,50233,118,0.94 [0.72-1.23],0.6631323799514637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",42299,95,0.86 [0.57-1.31],0.4880935934156081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MN1,Transcriptional activator MN1,42549,97,1.26 [0.95-1.66],0.10854316679339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MNAT1,CDK-activating kinase assembly factor MAT1,42949,99,0.92 [0.58-1.46],0.7329042853939498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MNDA,Myeloid cell nuclear differentiation antigen,50221,118,1.07 [0.92-1.24],0.3831519539747005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MOCS2,Molybdopterin synthase catalytic subunit,42800,100,1.11 [0.83-1.47],0.4753405028713255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MOG,Myelin-oligodendrocyte glycoprotein,50729,120,1.00 [0.62-1.61],0.9891773360413276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORC3,MORC family CW-type zinc finger protein 3,43641,99,0.73 [0.34-1.57],0.4261587446500342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORF4L1,Mortality factor 4-like protein 1,42949,99,0.73 [0.42-1.28],0.2779419098451468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORF4L2,Mortality factor 4-like protein 2,42186,96,0.52 [0.27-1.01],0.0552887489991427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MORN4,MORN repeat-containing protein 4,42186,96,0.79 [0.58-1.07],0.1325848265044805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPHOSPH8,M-phase phosphoprotein 8,49383,114,1.10 [0.89-1.36],0.3954484038299218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPI,Mannose-6-phosphate isomerase,50063,116,1.02 [0.84-1.23],0.8781950269603784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,50436,120,1.06 [0.85-1.31],0.6208556714511466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPO,Myeloperoxidase,50317,118,1.11 [0.79-1.55],0.5423648485718533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MPRIP,Myosin phosphatase Rho-interacting protein,43455,99,0.84 [0.54-1.32],0.4566406815290889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRC1,Macrophage mannose receptor 1,43781,100,2.64 [1.45-4.78],0.0014376766495042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRI1,Methylthioribose-1-phosphate isomerase,42549,97,1.10 [0.82-1.47],0.5241709464844737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL24,"39S ribosomal protein L24, mitochondrial",42299,95,0.70 [0.38-1.29],0.2518981471577466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL28,"39S ribosomal protein L28, mitochondrial",43667,97,1.09 [0.68-1.74],0.7286295069620985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL46,"39S ribosomal protein L46, mitochondrial",49125,114,0.60 [0.31-1.15],0.1241129895400196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL52,"39S ribosomal protein L52, mitochondrial",42106,96,1.06 [0.52-2.17],0.8659131361969663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",43667,97,1.07 [0.82-1.38],0.6309710089700238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRPS16,"28S ribosomal protein S16, mitochondrial",42481,99,0.76 [0.51-1.11],0.152340578364479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSLN,Mesothelin,49981,116,1.04 [0.80-1.37],0.7530782866227166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSLNL,Mesothelin-like protein,42549,97,0.69 [0.39-1.23],0.2085578761023061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSMB,Beta-microseminoprotein,50179,116,1.07 [0.85-1.35],0.5421397369707992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSR1,Macrophage scavenger receptor types I and II,50746,120,1.64 [1.16-2.31],0.0048046123747333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSRA,Mitochondrial peptide methionine sulfoxide reductase,50453,117,1.06 [0.85-1.33],0.6077438406482676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MST1,Hepatocyte growth factor-like protein,43125,98,1.08 [0.78-1.50],0.6508996036580308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSTN,Growth/differentiation factor 8,49383,114,1.00 [0.73-1.36],0.9830544239550996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTDH,Protein LYRIC,42481,99,1.06 [0.86-1.30],0.5973388503785799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",43641,99,0.68 [0.30-1.57],0.3685340519177057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,42949,99,0.94 [0.79-1.12],0.4778237951805415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTIF3,"Translation initiation factor IF-3, mitochondrial",43557,98,0.96 [0.77-1.19],0.7044006887115672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTPN,Myotrophin,49383,114,1.00 [0.60-1.66],0.9960964594398708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTR,Methionine synthase,42299,95,0.89 [0.64-1.24],0.4960966394653545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTSS1,Protein MTSS 1,43557,98,1.00 [0.85-1.19],0.9658901641592708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTSS2,Protein MTSS 2,43536,100,1.07 [0.88-1.29],0.5010101932510043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTUS1,Microtubule-associated tumor suppressor 1,42949,99,1.32 [0.98-1.78],0.0640132136973686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC13,Mucin-13,49125,114,1.21 [0.88-1.66],0.2315533570000793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC16,Mucin-16,50063,116,1.04 [0.95-1.14],0.3924569800834361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUC2,Mucin-2,43751,100,1.02 [0.83-1.25],0.8416743782492807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MUCL3,Mucin-like protein 3,42186,96,0.80 [0.47-1.36],0.4146083033771309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MVK,Mevalonate kinase,49349,116,1.24 [1.02-1.50],0.0301561142034779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MXRA8,Matrix remodeling-associated protein 8,42800,100,0.80 [0.43-1.49],0.4820340216057326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYBPC1,"Myosin-binding protein C, slow-type",43744,99,1.15 [0.89-1.48],0.2920403274526698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYBPC2,"Myosin-binding protein C, fast-type",42584,98,1.03 [0.82-1.29],0.7967743213588285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,43667,97,1.00 [0.74-1.34],0.977845216079292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYDGF,Myeloid-derived growth factor,43744,99,1.06 [0.87-1.28],0.5576657274225769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH4,Myosin-4,42299,95,0.86 [0.54-1.38],0.5357928604507785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH7B,Myosin-7B,42186,96,1.14 [0.75-1.73],0.5351695834539738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYH9,Myosin-9,43751,100,1.00 [0.85-1.18],0.987837872816677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",42299,95,1.15 [0.75-1.77],0.5236690410598743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL3,Myosin light chain 3,42584,98,1.03 [0.79-1.33],0.8527567218835183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL4,Myosin light chain 4,42584,98,0.89 [0.61-1.30],0.5442916046713877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYL6B,Myosin light chain 6B,42549,97,0.88 [0.69-1.12],0.2936992363864188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",42549,97,0.94 [0.62-1.43],0.7702638845967095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYO6,Unconventional myosin-VI,43667,97,0.87 [0.50-1.53],0.6313874488816678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYO9B,Unconventional myosin-IXb,49349,116,0.86 [0.66-1.12],0.2587603894455946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOC,Myocilin,50317,118,0.98 [0.69-1.41],0.9270881084877868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM1,Myomesin-1,42326,94,1.01 [0.67-1.54],0.94786352957449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM2,Myomesin-2,42299,95,0.89 [0.59-1.34],0.5766929653949537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MYOM3,Myomesin-3,42800,100,0.97 [0.79-1.19],0.8001120967190167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MZB1,Marginal zone B- and B1-cell-specific protein,50433,120,1.21 [0.90-1.63],0.2161567389906558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MZT1,Mitotic-spindle organizing protein 1,49115,114,1.01 [0.73-1.39],0.9549135255386946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAA10,N-alpha-acetyltransferase 10,42299,95,0.89 [0.60-1.31],0.542598349523022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAA80,N-alpha-acetyltransferase 80,42549,97,0.98 [0.83-1.15],0.8256055726974894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAAA,N-acylethanolamine-hydrolyzing acid amidase,49680,117,0.82 [0.62-1.08],0.1574751740263801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NACC1,Nucleus accumbens-associated protein 1,43536,100,0.99 [0.70-1.41],0.9690324716058184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NADK,NAD kinase,50298,118,1.19 [0.92-1.54],0.1751025655406877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGA,Alpha-N-acetylgalactosaminidase,42402,99,0.78 [0.52-1.19],0.2513505582316481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGK,N-acetyl-D-glucosamine kinase,42505,98,0.87 [0.61-1.23],0.4359468675024229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,42800,100,2.80 [1.19-6.60],0.0185324848949408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAMPT,Nicotinamide phosphoribosyltransferase,49115,114,0.96 [0.70-1.32],0.8059537857581867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAP1L4,Nucleosome assembly protein 1-like 4,43476,98,0.95 [0.60-1.50],0.811676767892676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAPRT,Nicotinate phosphoribosyltransferase,43641,99,1.02 [0.57-1.83],0.9393337277228996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NARS1,"Asparagine--tRNA ligase, cytoplasmic",43667,97,0.97 [0.65-1.47],0.9023164393133846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NBL1,Neuroblastoma suppressor of tumorigenicity 1,50453,117,1.24 [0.68-2.26],0.4827744755805613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NBN,Nibrin,49349,116,1.12 [0.86-1.46],0.4166521883594181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAM1,Neural cell adhesion molecule 1,50498,119,1.09 [0.65-1.83],0.7457195869158089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAM2,Neural cell adhesion molecule 2,50317,118,0.45 [0.25-0.83],0.0104857823186411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAN,Neurocan core protein,50746,120,0.51 [0.34-0.77],0.0014609964444888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCF2,Neutrophil cytosol factor 2,50141,119,1.02 [0.85-1.22],0.8497152343427128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCK2,Cytoplasmic protein NCK2,50517,120,1.06 [0.91-1.23],0.4564251166705321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCLN,Nicalin,49349,116,0.67 [0.42-1.06],0.0851373496206677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCR1,Natural cytotoxicity triggering receptor 1,50154,118,1.26 [0.82-1.93],0.2872282329347023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,43557,98,1.90 [1.12-3.21],0.0165448625335649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCS1,Neuronal calcium sensor 1,50729,120,1.19 [0.68-2.09],0.5372157343417014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDRG1,Protein NDRG1,49125,114,0.70 [0.50-0.99],0.0413967463299583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,43536,100,0.94 [0.67-1.30],0.6949908441578337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,42409,99,1.48 [0.87-2.50],0.1441337482812548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,43557,98,1.04 [0.84-1.29],0.7102206937119317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",49115,114,1.09 [0.90-1.31],0.3979362642019903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEB,Nebulin,42299,95,1.51 [1.05-2.18],0.0279101009776916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECAP2,Adaptin ear-binding coat-associated protein 2,42299,95,0.86 [0.63-1.17],0.3321755609866433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN1,Nectin-1,42481,99,0.93 [0.51-1.70],0.8167654118155065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN2,Nectin-2,50223,118,1.62 [0.98-2.69],0.0603042579072789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NECTIN4,Nectin-4,50453,117,1.20 [0.73-1.96],0.4703541336024371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,42481,99,0.79 [0.54-1.16],0.2239022239958993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEDD9,Enhancer of filamentation 1,42481,99,0.94 [0.53-1.67],0.8227389049887373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEFL,Neurofilament light polypeptide,48970,114,1.97 [1.50-2.58],8.31574102786701e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEK7,Serine/threonine-protein kinase Nek7,42949,99,0.96 [0.73-1.26],0.768044308169881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NELL1,Protein kinase C-binding protein NELL1,50453,117,1.07 [0.73-1.56],0.7444703232560741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NELL2,Protein kinase C-binding protein NELL2,50517,120,0.93 [0.53-1.62],0.7984052143458092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NENF,Neudesin,43536,100,0.84 [0.68-1.05],0.1267337952318576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEO1,Neogenin,43667,97,0.83 [0.34-2.03],0.6866211451231854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEXN,Nexilin,43781,100,0.88 [0.66-1.17],0.3708924092330654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFASC,Neurofascin,50851,119,1.49 [0.85-2.60],0.1615244273600282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFAT5,Nuclear factor of activated T-cells 5,42481,99,1.00 [0.80-1.25],0.9916977657257704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",50225,119,1.10 [0.93-1.30],0.2554955221976412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",49349,116,1.20 [0.92-1.55],0.1721079727735945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFE2,Transcription factor NF-E2 45 kDa subunit,42584,98,0.93 [0.71-1.21],0.5846946442173349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFIC,Nuclear factor 1 C-type,43667,97,0.66 [0.36-1.23],0.1889794450759192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKB1,Nuclear factor NF-kappa-B p105 subunit,42299,95,1.00 [0.76-1.31],0.9844026308912938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKB2,Nuclear factor NF-kappa-B p100 subunit,42949,99,0.90 [0.61-1.34],0.6191866830643267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKBIE,NF-kappa-B inhibitor epsilon,49115,114,1.36 [0.99-1.85],0.0557036392418103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",43557,98,1.01 [0.83-1.21],0.9458017715783508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFX1,Transcriptional repressor NF-X1,42299,95,1.06 [0.79-1.41],0.7069278441204196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFYA,Nuclear transcription factor Y subunit alpha,42299,95,1.02 [0.62-1.68],0.9383557838909397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGF,Beta-nerve growth factor,49913,118,0.65 [0.31-1.40],0.273199262440207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGFR,Tumor necrosis factor receptor superfamily member 16,43744,99,0.95 [0.49-1.86],0.882300863091479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NGRN,Neugrin,43641,99,0.91 [0.38-2.20],0.83668498428258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NHLRC3,NHL repeat-containing protein 3,41764,98,1.85 [1.00-3.44],0.050617238371753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID1,Nidogen-1,50336,119,1.56 [1.03-2.36],0.0345701756846497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID2,Nidogen-2,50317,118,1.12 [0.90-1.38],0.3132616285061991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NINJ1,Ninjurin-1,49115,114,0.88 [0.62-1.25],0.4779650265608937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NIT1,Deaminated glutathione amidase,42584,98,1.02 [0.67-1.55],0.9269190601568172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NIT2,Omega-amidase NIT2,43578,98,1.08 [0.83-1.40],0.5771252427035782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NLGN1,Neuroligin-1,42549,97,1.02 [0.77-1.36],0.8975984978450274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NLGN2,Neuroligin-2,42326,94,0.92 [0.58-1.45],0.7239327271619579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NME1,Nucleoside diphosphate kinase A,42481,99,0.46 [0.18-1.19],0.1081289414213148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NME3,Nucleoside diphosphate kinase 3,50352,120,0.67 [0.32-1.38],0.2758637885335054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMI,N-myc-interactor,43370,100,1.20 [0.93-1.54],0.1645972330739157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,49913,118,1.02 [0.83-1.26],0.8338305968462347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMRK2,Nicotinamide riboside kinase 2,42186,96,0.84 [0.49-1.46],0.548165771203148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,43667,97,0.89 [0.65-1.22],0.4854520563276754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOMO1,Nodal modulator 1,50317,118,0.93 [0.46-1.87],0.8435961733480655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOP56,Nucleolar protein 56,42299,95,1.04 [0.88-1.24],0.6285169556367544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS1,"Nitric oxide synthase, brain",49125,114,1.09 [0.80-1.47],0.5878046068410665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS2,"Nitric oxide synthase, inducible",42299,95,0.83 [0.49-1.40],0.4843563441367388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS3,"Nitric oxide synthase, endothelial",49125,114,1.37 [1.08-1.74],0.0089073068209845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH1,Neurogenic locus notch homolog protein 1,50919,116,0.47 [0.17-1.31],0.1478213572640081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH2,Neurogenic locus notch homolog protein 2,43751,100,1.10 [0.49-2.48],0.8234244550177462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOTCH3,Neurogenic locus notch homolog protein 3,50919,116,1.01 [0.63-1.64],0.9591316989122808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPC2,NPC intracellular cholesterol transporter 2,43011,98,1.93 [1.24-3.00],0.0037785671483307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPDC1,Neural proliferation differentiation and control protein 1,50298,118,1.43 [0.90-2.27],0.1316996523955386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPHS1,Nephrin,42481,99,0.98 [0.56-1.74],0.953563519295412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPHS2,Podocin,42481,99,1.08 [0.91-1.28],0.389593743359159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPL,N-acetylneuraminate lyase,43744,99,1.55 [1.05-2.27],0.0257942229390307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPPB,Natriuretic peptides B,49383,114,1.14 [1.01-1.29],0.0390686906629804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPPC,C-type natriuretic peptide,50225,119,1.13 [0.82-1.55],0.4571803533996765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPR1,Atrial natriuretic peptide receptor 1,42299,95,0.95 [0.56-1.59],0.8356088602229927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTN,Neuroplastin,49115,114,0.96 [0.76-1.20],0.6878578817046365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTX1,Neuronal pentraxin-1,50317,118,1.36 [0.92-1.99],0.1213277907920944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTX2,Neuronal pentraxin-2,43751,100,1.74 [0.99-3.07],0.0536036118443561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPTXR,Neuronal pentraxin receptor,50298,118,1.05 [0.65-1.67],0.853071123331819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPY,Pro-neuropeptide Y,50729,120,1.05 [0.82-1.35],0.6756819687642306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRCAM,Neuronal cell adhesion molecule,50298,118,1.05 [0.59-1.85],0.8764815066322734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRGN,Neurogranin,43781,100,1.03 [0.84-1.27],0.7702783194486935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRN1,Neuritin,43667,97,0.70 [0.36-1.36],0.2939873955368453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRP1,Neuropilin-1,50583,119,1.61 [0.90-2.87],0.10781948024984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRP2,Neuropilin-2,50317,118,1.52 [0.89-2.59],0.1247967592572819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRTN,Neurturin,49349,116,1.33 [1.02-1.74],0.0374081637772397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRXN3,Neurexin-3,42549,97,0.41 [0.19-0.88],0.0224863631248615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NSFL1C,NSFL1 cofactor p47,50746,120,1.09 [0.85-1.39],0.48452206183356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",43744,99,0.93 [0.71-1.21],0.5801433958130462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C1A,Cytosolic 5'-nucleotidase 1A,43641,99,1.67 [1.08-2.59],0.0201539883295499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C3A,Cytosolic 5'-nucleotidase 3A,50145,117,1.02 [0.85-1.23],0.8302865135172945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5E,5'-nucleotidase,50453,117,1.63 [1.27-2.08],9.792235348929446e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTF3,Neurotrophin-3,50225,119,1.71 [1.16-2.52],0.006822805304513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTF4,Neurotrophin-4,49115,114,1.13 [0.77-1.66],0.5271823694256073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTRK2,BDNF/NT-3 growth factors receptor,50298,118,0.61 [0.32-1.15],0.1269259324806079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTRK3,NT-3 growth factor receptor,50746,120,0.60 [0.29-1.24],0.1659148639323147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTproBNP,N-terminal prohormone of brain natriuretic peptide,50298,118,1.20 [1.05-1.38],0.0075684938782615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUB1,NEDD8 ultimate buster 1,50225,119,1.05 [0.87-1.27],0.6257989626573752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,43536,100,0.92 [0.75-1.14],0.4612920582018749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUCB2,Nucleobindin-2,50647,120,1.36 [0.89-2.07],0.1501983227833643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDC,Nuclear migration protein nudC,50851,119,1.12 [0.87-1.45],0.3721011804164874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,42584,98,1.06 [0.51-2.22],0.8773548697526803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,42299,95,0.93 [0.62-1.40],0.726823350549429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT16,U8 snoRNA-decapping enzyme,43482,98,1.06 [0.85-1.32],0.6223493090169893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],50063,116,0.99 [0.74-1.32],0.9438478858976262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUDT5,ADP-sugar pyrophosphatase,50317,118,1.11 [0.81-1.52],0.5264962204245118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUMB,Protein numb homolog,42481,99,0.99 [0.79-1.25],0.9484790398335792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUP50,Nuclear pore complex protein Nup50,42299,95,0.96 [0.52-1.77],0.8869920484651024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPE4,NXPE family member 4,42299,95,1.13 [0.65-1.97],0.6603194213743062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPH1,Neurexophilin-1,49125,114,1.09 [0.72-1.67],0.678159264960198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NXPH3,Neurexophilin-3,42481,99,0.65 [0.35-1.20],0.1705028888056103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OBP2B,Odorant-binding protein 2b,49748,118,0.94 [0.73-1.23],0.6696373214432993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OCLN,Occludin,43667,97,1.70 [1.16-2.49],0.0066377469671033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ODAM,Odontogenic ameloblast-associated protein,49041,114,0.91 [0.67-1.25],0.5681731993468715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OFD1,Oral-facial-digital syndrome 1 protein,42949,99,1.00 [0.75-1.35],0.9777354074040028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGA,Protein O-GlcNAcase,43557,98,1.00 [0.76-1.32],0.9887111775532172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGFR,Opioid growth factor receptor,50063,116,1.07 [0.65-1.76],0.7869860135331026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGN,Mimecan,50317,118,1.19 [0.81-1.73],0.3744074430813783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,42949,99,0.90 [0.64-1.26],0.5328649395941885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OLFM4,Olfactomedin-4,41206,95,1.01 [0.85-1.18],0.948106048293689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OLR1,Oxidized low-density lipoprotein receptor 1,49809,117,0.92 [0.69-1.21],0.5344957901793255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMD,Osteomodulin,50517,120,1.40 [0.95-2.06],0.0905894966651349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMG,Oligodendrocyte-myelin glycoprotein,50063,116,0.91 [0.71-1.15],0.4247622342996309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OMP,Olfactory marker protein,42326,94,0.97 [0.64-1.47],0.8845794390220478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPHN1,Oligophrenin-1,43641,99,1.06 [0.88-1.26],0.5408455224518551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPLAH,5-oxoprolinase,42584,98,0.92 [0.69-1.23],0.564823876805701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OPTC,Opticin,50063,116,0.86 [0.58-1.25],0.4243024293258707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ORM1,Alpha-1-acid glycoprotein 1,43656,100,1.29 [0.50-3.32],0.5932280861780541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSBPL2,Oxysterol-binding protein-related protein 2,43641,99,0.79 [0.44-1.41],0.4289967618587172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSCAR,Osteoclast-associated immunoglobulin-like receptor,50352,120,0.94 [0.59-1.49],0.7820709017105087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSM,Oncostatin-M,49986,119,1.02 [0.82-1.28],0.8362308679582748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSMR,Oncostatin-M-specific receptor subunit beta,50583,119,1.43 [0.64-3.19],0.3875293720176835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OSTN,Osteocrin,42549,97,0.81 [0.47-1.37],0.4262197752104837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTOA,Otoancorin,42326,94,0.96 [0.65-1.41],0.8291806745824415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTUD6B,Deubiquitinase OTUD6B,43557,98,0.96 [0.69-1.33],0.7881676604152053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OTUD7B,OTU domain-containing protein 7B,43667,97,0.98 [0.72-1.34],0.8977276728535072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",42584,98,1.05 [0.80-1.38],0.7310448157592898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OXT,Oxytocin-neurophysin 1,50746,120,1.05 [0.94-1.17],0.4045145950476905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,P4HB,Protein disulfide-isomerase,50047,117,1.10 [0.72-1.67],0.6583043707988412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PACS2,Phosphofurin acidic cluster sorting protein 2,42299,95,0.94 [0.68-1.31],0.7331689102112773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PADI2,Protein-arginine deiminase type-2,49349,116,0.89 [0.64-1.23],0.4723883360940536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PADI4,Protein-arginine deiminase type-4,49041,114,0.95 [0.76-1.20],0.689645467307241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAEP,Glycodelin,49913,118,1.03 [0.89-1.19],0.6732377154637235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,43667,97,0.84 [0.67-1.04],0.1151261089883427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",42949,99,0.80 [0.53-1.21],0.2869681061561255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,49383,114,1.16 [0.87-1.54],0.313830243570717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAGR1,PAXIP1-associated glutamate-rich protein 1,42584,98,0.74 [0.45-1.21],0.2267951101146821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,42110,96,0.76 [0.50-1.14],0.1851289457189109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAK4,Serine/threonine-protein kinase PAK 4,49125,114,1.00 [0.76-1.31],0.9958786262843904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALLD,Palladin,42481,99,0.85 [0.49-1.47],0.5588498364612835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM,Paralemmin-1,43319,98,1.23 [0.67-2.24],0.5031869798927273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM2,Paralemmin-2,43641,99,2.03 [1.36-3.03],0.0004952992588271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM3,Paralemmin-3,42299,95,0.80 [0.56-1.14],0.2229226068500248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAM,Peptidyl-glycine alpha-amidating monooxygenase,50672,116,1.10 [0.61-1.99],0.7554705925385536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAMR1,Inactive serine protease PAMR1,50317,118,0.89 [0.49-1.61],0.6998939653680154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAPPA,Pappalysin-1,49349,116,0.78 [0.55-1.11],0.1664323515127339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARD3,Partitioning defective 3 homolog,42949,99,1.09 [0.85-1.39],0.5050227668996345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARK7,Parkinson disease protein 7,50317,118,0.99 [0.73-1.35],0.9595442082017748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARP1,Poly [ADP-ribose] polymerase 1,50225,119,1.15 [0.91-1.45],0.2297804153555842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAXX,Protein PAXX,42800,100,1.14 [0.75-1.71],0.5436403850214468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBK,Lymphokine-activated killer T-cell-originated protein kinase,42186,96,0.91 [0.48-1.71],0.763504297499414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBLD,Phenazine biosynthesis-like domain-containing protein,49125,114,1.01 [0.73-1.41],0.9316521162708442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,43557,98,0.65 [0.32-1.31],0.225298173874109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCARE,Photoreceptor cilium actin regulator,42326,94,0.95 [0.74-1.23],0.7089327666308527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,42719,100,1.67 [1.17-2.37],0.0044754976375812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBP2,Poly(rC)-binding protein 2,43667,97,0.94 [0.72-1.23],0.6376614702053949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH1,Protocadherin-1,50688,117,1.38 [0.69-2.76],0.3638231503176552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH12,Protocadherin-12,43667,97,1.14 [0.54-2.44],0.7285726742147991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH17,Protocadherin-17,50298,118,1.53 [1.00-2.35],0.0509655111807872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH7,Protocadherin-7,43557,98,0.80 [0.44-1.47],0.480578057413179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH9,Protocadherin-9,43557,98,1.69 [0.97-2.96],0.0653313327551925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDHB15,Protocadherin beta-15,43536,100,0.86 [0.53-1.40],0.5369185681553856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCNA,Proliferating cell nuclear antigen,42186,96,0.95 [0.69-1.32],0.7751510830963536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCSK7,Proprotein convertase subtilisin/kexin type 7,43536,100,1.30 [0.92-1.82],0.1318221350641464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCSK9,Proprotein convertase subtilisin/kexin type 9,50919,116,1.09 [0.72-1.64],0.6832264421180021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCYT2,Ethanolamine-phosphate cytidylyltransferase,43557,98,1.06 [0.82-1.36],0.654867438821169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDAP1,28 kDa heat- and acid-stable phosphoprotein,43744,99,0.97 [0.79-1.18],0.7383871114392148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD1,Programmed cell death protein 1,50645,120,1.23 [0.86-1.77],0.2497367658578777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD1LG2,Programmed cell death 1 ligand 2,50063,116,0.78 [0.46-1.32],0.3607739439600339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD5,Programmed cell death protein 5,50746,120,1.10 [0.84-1.45],0.4751368338057002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCD6,Programmed cell death protein 6,50298,118,1.06 [0.83-1.36],0.6193327347760251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDCL2,Phosducin-like protein 2,42186,96,0.96 [0.66-1.41],0.8447538748253602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",42186,96,1.16 [0.86-1.57],0.3397571930981398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",42299,95,1.02 [0.74-1.41],0.9011789954909302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",42800,100,1.10 [0.91-1.33],0.301369529415925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFA,Platelet-derived growth factor subunit A,50919,116,1.03 [0.83-1.29],0.7678505027087876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFB,Platelet-derived growth factor subunit B,50517,120,1.04 [0.86-1.25],0.6668093024225118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFC,Platelet-derived growth factor C,49115,114,1.20 [0.68-2.13],0.5372041781322041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFRA,Platelet-derived growth factor receptor alpha,50298,118,1.14 [0.65-2.00],0.65211249723553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDGFRB,Platelet-derived growth factor receptor beta,50919,116,0.84 [0.53-1.33],0.4576265958602769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA2,Protein disulfide-isomerase A2,42186,96,0.97 [0.59-1.59],0.8979087912311924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA3,Protein disulfide-isomerase A3,42800,100,1.74 [1.01-3.01],0.0472764586143618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA4,Protein disulfide-isomerase A4,43751,100,1.00 [0.73-1.36],0.9839286904383316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA5,Protein disulfide-isomerase A5,42186,96,0.87 [0.62-1.24],0.4497121892806346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDLIM5,PDZ and LIM domain protein 5,43667,97,1.00 [0.85-1.17],0.9642292276516092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDLIM7,PDZ and LIM domain protein 7,50517,120,0.98 [0.87-1.12],0.8074953826658189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",49115,114,1.08 [0.79-1.48],0.6172721797238496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDRG1,p53 and DNA damage-regulated protein 1,42549,97,0.78 [0.50-1.20],0.2557355716814489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,42186,96,0.82 [0.53-1.26],0.3684690361292828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZD2,PDZ domain-containing protein 2,42299,95,1.20 [0.89-1.62],0.2305878101540588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,42481,99,1.55 [1.08-2.23],0.018276521410318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEAR1,Platelet endothelial aggregation receptor 1,50919,116,0.95 [0.46-1.95],0.8894420344339069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEBP1,Phosphatidylethanolamine-binding protein 1,50317,118,1.13 [0.86-1.49],0.370796973877287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PECAM1,Platelet endothelial cell adhesion molecule,50317,118,1.23 [0.73-2.09],0.4378342276749972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PECR,Peroxisomal trans-2-enoyl-CoA reductase,42584,98,0.57 [0.26-1.24],0.1588562294113262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PENK,Proenkephalin-A,42800,100,1.54 [0.94-2.53],0.0897920893942866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PEPD,Xaa-Pro dipeptidase,43781,100,0.97 [0.47-2.01],0.9426376707404748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PER3,Period circadian protein homolog 3,42481,99,1.10 [0.94-1.29],0.2246219713085736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PF4,Platelet factor 4,43489,101,1.13 [0.93-1.37],0.2144978983156359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN2,Prefoldin subunit 2,49125,114,1.01 [0.74-1.36],0.9642288103617408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN4,Prefoldin subunit 4,42186,96,0.53 [0.33-0.84],0.0066670088365869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN6,Prefoldin subunit 6,42549,97,0.98 [0.72-1.33],0.8827895327354262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",49980,115,0.97 [0.78-1.20],0.7620135493143978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGA4,Pepsin A-4,43781,100,1.07 [0.83-1.37],0.6076552502703823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",43744,99,1.18 [0.83-1.68],0.3466040005582878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGF,Placenta growth factor,50851,119,1.40 [0.77-2.53],0.2708541027211665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP1,Peptidoglycan recognition protein 1,50674,116,1.24 [0.87-1.78],0.2378968950033092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,43254,100,1.06 [0.56-2.01],0.8642545000230869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP4,Peptidoglycan recognition protein 4,42299,95,0.94 [0.66-1.33],0.7124085099832486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGM2,Phosphoglucomutase-2,42549,97,0.95 [0.67-1.35],0.7837314817351898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGR,Progesterone receptor,42481,99,0.77 [0.57-1.03],0.0763193918624948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHACTR2,Phosphatase and actin regulator 2,43667,97,1.01 [0.85-1.20],0.893085146043643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHLDB1,Pleckstrin homology-like domain family B member 1,43557,98,1.16 [0.81-1.66],0.4150199233262259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHLDB2,Pleckstrin homology-like domain family B member 2,42186,96,1.15 [0.97-1.37],0.116224780517253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,49913,118,1.01 [0.58-1.75],0.9703514413936272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,42800,100,1.61 [1.02-2.53],0.0403943947422143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PI16,Peptidase inhibitor 16,43781,100,1.07 [0.50-2.30],0.8526789836101112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PI3,Elafin,49636,114,0.86 [0.63-1.17],0.3402968548184613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",43667,97,0.97 [0.76-1.25],0.8263034859140406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIGR,Polymeric immunoglobulin receptor,49660,118,1.59 [1.04-2.42],0.0313667697051273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,50225,119,1.13 [0.87-1.45],0.3588737925270288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,50317,118,1.14 [0.65-2.01],0.6531460435045369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,42481,99,0.85 [0.58-1.24],0.3916723712059814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PILRA,Paired immunoglobulin-like type 2 receptor alpha,50317,118,1.37 [0.93-2.01],0.1130891714613087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PILRB,Paired immunoglobulin-like type 2 receptor beta,50298,118,1.27 [0.94-1.71],0.1135308346315003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,42800,100,1.09 [0.82-1.44],0.5572282020317324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PITHD1,PITH domain-containing protein 1,42110,96,0.92 [0.70-1.21],0.5669618524717737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKD1,Polycystin-1,43744,99,1.60 [0.78-3.32],0.2027288404606016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKD2,Polycystin-2,42299,95,1.11 [0.80-1.53],0.5459064726782261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKLR,Pyruvate kinase PKLR,50351,120,1.13 [0.89-1.42],0.3192053018414001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKN3,Serine/threonine-protein kinase N3,42949,99,0.92 [0.71-1.21],0.5595676840598862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G10,Group 10 secretory phospholipase A2,49913,118,1.18 [0.89-1.56],0.2437261806998087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G15,Phospholipase A2 group XV,50453,117,2.25 [1.28-3.96],0.0046859188681027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G1B,Phospholipase A2,50839,116,0.89 [0.62-1.29],0.5408375102952616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G2A,"Phospholipase A2, membrane associated",50203,115,1.21 [0.94-1.56],0.1478553829315627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G4A,Cytosolic phospholipase A2,50517,120,1.07 [0.89-1.28],0.4814728822970201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G7,Platelet-activating factor acetylhydrolase,50317,118,0.82 [0.51-1.32],0.419635147857483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAT,Tissue-type plasminogen activator,50754,116,1.07 [0.78-1.48],0.6731997192342305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAU,Urokinase-type plasminogen activator,50317,118,0.91 [0.52-1.60],0.7547941210481653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLAUR,Urokinase plasminogen activator surface receptor,49937,120,1.64 [0.95-2.83],0.0780731619702108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLB1,"Phospholipase B1, membrane-associated",43641,99,0.98 [0.71-1.36],0.9152193510140688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",42481,99,0.82 [0.49-1.36],0.4365114562233737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",43641,99,0.94 [0.78-1.15],0.5661446491532356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLEKHO1,Pleckstrin homology domain-containing family O member 1,43641,99,0.98 [0.74-1.29],0.8947780998255522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLG,Plasminogen,42694,100,0.81 [0.33-1.97],0.6431139626633355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLIN1,Perilipin-1,49125,114,1.09 [0.68-1.74],0.7306522918374194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLIN3,Perilipin-3,50298,118,1.02 [0.70-1.49],0.9216184599225504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLPBP,Pyridoxal phosphate homeostasis protein,50298,118,1.06 [0.83-1.34],0.6442703860504672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLSCR3,Phospholipid scramblase 3,43561,99,1.01 [0.73-1.41],0.932940050614002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLTP,Phospholipid transfer protein,50756,116,0.68 [0.44-1.05],0.0802310899225063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXDC1,Plexin domain-containing protein 1,49115,114,0.77 [0.44-1.36],0.3707345235379681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXDC2,Plexin domain-containing protein 2,43641,99,0.75 [0.36-1.57],0.4533696389036818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNA4,Plexin-A4,50225,119,0.97 [0.80-1.18],0.782902253163885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB2,Plexin-B2,50672,116,2.10 [1.10-3.98],0.0237840257934038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB3,Plexin-B3,50135,118,1.01 [0.72-1.42],0.9539568839119056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,50056,117,1.08 [0.99-1.19],0.0968519529234695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMCH,Pro-MCH,42299,95,1.04 [0.83-1.30],0.7321572091129744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMM2,Phosphomannomutase 2,42299,95,0.96 [0.69-1.35],0.8328971524066753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMS1,PMS1 protein homolog 1,42549,97,1.09 [0.76-1.57],0.6313304889332788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PMVK,Phosphomevalonate kinase,49046,113,1.01 [0.87-1.17],0.9057418041550978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIP,Pancreatic triacylglycerol lipase,43781,100,0.97 [0.72-1.30],0.8250111598175123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIPRP1,Inactive pancreatic lipase-related protein 1,43641,99,1.03 [0.82-1.31],0.7967915379387471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNLIPRP2,Pancreatic lipase-related protein 2,50268,120,1.00 [0.94-1.05],0.8653354364942439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNMA1,Paraneoplastic antigen Ma1,42584,98,0.91 [0.64-1.30],0.6111052242900905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNMA2,Paraneoplastic antigen Ma2,42326,94,1.15 [0.75-1.74],0.5285957172176541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",49349,116,1.01 [0.88-1.17],0.8617505765323679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PODXL,Podocalyxin,50063,116,0.61 [0.21-1.77],0.363952482442198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PODXL2,Podocalyxin-like protein 2,50453,117,1.38 [0.78-2.43],0.2714204671481303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POF1B,Protein POF1B,42481,99,1.11 [0.74-1.66],0.6059289997925872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POLR2A,DNA-directed RNA polymerase II subunit RPB1,42481,99,0.80 [0.40-1.60],0.5298443151518593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",50063,116,1.35 [0.93-1.96],0.1161461952350066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POMC,Pro-opiomelanocortin,42584,98,0.91 [0.69-1.19],0.4809606348313382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON1,Serum paraoxonase/arylesterase 1,43781,100,1.07 [0.54-2.12],0.8532107708908961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON2,Serum paraoxonase/arylesterase 2,49383,114,1.12 [0.70-1.79],0.6432039862273864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON3,Serum paraoxonase/lactonase 3,50517,120,0.66 [0.50-0.88],0.0047992414071421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POSTN,Periostin,43751,100,0.88 [0.53-1.46],0.6104214789878007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPBP,Platelet basic protein,43490,101,1.07 [0.85-1.34],0.5621549435450666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPCDC,Phosphopantothenoylcysteine decarboxylase,50746,120,1.21 [0.86-1.68],0.2729732483735791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIB,Peptidyl-prolyl cis-trans isomerase B,50342,115,1.01 [0.85-1.20],0.8926691829452955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIE,Peptidyl-prolyl cis-trans isomerase E,42949,99,1.10 [0.83-1.46],0.4962990961616995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",43751,100,0.88 [0.64-1.21],0.4314576966302443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPL,Periplakin,42481,99,0.95 [0.52-1.74],0.8796352895884576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1A,Protein phosphatase 1A,49115,114,0.74 [0.42-1.30],0.2926526750808782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1B,Protein phosphatase 1B,42481,99,0.70 [0.45-1.09],0.112636906938876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPM1F,Protein phosphatase 1F,43744,99,0.99 [0.69-1.42],0.9523385127729492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPME1,Protein phosphatase methylesterase 1,50063,116,1.11 [0.85-1.46],0.4366374137477392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,43536,100,0.93 [0.74-1.18],0.5639043218108177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,50453,117,1.10 [0.93-1.30],0.2800088601376017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,42949,99,0.97 [0.74-1.28],0.8360893662460156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,43667,97,0.92 [0.71-1.18],0.4937803363669518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,43667,97,1.19 [0.75-1.89],0.4554784745065623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R2,Protein phosphatase inhibitor 2,50298,118,1.01 [0.82-1.24],0.9182424408973268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP1R9B,Neurabin-2,50851,119,1.03 [0.87-1.22],0.7281045842057351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,43557,98,0.96 [0.81-1.12],0.5817879556407468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPP3R1,Calcineurin subunit B type 1,49913,118,1.02 [0.68-1.51],0.9372820750495297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPT1,Palmitoyl-protein thioesterase 1,42549,97,1.05 [0.83-1.34],0.6853659391337219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPY,Pancreatic prohormone,50221,116,1.18 [1.01-1.37],0.0401259735796321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PQBP1,Polyglutamine-binding protein 1,49115,114,1.04 [0.79-1.38],0.7785689881347823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRAME,Melanoma antigen preferentially expressed in tumors,42186,96,0.76 [0.35-1.67],0.4961770398053822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRAP1,Proline-rich acidic protein 1,43751,100,1.13 [0.71-1.81],0.6072907459150667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRC1,Protein regulator of cytokinesis 1,43536,100,0.85 [0.50-1.44],0.54018454205293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRCP,Lysosomal Pro-X carboxypeptidase,50606,115,1.23 [0.74-2.04],0.4189775327157319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX1,Peroxiredoxin-1,48871,114,0.91 [0.75-1.10],0.3311537406269207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX2,Peroxiredoxin-2,43048,97,1.00 [0.74-1.36],0.9964260266728712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",49349,116,1.10 [0.88-1.37],0.4216728806964959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX5,"Peroxiredoxin-5, mitochondrial",50851,119,0.98 [0.77-1.25],0.8761253316348415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRDX6,Peroxiredoxin-6,50729,120,0.97 [0.75-1.27],0.8390254406026129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PREB,Prolactin regulatory element-binding protein,49349,116,1.56 [1.01-2.40],0.0442129542516316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRELP,Prolargin,50268,120,0.90 [0.46-1.76],0.7566080498136467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRG2,Bone marrow proteoglycan,43751,100,1.22 [0.86-1.73],0.273682185079729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRG3,Proteoglycan 3,43751,100,0.86 [0.60-1.24],0.4337817360369197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,49349,116,1.04 [0.77-1.41],0.8026385868968597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,42549,97,0.75 [0.38-1.48],0.411372616769899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,50298,118,0.94 [0.77-1.14],0.5219883497315584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,43557,99,0.96 [0.76-1.22],0.7274165140764648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKCQ,Protein kinase C theta type,49349,116,0.80 [0.53-1.23],0.3108427738507008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKD2,Serine/threonine-protein kinase D2,42299,95,0.80 [0.47-1.35],0.4028539994618951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKG1,cGMP-dependent protein kinase 1,42800,100,1.01 [0.87-1.17],0.911414671260616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,49115,114,1.10 [0.86-1.41],0.4377702613369195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRL,Prolactin,50746,120,1.10 [0.90-1.36],0.3538924376106005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRND,Prion-like protein doppel,43641,99,1.13 [0.78-1.63],0.5102801188537041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROC,Vitamin K-dependent protein C,50417,119,0.94 [0.50-1.76],0.8435008359487309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROCR,Endothelial protein C receptor,42299,95,1.04 [0.60-1.80],0.8754818807411853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROK1,Prokineticin-1,50225,119,0.95 [0.71-1.26],0.7172325680704823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PROS1,Vitamin K-dependent protein S,43812,101,0.75 [0.35-1.59],0.4491737349827266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRR4,Proline-rich protein 4,42485,100,1.07 [0.82-1.40],0.6121427097900612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRR5,Proline-rich protein 5,42481,99,0.85 [0.54-1.33],0.4703057999534402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRRT3,Proline-rich transmembrane protein 3,42584,98,0.81 [0.49-1.34],0.409887000589325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS2,Trypsin-2,50498,119,1.27 [0.97-1.67],0.0835404044001141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS22,Brain-specific serine protease 4,42481,99,0.94 [0.53-1.65],0.8269139125180467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS27,Serine protease 27,50135,118,0.90 [0.60-1.34],0.5900808449385508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS53,Serine protease 53,43641,99,0.92 [0.57-1.48],0.7378577887774829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS8,Prostasin,50098,120,1.17 [0.80-1.71],0.4155534310321969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,49125,114,1.02 [0.88-1.19],0.7682313777710267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTG,Protogenin,50729,120,1.02 [0.53-1.96],0.952069383570756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRTN3,Myeloblastin,49041,114,1.02 [0.73-1.42],0.9298280270934828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRUNE2,Protein prune homolog 2,42949,99,1.27 [0.70-2.30],0.4345981263167454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAP,Prosaposin,43337,99,2.29 [1.49-3.53],0.0001536833332765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAPL1,Proactivator polypeptide-like 1,43557,98,0.75 [0.51-1.10],0.136845195979676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSCA,Prostate stem cell antigen,43557,98,1.01 [0.94-1.09],0.7514166781392142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSG1,Pregnancy-specific beta-1-glycoprotein 1,49913,118,1.07 [0.92-1.25],0.3520576259699116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSIP1,PC4 and SFRS1-interacting protein,50225,119,1.15 [0.93-1.43],0.1935276960945794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMA1,Proteasome subunit alpha type-1,49115,114,0.77 [0.52-1.16],0.2091183898840442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMC3,26S proteasome regulatory subunit 6A,42186,96,1.16 [0.62-2.17],0.6447409491939106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD1,26S proteasome non-ATPase regulatory subunit 1,43667,97,0.81 [0.54-1.22],0.3090901857938712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD5,26S proteasome non-ATPase regulatory subunit 5,42549,97,1.21 [0.91-1.61],0.1866315281354228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMD9,26S proteasome non-ATPase regulatory subunit 9,50063,116,1.14 [0.86-1.51],0.3606067441701248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSME1,Proteasome activator complex subunit 1,49830,118,1.32 [0.86-2.03],0.20225069591233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSME2,Proteasome activator complex subunit 2,49681,118,1.32 [0.85-2.04],0.2148394121969567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMG3,Proteasome assembly chaperone 3,50225,119,1.26 [0.93-1.71],0.1302879999815397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMG4,Proteasome assembly chaperone 4,42481,99,1.02 [0.74-1.42],0.8968256855962526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSPN,Persephin,50225,119,1.04 [0.87-1.24],0.6579347339209309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSRC1,Proline/serine-rich coiled-coil protein 1,49115,114,1.16 [0.89-1.51],0.2731635153393819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,41271,96,1.07 [0.89-1.30],0.4605013583173917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",49125,114,1.14 [0.66-1.96],0.6444921363473471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGDS,Prostaglandin-H2 D-isomerase,49924,119,1.31 [0.80-2.16],0.2830330739133209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGES2,Prostaglandin E synthase 2,42158,99,1.01 [0.71-1.44],0.9571483410398596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTGR1,Prostaglandin reductase 1,43744,99,1.12 [0.90-1.41],0.3097987232774712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTH,Parathyroid hormone,42549,97,0.94 [0.74-1.19],0.5986930317011854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,50225,119,1.09 [0.73-1.62],0.6727023649157542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTK7,Inactive tyrosine-protein kinase 7,49125,114,0.82 [0.53-1.28],0.3897702669616526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTN,Pleiotrophin,49383,114,1.35 [0.98-1.86],0.0676933882411572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTP4A3,Protein tyrosine phosphatase type IVA 3,42481,99,1.25 [0.91-1.71],0.1619549356251827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,49913,118,1.05 [0.86-1.29],0.6189914058984353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,50436,120,1.06 [0.88-1.27],0.5524635765121406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,42403,99,1.10 [0.68-1.78],0.7007645600391075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRB,Receptor-type tyrosine-protein phosphatase beta,43744,99,2.49 [1.37-4.51],0.0027093187340033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRC,Receptor-type tyrosine-protein phosphatase C,43751,100,1.55 [0.71-3.41],0.2733342928271386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRF,Receptor-type tyrosine-protein phosphatase F,50919,116,0.77 [0.44-1.35],0.3622101487886404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRH,Receptor-type tyrosine-protein phosphatase H,43557,98,1.38 [0.94-2.03],0.09587611656573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,43557,98,1.35 [0.60-3.00],0.4666515918533198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRM,Receptor-type tyrosine-protein phosphatase mu,50144,119,0.83 [0.43-1.60],0.5776990127132055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,49748,118,1.12 [0.69-1.83],0.6495961880832808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRR,Receptor-type tyrosine-protein phosphatase R,43641,99,0.90 [0.54-1.51],0.6875504912434962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRS,Receptor-type tyrosine-protein phosphatase S,50919,116,0.87 [0.45-1.67],0.6705369384227584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,43744,99,1.19 [0.66-2.15],0.5741539299559968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,42800,100,1.00 [0.72-1.38],0.9844122203929486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTS,6-pyruvoyl tetrahydrobiopterin synthase,48891,113,1.54 [1.18-2.00],0.0012972060226393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTTG1,Securin,42949,99,0.78 [0.47-1.30],0.3413721397808366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTX3,Pentraxin-related protein PTX3,50225,119,1.31 [0.92-1.87],0.1342388616061719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PVALB,Parvalbumin alpha,50498,118,1.03 [0.89-1.18],0.7305046769364925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PVR,Poliovirus receptor,50746,120,1.27 [0.84-1.92],0.2563421602353598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PXDNL,Peroxidasin-like protein,43536,100,1.13 [0.85-1.50],0.3910326950987364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PXN,Paxillin,49125,114,0.96 [0.69-1.33],0.8038391274481317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PYDC1,Pyrin domain-containing protein 1,42584,98,0.97 [0.60-1.56],0.8869678830946658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PYY,Peptide YY,42299,95,1.09 [0.90-1.32],0.3745135617885642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PZP,Pregnancy zone protein,43812,101,1.03 [0.70-1.52],0.8802832559542866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QDPR,Dihydropteridine reductase,50054,117,1.09 [0.75-1.59],0.6528753689780875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QPCT,Glutaminyl-peptide cyclotransferase,50359,115,1.23 [0.68-2.22],0.4954413648988205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QSOX1,Sulfhydryl oxidase 1,42921,100,1.25 [0.89-1.75],0.2006620561567967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB10,Ras-related protein Rab-10,43744,99,0.89 [0.62-1.29],0.5451936450659326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB11FIP3,Rab11 family-interacting protein 3,43744,99,0.99 [0.83-1.19],0.9526617342967418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB27B,Ras-related protein Rab-27B,43744,99,1.01 [0.80-1.27],0.9661851546600412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB2B,Ras-related protein Rab-2B,43536,100,0.89 [0.65-1.23],0.4915739303920959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB33A,Ras-related protein Rab-33A,42299,95,0.88 [0.65-1.19],0.3986889616578257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB37,Ras-related protein Rab-37,49349,116,1.10 [0.91-1.32],0.3195541223753724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB39B,Ras-related protein Rab-39B,42299,95,1.05 [0.86-1.29],0.6361177610051902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,42326,94,1.35 [1.08-1.70],0.0091267201281821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB44,Ras-related protein Rab-44,43536,100,0.97 [0.63-1.50],0.8907473250701825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB6A,Ras-related protein Rab-6A,50225,119,0.85 [0.60-1.22],0.3848373351034506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB6B,Ras-related protein Rab-6B,49125,114,0.98 [0.69-1.40],0.9147029710719856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABEP1,Rab GTPase-binding effector protein 1,42800,100,1.00 [0.78-1.28],0.9742217653280002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABEPK,Rab9 effector protein with kelch motifs,49115,114,1.29 [1.01-1.64],0.0374009656349988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABGAP1L,Rab GTPase-activating protein 1-like,49349,116,1.17 [0.90-1.53],0.2386352936702211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAC3,Ras-related C3 botulinum toxin substrate 3,42549,97,1.06 [0.82-1.39],0.6493866535374762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAD23B,UV excision repair protein RAD23 homolog B,49115,114,0.88 [0.61-1.27],0.4905330669631794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAD51,DNA repair protein RAD51 homolog 1,42949,99,1.14 [0.84-1.55],0.391208020646739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RALB,Ras-related protein Ral-B,42481,99,0.63 [0.33-1.20],0.1595765107760071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RALY,RNA-binding protein Raly,43536,100,1.27 [0.93-1.74],0.1292867647480517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANBP1,Ran-specific GTPase-activating protein,42584,98,0.83 [0.57-1.21],0.3276555532611785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANBP2,E3 SUMO-protein ligase RanBP2,42326,94,0.86 [0.46-1.61],0.6422742975723744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANGAP1,Ran GTPase-activating protein 1,49115,114,0.63 [0.41-0.96],0.0315068054434554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAP1A,Ras-related protein Rap-1A,42481,99,0.88 [0.63-1.22],0.4348704806031421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAPGEF2,Rap guanine nucleotide exchange factor 2,42949,99,0.77 [0.52-1.14],0.1968703074513529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES1,Retinoic acid receptor responder protein 1,49115,114,1.29 [0.85-1.94],0.2262984685563472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES2,Retinoic acid receptor responder protein 2,50583,119,1.20 [0.88-1.66],0.2500219664310875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASA1,Ras GTPase-activating protein 1,49125,114,0.83 [0.49-1.40],0.4767449480847604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,42186,96,1.01 [0.65-1.59],0.951343443178181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASSF2,Ras association domain-containing protein 2,49115,114,1.06 [0.81-1.39],0.6760875175828052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBFOX3,RNA binding protein fox-1 homolog 3,43667,97,1.44 [0.95-2.18],0.0876698550863342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBKS,Ribokinase,49128,117,1.07 [0.78-1.48],0.6765864508719717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM17,Splicing factor 45,43667,97,1.10 [0.86-1.41],0.4478700621902854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM19,Probable RNA-binding protein 19,42299,95,0.84 [0.52-1.35],0.467130125957265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBM25,RNA-binding protein 25,42186,96,1.31 [0.89-1.92],0.1776655048367059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP1,Retinol-binding protein 1,42549,97,0.79 [0.55-1.14],0.2100143320458249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP2,Retinol-binding protein 2,50063,116,1.04 [0.85-1.29],0.6806685921430942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP5,Retinol-binding protein 5,50063,116,1.31 [1.00-1.73],0.0531224195910076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP7,Retinoid-binding protein 7,43557,98,0.95 [0.70-1.31],0.7728785692502849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBPMS,RNA-binding protein with multiple splicing,42481,99,0.77 [0.52-1.13],0.1772151314537668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBPMS2,RNA-binding protein with multiple splicing 2,42584,98,0.94 [0.77-1.13],0.5016461698391035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RCC1,Regulator of chromosome condensation,43536,100,1.39 [1.06-1.84],0.0177711388136791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RCOR1,REST corepressor 1,49383,114,0.95 [0.63-1.41],0.7868664690438778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,42584,98,1.20 [0.47-3.05],0.707973846992647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REEP4,Receptor expression-enhancing protein 4,43667,97,0.86 [0.62-1.20],0.3766730796697388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG1A,Lithostathine-1-alpha,50011,119,1.20 [0.89-1.63],0.2336128810899573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG1B,Lithostathine-1-beta,50919,116,1.12 [0.85-1.47],0.4294056925439393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG3A,Regenerating islet-derived protein 3-alpha,50919,116,1.23 [0.96-1.56],0.0972243957024479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG3G,Regenerating islet-derived protein 3-gamma,43536,100,1.04 [0.65-1.67],0.855639159491095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG4,Regenerating islet-derived protein 4,50352,120,1.07 [0.78-1.46],0.6824259592015792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RELB,Transcription factor RelB,42481,99,0.91 [0.60-1.39],0.6754453388000827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RELT,Tumor necrosis factor receptor superfamily member 19L,50317,118,1.52 [0.89-2.59],0.1263092599402962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REN,Renin,50298,118,0.94 [0.76-1.16],0.5559932369322629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REPS1,RalBP1-associated Eps domain-containing protein 1,42481,99,0.63 [0.36-1.10],0.1007838534910176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REST,RE1-silencing transcription factor,42186,96,1.42 [0.89-2.29],0.1452069341078348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,50063,116,0.83 [0.54-1.26],0.3747121082876765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RETN,Resistin,50187,115,1.21 [0.84-1.74],0.3092678826717884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REXO2,"Oligoribonuclease, mitochondrial",42299,95,0.99 [0.66-1.49],0.955308528749349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RFC4,Replication factor C subunit 4,43536,100,0.93 [0.37-2.30],0.8697331137233941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGCC,Regulator of cell cycle RGCC,43667,97,0.90 [0.70-1.16],0.4213410223312304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,42949,99,1.15 [0.89-1.48],0.2950616644329384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGMA,Repulsive guidance molecule A,50746,120,0.83 [0.50-1.38],0.4799994556038147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGMB,RGM domain family member B,50746,120,0.66 [0.36-1.20],0.1736444538423901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGS10,Regulator of G-protein signaling 10,43667,97,0.85 [0.61-1.19],0.3437875371634381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGS8,Regulator of G-protein signaling 8,49349,116,0.94 [0.71-1.22],0.6255699877378682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RHOC,Rho-related GTP-binding protein RhoC,49619,117,1.04 [0.90-1.20],0.5913728376490337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RICTOR,Rapamycin-insensitive companion of mTOR,42481,99,1.08 [0.75-1.57],0.671043289366973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,42800,100,1.50 [1.06-2.12],0.0209256371687886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RILP,Rab-interacting lysosomal protein,50582,119,1.21 [0.93-1.58],0.1540089429140163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RILPL2,RILP-like protein 2,43744,99,1.01 [0.83-1.23],0.8838735400354887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,42299,95,0.89 [0.64-1.23],0.4762303509192329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RLN1,Prorelaxin H1,43667,97,1.26 [0.99-1.62],0.0642985323506498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RLN2,Prorelaxin H2,42723,100,1.06 [0.84-1.34],0.6229016124847045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE1,Ribonuclease pancreatic,43781,100,2.14 [1.28-3.56],0.0036539994515698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE10,Inactive ribonuclease-like protein 10,42584,98,0.88 [0.58-1.34],0.5552461980597879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE3,Eosinophil cationic protein,50058,118,0.95 [0.82-1.10],0.5237168635328564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE4,Ribonuclease 4,42325,95,1.46 [0.76-2.79],0.2545488569920092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE6,Ribonuclease K6,43466,99,1.87 [1.32-2.64],0.0003743568237158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASEH2A,Ribonuclease H2 subunit A,43667,97,0.82 [0.53-1.27],0.372547268950654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASET2,Ribonuclease T2,50683,115,1.64 [0.94-2.87],0.0802984808123028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF149,E3 ubiquitin-protein ligase RNF149,42584,98,1.65 [0.96-2.86],0.0719258490620256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF168,E3 ubiquitin-protein ligase RNF168,42481,99,0.69 [0.40-1.20],0.1933952782235565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF31,E3 ubiquitin-protein ligase RNF31,42481,99,0.90 [0.51-1.60],0.7140303577780343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF4,E3 ubiquitin-protein ligase RNF4,42949,99,0.94 [0.69-1.28],0.6871795764780362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF41,E3 ubiquitin-protein ligase NRDP1,49115,114,1.00 [0.78-1.29],0.9841696758596644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF43,E3 ubiquitin-protein ligase RNF43,42949,99,0.87 [0.59-1.27],0.4597208182663943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF5,E3 ubiquitin-protein ligase RNF5,42584,98,1.08 [0.82-1.41],0.5882212133306056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO1,Roundabout homolog 1,50352,120,1.51 [0.78-2.90],0.2216375518346147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO2,Roundabout homolog 2,50746,120,0.59 [0.29-1.20],0.1449354034186435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROBO4,Roundabout homolog 4,42584,98,0.97 [0.33-2.90],0.9619203848710778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,50298,118,0.96 [0.58-1.58],0.8589932399728193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RP2,Protein XRP2,50063,116,1.03 [0.70-1.51],0.8793509926349516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPA2,Replication protein A 32 kDa subunit,42481,99,0.70 [0.36-1.39],0.3147176201837538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPE,Ribulose-phosphate 3-epimerase,42949,99,0.94 [0.71-1.25],0.6741624930473924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPGR,X-linked retinitis pigmentosa GTPase regulator,42549,97,0.96 [0.59-1.56],0.8714541455208522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPL14,60S ribosomal protein L14,42584,98,0.76 [0.44-1.30],0.3130306759850539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RPS10,40S ribosomal protein S10,42299,95,0.68 [0.38-1.20],0.1788001327675019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRAS,Ras-related protein R-Ras,42549,97,0.99 [0.85-1.15],0.9121170269600885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRM2,Ribonucleoside-diphosphate reductase subunit M2,49115,114,1.36 [1.09-1.69],0.0071689126040062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,49115,114,0.97 [0.76-1.24],0.7995645920341832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRP15,RRP15-like protein,42326,94,1.06 [0.86-1.32],0.5607161698516241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RSPO1,R-spondin-1,49913,118,1.12 [0.70-1.79],0.6335892181456062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RSPO3,R-spondin-3,50729,120,1.17 [0.67-2.05],0.5856174409343273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTBDN,Retbindin,50063,116,1.00 [0.58-1.73],0.996705450351739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTKN2,Rhotekin-2,42299,95,1.30 [0.97-1.73],0.0760159243977683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",43667,97,0.97 [0.79-1.20],0.7937693329810735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTN4R,Reticulon-4 receptor,50729,120,1.45 [0.94-2.23],0.0907620123731439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RUVBL1,RuvB-like 1,49115,114,1.04 [0.89-1.21],0.6436421659556527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RWDD1,RWD domain-containing protein 1,50746,120,1.09 [0.85-1.41],0.495815540883989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RYR1,Ryanodine receptor 1,42299,95,0.97 [0.54-1.75],0.9173437501931934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A11,Protein S100-A11,49900,118,1.03 [0.74-1.43],0.8661995908560512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A12,Protein S100-A12,49582,115,1.06 [0.85-1.32],0.6013293138002617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A13,Protein S100-A13,42481,99,1.08 [0.64-1.84],0.7748223573282648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A14,Protein S100-A14,43667,97,1.17 [0.83-1.65],0.3613531261604801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A16,Protein S100-A16,49041,114,0.89 [0.67-1.18],0.4174173530090804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A3,Protein S100-A3,43536,100,0.42 [0.20-0.85],0.0169189899045801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A4,Protein S100-A4,50453,117,1.03 [0.77-1.38],0.8416120389656585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100G,Protein S100-G,43667,97,1.11 [0.76-1.64],0.5893667736326872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100P,Protein S100-P,49383,114,1.14 [0.87-1.49],0.3306584410773115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAA4,Serum amyloid A-4 protein,43812,101,1.48 [1.04-2.09],0.0285282513067231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAFB2,Scaffold attachment factor B2,43667,97,0.78 [0.37-1.67],0.523509060613758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAG,S-arrestin,42326,94,1.15 [0.81-1.65],0.4324266126046072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAMD9L,Sterile alpha motif domain-containing protein 9-like,50225,119,1.04 [0.84-1.30],0.7143005517212431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAP18,Histone deacetylase complex subunit SAP18,42949,99,0.72 [0.55-0.95],0.0214469320701967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SARG,Specifically androgen-regulated gene protein,43575,99,1.04 [0.88-1.24],0.6346529954811428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SART1,U4/U6.U5 tri-snRNP-associated protein 1,42299,95,1.18 [0.76-1.84],0.4589961256053989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAT1,Diamine acetyltransferase 1,42299,95,0.70 [0.43-1.14],0.1546368038990701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAT2,Thialysine N-epsilon-acetyltransferase,42949,99,0.69 [0.49-0.97],0.033005118301731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SATB1,DNA-binding protein SATB1,43667,97,0.88 [0.43-1.78],0.7135847482943314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SBSN,Suprabasin,43669,100,0.79 [0.46-1.38],0.4086938080128612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCAMP3,Secretory carrier-associated membrane protein 3,50063,116,1.09 [0.90-1.32],0.380544873504049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARA5,Scavenger receptor class A member 5,50746,120,0.94 [0.55-1.61],0.8198314877692363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB1,Scavenger receptor class B member 1,49125,114,1.06 [0.80-1.40],0.6998553791696741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB2,Lysosome membrane protein 2,48955,113,1.98 [1.28-3.06],0.0022786603300056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARF1,Scavenger receptor class F member 1,50919,116,1.20 [0.82-1.76],0.344830951406783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARF2,Scavenger receptor class F member 2,50746,120,1.04 [0.60-1.82],0.887757959501233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCG2,Secretogranin-2,50500,119,1.51 [0.94-2.45],0.0908169211809914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCG3,Secretogranin-3,50352,120,0.95 [0.59-1.53],0.8393017971707637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB1A1,Uteroglobin,50348,119,1.03 [0.78-1.37],0.8306235978574794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB2A2,Mammaglobin-A,42299,95,1.18 [0.65-2.13],0.5872834875276153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB3A1,Secretoglobin family 3A member 1,42800,100,0.92 [0.44-1.92],0.8179411349795344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGB3A2,Secretoglobin family 3A member 2,50436,120,0.88 [0.71-1.08],0.2113963739513051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCGN,Secretagogin,49349,116,1.10 [0.77-1.58],0.5871461692541573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCIN,Adseverin,42326,94,1.07 [0.83-1.39],0.5815253779003278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCLY,Selenocysteine lyase,50582,119,1.77 [1.30-2.40],0.0002720669099987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN2A,Sodium channel protein type 2 subunit alpha,42326,94,1.22 [0.86-1.74],0.2672426735157926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN2B,Sodium channel subunit beta-2,42549,97,1.03 [0.52-2.04],0.9278886207829934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN3A,Sodium channel protein type 3 subunit alpha,42549,97,0.97 [0.56-1.67],0.9077764742657274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN3B,Sodium channel subunit beta-3,42326,94,0.82 [0.51-1.32],0.4160071043496499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN4B,Sodium channel subunit beta-4,42584,98,0.81 [0.51-1.28],0.3643073346485521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCP2,Non-specific lipid-transfer protein,49115,114,1.10 [0.90-1.35],0.3506426182365582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCPEP1,Retinoid-inducible serine carboxypeptidase,42426,98,1.03 [0.70-1.52],0.8885740038231741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRG1,Scrapie-responsive protein 1,43744,99,1.27 [0.67-2.44],0.4628394738866945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRIB,Protein scribble homolog,42584,98,1.06 [0.86-1.30],0.608047899599345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCRN1,Secernin-1,50225,119,1.00 [0.75-1.34],0.9975713454903964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCT,Secretin,42549,97,0.83 [0.55-1.27],0.396876844507851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC1,Syndecan-1,50298,118,1.72 [1.20-2.46],0.0029031499440718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC4,Syndecan-4,50298,118,0.87 [0.62-1.22],0.4224439640770393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDCCAG8,Serologically defined colon cancer antigen 8,43536,100,1.01 [0.86-1.20],0.8634583135179216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDHB,Succinate dehydrogenase,43557,98,1.18 [0.91-1.54],0.2151525219432395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDK2,Protein sidekick-2,42800,100,1.01 [0.61-1.67],0.9750488872661544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEC31A,Protein transport protein Sec31A,42584,98,1.05 [0.82-1.36],0.6888899663755417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEL1L,Protein sel-1 homolog 1,42584,98,1.37 [0.88-2.15],0.1628050685038856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELE,E-selectin,50919,116,1.27 [0.92-1.77],0.1458551758098047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELENOP,Selenoprotein P,43812,101,0.82 [0.36-1.90],0.6446744561326839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELL,L-selectin,43812,101,1.29 [0.57-2.91],0.5455430279382689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELP,P-selectin,50498,119,0.97 [0.73-1.29],0.8488669709073318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SELPLG,P-selectin glycoprotein ligand 1,50225,119,0.77 [0.48-1.23],0.2708225327536452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA3F,Semaphorin-3F,50298,118,1.22 [0.66-2.23],0.5245899316970205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA3G,Semaphorin-3G,42800,100,1.44 [0.97-2.12],0.0677111001109431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA4C,Semaphorin-4C,50063,116,1.09 [0.62-1.93],0.7630627384061645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA4D,Semaphorin-4D,50746,120,0.97 [0.57-1.66],0.9244225114783567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA6C,Semaphorin-6C,42481,99,0.67 [0.29-1.52],0.33580428279631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA7A,Semaphorin-7A,50754,116,1.71 [1.05-2.78],0.030885567282064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN3,Neuronal-specific septin-3,43667,97,0.91 [0.70-1.19],0.4942738143941169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN7,Septin-7,42949,99,0.67 [0.41-1.08],0.0975429218596797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN8,Septin-8,43558,99,1.59 [0.97-2.62],0.0675291981156433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEPTIN9,Septin-9,50063,116,0.69 [0.37-1.27],0.2279921899976975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA1,Alpha-1-antitrypsin,42991,99,2.26 [0.27-18.91],0.4524528541743733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA11,Serpin A11,50919,116,1.20 [0.80-1.79],0.3819461087531134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA12,Serpin A12,48849,115,1.02 [0.89-1.17],0.8054792058642789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA3,Alpha-1-antichymotrypsin,43649,101,2.07 [0.71-6.04],0.1808049676843579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA4,Kallistatin,43006,101,0.95 [0.43-2.11],0.8993379886017622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA5,Plasma serine protease inhibitor,43173,101,0.53 [0.27-1.04],0.0657435251515919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA6,Corticosteroid-binding globulin,43812,101,2.32 [0.75-7.18],0.1459780701906585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA7,Thyroxine-binding globulin,43812,101,1.20 [0.44-3.30],0.7182491582588688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA9,Serpin A9,49825,116,1.04 [0.83-1.29],0.7510056656609697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB1,Leukocyte elastase inhibitor,50149,118,1.01 [0.85-1.21],0.8825514551413497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB5,Serpin B5,49383,114,0.94 [0.67-1.32],0.7224394564853454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB6,Serpin B6,50579,120,0.98 [0.74-1.29],0.8895168906008258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB8,Serpin B8,50851,119,1.02 [0.78-1.33],0.8901332270356082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB9,Serpin B9,49913,118,1.29 [0.79-2.12],0.3154225537539454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINC1,Antithrombin-III,43730,101,1.48 [0.41-5.30],0.549402311768066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPIND1,Heparin cofactor 2,43730,101,1.16 [0.60-2.24],0.6689740722050046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINE1,Plasminogen activator inhibitor 1,50919,116,0.96 [0.76-1.22],0.7503277488616885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINE2,Glia-derived nexin,43744,99,0.99 [0.74-1.34],0.9638038481890476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINF1,Pigment epithelium-derived factor,43156,98,0.79 [0.38-1.64],0.5207796981045996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINF2,Alpha-2-antiplasmin,42998,99,1.44 [0.36-5.83],0.6061903945079331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPING1,Plasma protease C1 inhibitor,43730,101,1.15 [0.42-3.18],0.7840054231992812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINH1,Serpin H1,42949,99,1.03 [0.89-1.20],0.651881522845984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINI1,Neuroserpin,42720,100,0.69 [0.35-1.35],0.2807104277307831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINI2,Serpin I2,43557,98,1.02 [0.74-1.42],0.8910348314744897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,49125,114,1.03 [0.80-1.34],0.8076945393156162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SETMAR,Histone-lysine N-methyltransferase SETMAR,49749,118,1.61 [1.00-2.60],0.0505098401225138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6,Seizure protein 6 homolog,42549,97,0.82 [0.43-1.57],0.5479029475979252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6L,Seizure 6-like protein,50453,117,1.13 [0.63-2.02],0.689200725189165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6L2,Seizure 6-like protein 2,50063,116,1.51 [0.78-2.95],0.2247418419118196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SF3B4,Splicing factor 3B subunit 4,50063,116,0.92 [0.74-1.15],0.4717571409098678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFRP1,Secreted frizzled-related protein 1,49749,118,1.26 [0.88-1.80],0.2104352280685505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFRP4,Secreted frizzled-related protein 4,42800,100,1.23 [0.76-1.98],0.3951862888378097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPA1,Pulmonary surfactant-associated protein A1,49115,114,1.10 [0.84-1.44],0.5031200432172085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPA2,Pulmonary surfactant-associated protein A2,49115,114,1.32 [0.98-1.76],0.063621075168938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SFTPD,Pulmonary surfactant-associated protein D,50298,118,1.00 [0.79-1.27],0.9900245555570384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SGSH,N-sulphoglucosamine sulphohydrolase,43009,99,1.21 [0.88-1.68],0.2373648563422231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH2B3,SH2B adapter protein 3,49115,114,1.07 [0.91-1.28],0.4087626696444608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH2D1A,SH2 domain-containing protein 1A,50225,119,1.14 [0.89-1.47],0.2845334057274433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,42326,94,0.87 [0.60-1.26],0.4634816979661541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3BP1,SH3 domain-binding protein 1,43557,98,0.96 [0.64-1.44],0.8552829420472928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3GL3,Endophilin-A3,42704,99,0.89 [0.71-1.11],0.2871092997006473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SH3GLB2,Endophilin-B2,43641,99,0.91 [0.68-1.21],0.4979898811388855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHBG,Sex hormone-binding globulin,43781,100,0.85 [0.58-1.24],0.3909620294916023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHC1,SHC-transforming protein 1,42186,96,1.09 [0.93-1.27],0.2868581543236654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHD,SH2 domain-containing adapter protein D,42219,95,1.03 [0.82-1.29],0.801292151037429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHH,Sonic hedgehog protein,42481,99,0.87 [0.54-1.39],0.5534818097359357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHISA5,Protein shisa-5,43751,100,1.94 [1.18-3.17],0.0086547797303575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHMT1,"Serine hydroxymethyltransferase, cytosolic",50436,120,1.08 [0.90-1.31],0.4018639091527317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHPK,Sedoheptulokinase,42949,99,0.91 [0.55-1.50],0.6996367615456898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIAE,Sialate O-acetylesterase,50369,117,1.33 [0.95-1.87],0.0992268879272753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC1,Sialoadhesin,50517,120,1.40 [0.97-2.02],0.0729882231992417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC10,Sialic acid-binding Ig-like lectin 10,50225,119,1.69 [1.12-2.56],0.0132410478651528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC15,Sialic acid-binding Ig-like lectin 15,49125,114,0.97 [0.78-1.21],0.7993602794705813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC5,Sialic acid-binding Ig-like lectin 5,50317,118,0.99 [0.87-1.13],0.8478925326678021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC6,Sialic acid-binding Ig-like lectin 6,50729,120,1.37 [0.86-2.20],0.1835436815851507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC7,Sialic acid-binding Ig-like lectin 7,50298,118,1.24 [0.70-2.20],0.4699983112742091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC8,Sialic acid-binding Ig-like lectin 8,42584,98,1.38 [0.91-2.08],0.1302087321210029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC9,Sialic acid-binding Ig-like lectin 9,50656,119,1.05 [0.62-1.78],0.8472384868969105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIL1,Nucleotide exchange factor SIL1,42584,98,1.24 [0.75-2.05],0.4037436465299482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,50428,115,0.99 [0.75-1.32],0.9624630397209132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRPB1,Signal-regulatory protein beta-1,50183,120,1.14 [0.81-1.60],0.4571988111634369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT1,NAD-dependent protein deacetylase sirtuin-1,42481,99,0.71 [0.50-1.01],0.0564979543940639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT2,NAD-dependent protein deacetylase sirtuin-2,50063,116,1.03 [0.85-1.24],0.7884461947541845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",49125,114,1.01 [0.75-1.37],0.93669542534879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIT1,Signaling threshold-regulating transmembrane adapter 1,49349,116,1.10 [0.82-1.48],0.5188040396966167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKAP1,Src kinase-associated phosphoprotein 1,49830,118,1.03 [0.83-1.29],0.7940293340471611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKAP2,Src kinase-associated phosphoprotein 2,50517,120,0.95 [0.81-1.11],0.4959532442130981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SKIV2L,Helicase SKI2W,42299,95,1.10 [0.69-1.77],0.6901557314542305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLA2,Src-like-adapter 2,43667,97,0.98 [0.82-1.18],0.8697184623792531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF1,Signaling lymphocytic activation molecule,49349,116,1.31 [0.99-1.73],0.0613093528473848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF6,SLAM family member 6,49115,114,1.57 [1.07-2.30],0.0213562967680207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF7,SLAM family member 7,50225,119,1.31 [1.01-1.71],0.0452212493562301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF8,SLAM family member 8,49115,114,1.28 [0.94-1.76],0.1190356502518694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC12A2,Solute carrier family 12 member 2,42299,95,1.00 [0.48-2.08],0.9996619594653564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC13A1,Solute carrier family 13 member 1,43536,100,1.07 [0.79-1.43],0.6715698789640838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC16A1,Monocarboxylate transporter 1,49125,114,1.28 [1.02-1.62],0.0364977315858074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC1A4,Neutral amino acid transporter A,42549,97,1.00 [0.68-1.47],0.9986372973326284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC27A4,Long-chain fatty acid transport protein 4,49125,114,0.92 [0.70-1.20],0.5330341513466329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC28A1,Sodium/nucleoside cotransporter 1,42186,96,0.91 [0.63-1.30],0.6068170328655185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC34A3,Sodium-dependent phosphate transport protein 2C,42186,96,1.12 [0.77-1.63],0.5528517283609239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC39A14,Zinc transporter ZIP14,49125,114,1.00 [0.61-1.63],0.9974444408591372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC39A5,Zinc transporter ZIP5,50225,119,0.80 [0.59-1.09],0.1604729586133968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC44A4,Choline transporter-like protein 4,42549,97,0.95 [0.71-1.29],0.7591545569926232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC4A1,Band 3 anion transport protein,43751,100,0.88 [0.59-1.32],0.5340132397600015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC51B,Organic solute transporter subunit beta,42299,95,1.17 [0.92-1.48],0.1998865618928949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,42800,100,1.00 [0.79-1.25],0.9679898579629111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,43557,98,0.98 [0.66-1.44],0.900216632729283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",42186,96,1.04 [0.74-1.45],0.8413934079232172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLIT2,Slit homolog 2 protein,49125,114,0.99 [0.72-1.37],0.9527867712045086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK1,SLIT and NTRK-like protein 1,42481,99,0.58 [0.32-1.05],0.073099562878384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK2,SLIT and NTRK-like protein 2,50729,120,1.14 [0.77-1.70],0.5137183432041099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK6,SLIT and NTRK-like protein 6,49383,114,0.60 [0.37-0.98],0.0427767539853217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLK,STE20-like serine/threonine-protein kinase,42949,99,0.99 [0.77-1.28],0.9447079417513672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLMAP,Sarcolemmal membrane-associated protein,43557,98,1.00 [0.79-1.26],0.9844786993098652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLURP1,Secreted Ly-6/uPAR-related protein 1,43433,100,1.30 [0.84-2.02],0.2344972612385543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD1,Mothers against decapentaplegic homolog 1,49115,114,1.06 [0.87-1.30],0.5408503677176595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD2,Mothers against decapentaplegic homolog 2,43536,100,0.96 [0.72-1.26],0.7596822080467326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD3,Mothers against decapentaplegic homolog 3,43536,100,0.90 [0.62-1.31],0.586861118072729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMAD5,Mothers against decapentaplegic homolog 5,50063,116,0.75 [0.33-1.68],0.486604860898117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMARCA2,Probable global transcription activator SNF2L2,49125,114,1.01 [0.80-1.27],0.93166572535642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMC3,Structural maintenance of chromosomes protein 3,42186,96,1.04 [0.73-1.48],0.8293203867528458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMNDC1,Survival of motor neuron-related-splicing factor 30,43557,98,1.03 [0.77-1.39],0.8326391088376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMOC1,SPARC-related modular calcium-binding protein 1,50729,120,1.46 [0.91-2.33],0.1150913690459205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMOC2,SPARC-related modular calcium-binding protein 2,50517,120,1.20 [0.80-1.82],0.3784214194725677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPD1,Sphingomyelin phosphodiesterase,50498,120,0.94 [0.68-1.29],0.6877432149525622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPD3,Sphingomyelin phosphodiesterase 3,42481,99,0.61 [0.36-1.03],0.065165927605183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,50432,120,0.90 [0.71-1.14],0.3885642777451805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,43536,100,0.99 [0.77-1.28],0.9674999124551612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMS,Spermine synthase,42326,94,0.87 [0.62-1.23],0.4419173534949888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SMTN,Smoothelin,43556,99,0.97 [0.78-1.19],0.743117774268892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP23,Synaptosomal-associated protein 23,50298,118,1.06 [0.88-1.28],0.5539534860131945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP25,Synaptosomal-associated protein 25,42326,94,1.22 [0.81-1.84],0.3379656298023953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAP29,Synaptosomal-associated protein 29,50453,117,1.08 [0.90-1.29],0.3943277911245034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNAPIN,SNARE-associated protein Snapin,43667,97,0.77 [0.54-1.09],0.1429398898005369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNCA,Alpha-synuclein,42800,100,1.01 [0.85-1.19],0.943479561340926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNCG,Gamma-synuclein,49913,118,1.07 [0.84-1.38],0.5671525773820126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",42584,98,1.17 [0.66-2.09],0.5923542078210927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNRPB2,U2 small nuclear ribonucleoprotein B'',43641,99,1.00 [0.66-1.52],0.996528372815115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNU13,NHP2-like protein 1,42299,95,0.55 [0.34-0.88],0.0122867697889458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX15,Sorting nexin-15,42800,100,1.14 [0.80-1.61],0.462867610422237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX18,Sorting nexin-18,43557,98,1.00 [0.64-1.55],0.9840045327916984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX2,Sorting nexin-2,43536,100,0.82 [0.63-1.06],0.1230525454871898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX5,Sorting nexin-5,42584,98,0.37 [0.17-0.80],0.0115446029517801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX9,Sorting nexin-9,50298,118,1.13 [0.89-1.42],0.3203778248400761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD1,Superoxide dismutase [Cu-Zn],49287,115,1.23 [0.88-1.71],0.2178345842759586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD2,"Superoxide dismutase [Mn], mitochondrial",50317,118,1.50 [1.02-2.21],0.0374429292881849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD3,Extracellular superoxide dismutase,43781,100,0.74 [0.48-1.14],0.1743192396176033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORBS1,Sorbin and SH3 domain-containing protein 1,43667,97,1.06 [0.66-1.70],0.8015268605363479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORCS2,VPS10 domain-containing receptor SorCS2,49115,114,1.38 [0.88-2.16],0.1584721086241972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORD,Sorbitol dehydrogenase,50500,119,1.11 [0.87-1.41],0.4039268936112776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SORT1,Sortilin,50223,118,1.22 [0.79-1.87],0.3690890602410545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOST,Sclerostin,50223,118,1.00 [0.66-1.51],0.9970789338387812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,42549,97,0.98 [0.66-1.47],0.9326432777246566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOX2,Transcription factor SOX-2,43587,97,0.85 [0.37-1.98],0.7124957874417485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOX9,Transcription factor SOX-9,42549,97,0.99 [0.48-2.02],0.967303966055729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,43667,97,1.47 [0.87-2.48],0.1473483322910434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPAG1,Sperm-associated antigen 1,43667,97,1.02 [0.74-1.42],0.8977868843402147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPARC,SPARC,50453,117,1.04 [0.83-1.31],0.7148861981618365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPARCL1,SPARC-like protein 1,50328,119,1.11 [0.63-1.97],0.7144431872309516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPART,Spartin,42800,100,1.01 [0.79-1.30],0.91851463505467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPESP1,Sperm equatorial segment protein 1,43744,99,1.36 [0.76-2.42],0.3027117153299394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK1,Serine protease inhibitor Kazal-type 1,50317,118,1.36 [0.96-1.94],0.0858068760762227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK2,Serine protease inhibitor Kazal-type 2,42800,100,1.39 [0.89-2.19],0.1518728203721038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK4,Serine protease inhibitor Kazal-type 4,50225,119,1.29 [1.03-1.62],0.0265239458687509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK5,Serine protease inhibitor Kazal-type 5,50317,118,0.67 [0.41-1.09],0.1042725220402911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK6,Serine protease inhibitor Kazal-type 6,50729,120,1.27 [0.94-1.73],0.1180047489071864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK8,Serine protease inhibitor Kazal-type 8,42299,95,0.97 [0.56-1.68],0.9121544970655012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT1,Kunitz-type protease inhibitor 1,50151,118,0.89 [0.46-1.71],0.7320260244898756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT2,Kunitz-type protease inhibitor 2,50517,120,1.48 [0.99-2.21],0.0555167993395599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT3,Kunitz-type protease inhibitor 3,43557,98,0.94 [0.83-1.06],0.3357122630495462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPOCK1,Testican-1,49913,118,0.84 [0.45-1.57],0.582148552643657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPON1,Spondin-1,50352,120,1.56 [1.00-2.43],0.0514909961017187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPON2,Spondin-2,50058,118,1.18 [0.74-1.89],0.4817337082491291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPP1,Osteopontin,50839,116,1.36 [0.96-1.93],0.0834697694272448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",42481,99,0.63 [0.38-1.05],0.0738790977960363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRING1,SREBP regulating gene protein,42186,96,0.78 [0.52-1.19],0.2535744660041861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRR1B,Cornifin-B,42949,99,1.02 [0.81-1.29],0.8484603867541826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRR3,Small proline-rich protein 3,43641,99,0.95 [0.71-1.27],0.7405044168011616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPRY2,Protein sprouty homolog 2,49349,116,1.01 [0.84-1.20],0.9436692935719112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",42326,94,0.88 [0.46-1.69],0.7022452115574025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPTLC1,Serine palmitoyltransferase 1,43641,99,1.02 [0.61-1.69],0.9517994619994672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRC,Proto-oncogene tyrosine-protein kinase Src,50368,117,1.02 [0.89-1.16],0.8237561903151752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRP14,Signal recognition particle 14 kDa protein,50063,116,1.16 [0.90-1.50],0.2633410132158629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRPK2,SRSF protein kinase 2,50225,119,1.05 [0.87-1.27],0.6040283976524874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SRPX,Sushi repeat-containing protein SRPX,43744,99,1.60 [0.95-2.71],0.0768577811115768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSB,Lupus La protein,49125,114,0.94 [0.70-1.27],0.6984723068369922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",42481,99,1.12 [0.66-1.89],0.67589577249425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,50223,118,0.93 [0.80-1.07],0.3054290573157113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,50498,119,1.15 [0.78-1.67],0.480900352299875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSH3,Protein phosphatase Slingshot homolog 3,42186,96,0.78 [0.38-1.59],0.4960603350390988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SSNA1,Sjoegren syndrome nuclear autoantigen 1,43557,98,0.97 [0.67-1.41],0.8865399085177926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST13,Hsc70-interacting protein,42800,100,1.00 [0.71-1.42],0.9821476699255972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",50063,116,1.04 [0.71-1.53],0.8226980234029918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",50919,116,1.73 [1.09-2.73],0.0193557891854353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",42481,99,0.88 [0.56-1.38],0.5736025207648405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAB2,Stabilin-2,43751,100,1.23 [0.62-2.42],0.5527583913351217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAM,Signal transducing adapter molecule 1,43536,100,1.03 [0.62-1.71],0.9210472293894636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAMBP,STAM-binding protein,49830,118,1.06 [0.82-1.37],0.6694528820298444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAT2,Signal transducer and activator of transcription 2,42481,99,1.09 [0.85-1.40],0.5050999496541524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAT5B,Signal transducer and activator of transcription 5B,50063,116,1.04 [0.92-1.17],0.5518809968982352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,42186,96,1.06 [0.79-1.42],0.6920216669572069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STC1,Stanniocalcin-1,50746,120,1.22 [0.86-1.72],0.268210163359399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STC2,Stanniocalcin-2,50249,118,1.40 [0.72-2.72],0.3168893664989312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STEAP4,Metalloreductase STEAP4,42326,94,0.84 [0.61-1.16],0.2868940707782078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STIP1,Stress-induced-phosphoprotein 1,50233,118,0.98 [0.76-1.26],0.8803512375125411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK11,Serine/threonine-protein kinase STK11,49383,114,1.08 [0.86-1.35],0.5176997278614874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK24,Serine/threonine-protein kinase 24,49125,114,0.95 [0.72-1.24],0.7010710334530228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STK4,Serine/threonine-protein kinase 4,50298,118,1.02 [0.84-1.23],0.8572409591732911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STOML2,"Stomatin-like protein 2, mitochondrial",42186,96,0.86 [0.68-1.10],0.2343391584753647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX16,Syntaxin-16,49115,114,0.89 [0.65-1.21],0.4566135643592047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX1B,Syntaxin-1B,42549,97,0.74 [0.42-1.30],0.2953640883250928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX3,Syntaxin-3,43641,99,1.25 [0.82-1.90],0.3076813865104486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX4,Syntaxin-4,50063,116,1.03 [0.78-1.34],0.8533723333861285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX5,Syntaxin-5,42481,99,1.08 [0.69-1.70],0.7301553549990993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX6,Syntaxin-6,49115,114,0.81 [0.61-1.08],0.1575456013690799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX7,Syntaxin-7,42481,99,0.94 [0.63-1.39],0.7468323851183464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STX8,Syntaxin-8,50225,119,0.99 [0.71-1.39],0.9672793740165224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STXBP1,Syntaxin-binding protein 1,43667,97,1.00 [0.78-1.29],0.9852539171448464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,STXBP3,Syntaxin-binding protein 3,49115,114,0.79 [0.52-1.20],0.2716787446281685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUGP1,SURP and G-patch domain-containing protein 1,43557,98,0.97 [0.59-1.57],0.888398290666791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUGT1,Protein SGT1 homolog,49115,114,1.00 [0.81-1.23],0.997013894032906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SULT1A1,Sulfotransferase 1A1,50746,120,1.01 [0.89-1.14],0.8707220997224936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SULT2A1,Bile salt sulfotransferase,50225,119,1.24 [0.96-1.59],0.1007138081723407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUMF1,Formylglycine-generating enzyme,42481,99,1.09 [0.84-1.42],0.5002163576137112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,50746,120,1.12 [0.82-1.53],0.4680593110612721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUOX,"Sulfite oxidase, mitochondrial",43667,97,1.16 [0.86-1.56],0.3373772221453262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD1,Sushi domain-containing protein 1,49383,114,1.19 [0.84-1.66],0.3255419634338606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD2,Sushi domain-containing protein 2,50317,118,0.85 [0.48-1.49],0.5659543713639723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD4,Sushi domain-containing protein 4,43536,100,0.90 [0.56-1.45],0.6550754227217139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD5,Sushi domain-containing protein 5,42559,99,1.81 [1.04-3.14],0.0356239990847529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SV2A,Synaptic vesicle glycoprotein 2A,42549,97,1.22 [0.92-1.61],0.1621626772526793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SWAP70,Switch-associated protein 70,43557,98,1.39 [0.88-2.20],0.1575258104813517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYAP1,Synapse-associated protein 1,42800,100,0.90 [0.64-1.27],0.551892065442375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,42326,94,1.05 [0.75-1.46],0.7766801109861698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYT1,Synaptotagmin-1,43641,99,1.04 [0.65-1.66],0.8771056765834102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SYTL4,Synaptotagmin-like protein 4,43744,99,0.84 [0.64-1.11],0.2171399671757354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,42949,99,0.95 [0.79-1.14],0.5986340100717006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TACC3,Transforming acidic coiled-coil-containing protein 3,50063,116,0.99 [0.86-1.14],0.908420157362162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TACSTD2,Tumor-associated calcium signal transducer 2,44551,110,0.61 [0.34-1.10],0.1013681782918283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TADA3,Transcriptional adapter 3,43536,100,1.17 [0.73-1.88],0.5212222318614006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAFA5,Chemokine-like protein TAFA-5,50063,116,1.13 [0.73-1.76],0.5851405244231989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAGLN3,Transgelin-3,42186,96,0.79 [0.56-1.12],0.185102370964054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TALDO1,Transaldolase,43587,100,1.07 [0.70-1.64],0.7577379279878177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TANK,TRAF family member-associated NF-kappa-B activator,49349,116,0.97 [0.77-1.24],0.8313725837899127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAP1,Antigen peptide transporter 1,42949,99,1.24 [0.97-1.58],0.0876623438622434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARBP2,RISC-loading complex subunit TARBP2,49125,114,1.02 [0.82-1.26],0.8802718253809242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",42549,97,0.94 [0.72-1.23],0.6634972175625101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",43536,100,0.80 [0.47-1.37],0.4199605670341666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAX1BP1,Tax1-binding protein 1,43641,99,0.88 [0.64-1.21],0.425932987486548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D17,TBC1 domain family member 17,49125,114,1.21 [0.87-1.69],0.254540207032045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D23,TBC1 domain family member 23,50063,116,0.96 [0.80-1.16],0.6827130865942824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBC1D5,TBC1 domain family member 5,50225,119,1.01 [0.83-1.24],0.92003342907144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCA,Tubulin-specific chaperone A,42800,100,1.00 [0.80-1.25],0.9834349855684266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCB,Tubulin-folding cofactor B,49913,118,1.03 [0.88-1.22],0.7016417962793164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBCC,Tubulin-specific chaperone C,49913,118,1.06 [0.87-1.30],0.5723352328988283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBL1X,F-box-like/WD repeat-containing protein TBL1X,49115,114,1.10 [0.90-1.33],0.3592898217570687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TBR1,T-box brain protein 1,42549,97,1.11 [0.77-1.59],0.5808020387827553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCL1A,T-cell leukemia/lymphoma protein 1A,49838,117,1.04 [0.89-1.22],0.6260783777451975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCL1B,T-cell leukemia/lymphoma protein 1B,49383,114,0.87 [0.68-1.12],0.2775654186682545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCN1,Transcobalamin-1,42891,96,1.23 [0.73-2.09],0.4402169335665793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCN2,Transcobalamin-2,50839,116,1.26 [0.75-2.09],0.3813907234305452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCOF1,Treacle protein,43744,99,1.33 [0.78-2.28],0.2981291586682268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCP11,T-complex protein 11 homolog,42949,99,0.89 [0.61-1.31],0.558647722740077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TCTN3,Tectonic-3,43744,99,0.86 [0.45-1.64],0.6544785988106012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDGF1,Teratocarcinoma-derived growth factor 1,49125,114,0.99 [0.88-1.11],0.8316135364870595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDO2,"Tryptophan 2,3-dioxygenase",42549,97,1.30 [0.85-1.98],0.2262292987181186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDP1,Tyrosyl-DNA phosphodiesterase 1,43536,100,0.93 [0.70-1.25],0.6499131576551851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TDRKH,Tudor and KH domain-containing protein,49125,114,1.04 [0.86-1.27],0.6942419699630276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEF,Thyrotroph embryonic factor,42299,95,1.13 [0.74-1.73],0.5775694304584528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEK,Angiopoietin-1 receptor,50453,117,1.90 [0.91-3.95],0.0871841552951342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TERF1,Telomeric repeat-binding factor 1,42481,99,0.87 [0.44-1.73],0.6918577756129156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TET2,Methylcytosine dioxygenase TET2,42868,98,1.09 [0.93-1.29],0.2969766131929012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEX101,Testis-expressed protein 101,42549,97,1.25 [0.88-1.78],0.2053496320836725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEX33,Testis-expressed protein 33,42949,99,1.37 [0.99-1.91],0.0580305993749164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TF,Serotransferrin,43812,101,1.67 [0.71-3.96],0.2420210121436677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFAP2A,Transcription factor AP-2-alpha,42326,94,0.94 [0.66-1.33],0.7169028922496073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF1,Trefoil factor 1,50067,118,1.29 [1.09-1.54],0.0040321490372537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF2,Trefoil factor 2,50436,120,1.47 [1.15-1.89],0.0023737425702233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF3,Trefoil factor 3,50249,119,1.13 [0.79-1.62],0.5090881546643959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFPI,Tissue factor pathway inhibitor,50171,119,0.85 [0.50-1.44],0.5384687143029165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFPI2,Tissue factor pathway inhibitor 2,50301,117,1.36 [1.02-1.80],0.0362758890307186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFRC,Transferrin receptor protein 1,50500,119,1.42 [0.95-2.12],0.0885206620842053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TG,Thyroglobulin,43536,100,1.09 [0.93-1.28],0.2861165882417618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFA,Protransforming growth factor alpha,50225,119,1.15 [0.82-1.61],0.4198021954244665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFB1,Transforming growth factor beta-1 proprotein,50768,117,1.37 [0.91-2.05],0.1290244647659462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFB2,Transforming growth factor beta-2 proprotein,43536,100,1.28 [0.92-1.78],0.1387203062310986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBI,Transforming growth factor-beta-induced protein ig-h3,50008,119,1.41 [0.78-2.56],0.2524729052614873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR1,TGF-beta receptor type-1,42481,99,0.83 [0.33-2.07],0.6904700022992607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR2,TGF-beta receptor type-2,50453,117,1.28 [0.81-2.04],0.2930019003917824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGFBR3,Transforming growth factor beta receptor type 3,50919,116,0.92 [0.55-1.54],0.755581920485937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGM2,Protein-glutamine gamma-glutamyltransferase 2,50217,118,1.20 [0.97-1.48],0.0985286433692893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TGOLN2,Trans-Golgi network integral membrane protein 2,43781,100,1.11 [0.54-2.28],0.7673316520972184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THAP12,52 kDa repressor of the inhibitor of the protein kinase,42110,96,1.10 [0.90-1.35],0.3559565813410369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBD,Thrombomodulin,50298,118,1.04 [0.59-1.83],0.891320227514397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBS2,Thrombospondin-2,50317,118,1.48 [0.99-2.21],0.0559692505310906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBS4,Thrombospondin-4,50336,119,1.36 [0.95-1.94],0.0893614615224139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THOP1,Thimet oligopeptidase,50058,117,1.35 [0.82-2.22],0.2307379560164527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THPO,Thrombopoietin,49383,114,0.72 [0.47-1.10],0.1302004795374945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THRAP3,Thyroid hormone receptor-associated protein 3,42299,95,1.20 [1.05-1.38],0.0067119159772261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THSD1,Thrombospondin type-1 domain-containing protein 1,42160,99,1.38 [0.82-2.33],0.2207412606183654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THTPA,Thiamine-triphosphatase,43453,100,1.00 [0.81-1.25],0.9878068741223458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THY1,Thy-1 membrane glycoprotein,50746,120,1.09 [0.62-1.91],0.7573040338677518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIA1,Nucleolysin TIA-1 isoform p40,48832,112,1.00 [0.87-1.15],0.9906086686902988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIE1,Tyrosine-protein kinase receptor Tie-1,50919,116,1.18 [0.78-1.80],0.431012230211577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",49042,114,0.99 [0.69-1.41],0.9530084128937868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,42949,99,1.10 [0.67-1.81],0.7183125383689424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,50498,119,1.03 [0.71-1.49],0.8709288432644684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,43744,99,0.87 [0.53-1.43],0.5852234232929396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,43641,99,0.93 [0.74-1.16],0.5156680235685731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP1,Metalloproteinase inhibitor 1,49754,119,2.03 [1.23-3.33],0.0053891340870758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP2,Metalloproteinase inhibitor 2,43744,99,0.86 [0.38-1.92],0.7101437032645014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP3,Metalloproteinase inhibitor 3,50517,120,1.09 [0.97-1.23],0.1557024377169494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP4,Metalloproteinase inhibitor 4,50317,118,0.85 [0.56-1.28],0.4424275938535192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TINAGL1,Tubulointerstitial nephritis antigen-like,50141,118,2.17 [1.06-4.46],0.0348191717526681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TJAP1,Tight junction-associated protein 1,50453,117,1.06 [0.87-1.29],0.556035348660586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TJP3,Tight junction protein ZO-3,42326,94,1.30 [0.87-1.93],0.1990939464833665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TK1,"Thymidine kinase, cytosolic",42949,99,1.02 [0.66-1.56],0.942778624693346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR1,Toll-like receptor 1,42481,99,1.10 [0.53-2.29],0.7888891515110603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR2,Toll-like receptor 2,42949,99,0.82 [0.36-1.89],0.6410490529173289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR3,Toll-like receptor 3,50851,119,1.09 [0.83-1.44],0.5167177005257372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TLR4,Toll-like receptor 4,42481,99,0.79 [0.39-1.58],0.5041754099136788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,42549,97,1.18 [0.84-1.64],0.3328058371782681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED1,Transmembrane emp24 domain-containing protein 1,42949,99,1.00 [0.70-1.41],0.978786414301472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED10,Transmembrane emp24 domain-containing protein 10,42299,95,0.50 [0.24-1.01],0.0524878931784088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED4,Transmembrane emp24 domain-containing protein 4,42299,95,0.85 [0.57-1.27],0.4232331056213658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMED8,Protein TMED8,43557,98,1.01 [0.83-1.21],0.9552921677487872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM106A,Transmembrane protein 106A,43536,100,1.06 [0.82-1.38],0.6598187343975925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM132A,Transmembrane protein 132A,42584,98,0.98 [0.72-1.34],0.9229324352993946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMEM25,Transmembrane protein 25,43667,97,0.92 [0.59-1.44],0.7254972172571601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMOD4,Tropomodulin-4,42186,96,0.76 [0.46-1.27],0.2910249710369904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS11B,Transmembrane protease serine 11B,42326,94,0.79 [0.58-1.09],0.1481940073043131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS11D,Transmembrane protease serine 11D,43558,99,1.28 [0.81-2.02],0.2865649702947661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS15,Enteropeptidase,50063,116,1.18 [0.98-1.41],0.076393541445364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMPRSS5,Transmembrane protease serine 5,49672,117,1.07 [0.70-1.65],0.7505678169506667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TMSB10,Thymosin beta-10,50317,118,1.06 [0.86-1.32],0.5696615379205944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNC,Tenascin,50498,119,1.49 [1.08-2.06],0.0162658458080553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNF,Tumor necrosis factor,49306,114,1.38 [1.00-1.92],0.0494159971931734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,43557,98,1.21 [0.84-1.75],0.3097580421615001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,49349,116,1.03 [0.66-1.61],0.8958228611524468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,42800,100,0.88 [0.65-1.21],0.4335886975154712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,49913,118,1.75 [1.16-2.65],0.008205496241705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,49913,118,1.25 [0.96-1.62],0.0969749227071598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,50425,115,0.84 [0.60-1.16],0.2818486459248605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,50851,119,1.41 [0.95-2.09],0.0887501269370737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,50268,120,0.99 [0.57-1.72],0.9800363592294028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,50453,117,1.29 [0.83-2.02],0.2619074722050376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,50352,120,1.74 [1.27-2.39],0.000644027293418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,49349,116,1.19 [0.82-1.72],0.3683685876410673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,50352,120,1.45 [0.88-2.39],0.1466088364237233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,42800,100,1.58 [1.01-2.46],0.0434350438475708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,50729,120,1.43 [0.90-2.26],0.1316783363139489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,50317,118,1.38 [0.83-2.31],0.2194871796965988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,50317,118,1.52 [1.12-2.05],0.0068086413397256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,50746,120,0.79 [0.44-1.42],0.4289180484185028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,50768,117,1.37 [0.91-2.05],0.1276952181638968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,49913,118,1.28 [0.99-1.66],0.0631849566762322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,50746,120,1.44 [1.04-1.98],0.0267548995251583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,49913,118,1.23 [0.85-1.76],0.2679416999215886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF10,Tumor necrosis factor ligand superfamily member 10,50851,119,0.56 [0.30-1.05],0.0692753398405169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF11,Tumor necrosis factor ligand superfamily member 11,50225,119,0.93 [0.71-1.21],0.5823460512315822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF12,Tumor necrosis factor ligand superfamily member 12,50851,119,1.07 [0.61-1.90],0.8040516427552112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF13,Tumor necrosis factor ligand superfamily member 13,50517,120,1.82 [1.02-3.25],0.0421006241570632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,50837,116,1.43 [0.82-2.49],0.2027569058834241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF14,Tumor necrosis factor ligand superfamily member 14,49913,118,1.15 [0.87-1.51],0.3267980712492579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF8,Tumor necrosis factor ligand superfamily member 8,43751,100,1.10 [0.65-1.87],0.710396229004588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNIP1,TNFAIP3-interacting protein 1,43641,99,0.97 [0.78-1.20],0.7643449053830815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNN,Tenascin-N,43751,100,1.47 [0.96-2.26],0.0773936986082874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNNI3,"Troponin I, cardiac muscle",49383,114,1.14 [0.93-1.40],0.2193405692332434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNPO1,Transportin-1,42949,99,0.60 [0.34-1.06],0.0767927348508602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNR,Tenascin-R,49913,118,0.91 [0.62-1.34],0.6315098536941397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNXB,Tenascin-X,50317,118,1.07 [0.57-2.01],0.8268013147156796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,43744,99,1.00 [0.78-1.28],0.9975710053946228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP1,DNA topoisomerase 1,43557,98,1.16 [0.98-1.38],0.0756726887398573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP1MT,"DNA topoisomerase I, mitochondrial",42186,96,1.11 [0.76-1.60],0.5936387424415154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOP2B,DNA topoisomerase 2-beta,42481,99,1.04 [0.82-1.32],0.7579687613817162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TOR1AIP1,Torsin-1A-interacting protein 1,42584,98,0.93 [0.63-1.35],0.6937330941538415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53,Cellular tumor antigen p53,49115,114,0.89 [0.60-1.32],0.5709995259300145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53BP1,TP53-binding protein 1,42481,99,1.03 [0.82-1.29],0.791539446943818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53I3,Quinone oxidoreductase PIG3,41867,98,1.23 [0.86-1.76],0.2606814219332087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP53INP1,Tumor protein p53-inducible nuclear protein 1,49383,114,0.96 [0.55-1.67],0.8834272522905045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TP73,Tumor protein p73,42549,97,1.13 [0.64-1.99],0.6847748165037654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPBGL,Trophoblast glycoprotein-like,42549,97,0.88 [0.53-1.46],0.6298924394782677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPD52L2,Tumor protein D54,42800,100,1.05 [0.87-1.25],0.622251072670285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPK1,Thiamin pyrophosphokinase 1,43744,99,1.03 [0.52-2.04],0.9422739408500213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPM3,Tropomyosin alpha-3 chain,42299,95,0.66 [0.40-1.10],0.1113861076746049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPMT,Thiopurine S-methyltransferase,49115,114,1.10 [0.88-1.38],0.3924415765526443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPP1,Tripeptidyl-peptidase 1,49933,119,1.36 [1.00-1.84],0.0468394371435776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPPP2,Tubulin polymerization-promoting protein family member 2,42949,99,1.13 [0.91-1.40],0.2576311275860544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPPP3,Tubulin polymerization-promoting protein family member 3,49125,114,1.27 [0.90-1.81],0.1763459374967871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPR,Nucleoprotein TPR,42299,95,0.93 [0.61-1.42],0.7483618890389292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPRKB,EKC/KEOPS complex subunit TPRKB,42186,96,1.02 [0.75-1.38],0.9185518889405616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSAB1,Tryptase alpha/beta-1,50768,119,0.96 [0.70-1.31],0.7976786011078664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSD1,Tryptase delta,43667,97,0.85 [0.48-1.49],0.5692498472571107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPSG1,Tryptase gamma,42481,99,0.73 [0.34-1.57],0.4147397584351806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPT1,Translationally-controlled tumor protein,49349,116,0.77 [0.56-1.06],0.1028134674455886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF2,TNF receptor-associated factor 2,50225,119,1.06 [0.84-1.33],0.6215193575127935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF3,"TNF receptor-associated factor 3, Isoform 2",42481,99,0.95 [0.56-1.61],0.8393676779785149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,42299,95,1.02 [0.68-1.53],0.9150869752540264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,42949,99,0.96 [0.76-1.20],0.7030593162259944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREH,Trehalase,43751,100,1.05 [0.81-1.37],0.6916713139065224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREM2,Triggering receptor expressed on myeloid cells 2,50268,120,1.03 [0.76-1.39],0.8539825381901004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREML1,Trem-like transcript 1 protein,43781,100,1.06 [0.74-1.52],0.7452171282414252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREML2,Trem-like transcript 2 protein,50317,118,1.11 [0.69-1.77],0.6772917215528876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIAP1,TP53-regulated inhibitor of apoptosis 1,50729,120,1.08 [0.84-1.39],0.5655239604168874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM21,E3 ubiquitin-protein ligase TRIM21,50225,119,0.81 [0.67-0.98],0.0266693533899622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM24,Transcription intermediary factor 1-alpha,42867,99,1.10 [0.82-1.47],0.5159998972080166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,43557,98,1.06 [0.88-1.26],0.5480394489200169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM26,Tripartite motif-containing protein 26,42186,96,1.01 [0.71-1.42],0.9766743794284434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM40,E3 ubiquitin ligase TRIM40,42549,97,0.98 [0.75-1.29],0.9042805275981894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM5,Tripartite motif-containing protein 5,50225,119,1.11 [0.92-1.34],0.2737576344984073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM58,E3 ubiquitin-protein ligase TRIM58,43536,100,0.84 [0.67-1.05],0.1247561952892619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRPV3,Transient receptor potential cation channel subfamily V member 3,42299,95,0.76 [0.48-1.21],0.2500872162171438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSC1,Hamartin,42481,99,0.74 [0.52-1.06],0.1049442348930248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSC22D1,TSC22 domain family protein 1,43667,97,1.03 [0.77-1.38],0.8400584368936417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSHB,Thyrotropin subunit beta,50298,118,0.94 [0.76-1.16],0.5705625445591397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSLP,Thymic stromal lymphopoietin,49383,114,0.83 [0.60-1.14],0.2417257415042379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSNAX,Translin-associated protein X,42299,95,0.71 [0.42-1.20],0.197654161633995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN1,Tetraspanin-1,49383,114,0.92 [0.71-1.18],0.5029263340978711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN15,Tetraspanin-15,42299,95,0.65 [0.40-1.06],0.0857357981890455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN7,Tetraspanin-7,42326,94,0.95 [0.75-1.19],0.6495884886211076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPAN8,Tetraspanin-8,43557,98,1.16 [0.96-1.40],0.1289313887490334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSPYL1,Testis-specific Y-encoded-like protein 1,42481,99,0.79 [0.47-1.31],0.3559072946523409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TST,Thiosulfate sulfurtransferase,49044,114,0.93 [0.74-1.16],0.5093909104524772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTF2,Transcription termination factor 2,42549,97,0.94 [0.63-1.41],0.7802379181746466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTN,Titin,42299,95,0.73 [0.50-1.06],0.0968203117553379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TTR,Transthyretin,43332,100,0.57 [0.27-1.18],0.1280301932238877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TUBB3,Tubulin beta-3 chain,42326,94,0.94 [0.46-1.92],0.8726741822300936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TWF2,Twinfilin-2,43751,100,0.95 [0.76-1.20],0.6906161900222769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXK,Tyrosine-protein kinase TXK,42949,99,0.84 [0.61-1.14],0.2566857777501925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXLNA,Alpha-taxilin,49913,118,1.12 [0.93-1.35],0.2182610569607883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXN,Thioredoxin,43058,98,1.06 [0.70-1.62],0.7803707563498887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC15,Thioredoxin domain-containing protein 15,50453,117,1.21 [0.68-2.17],0.5170754103251494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC5,Thioredoxin domain-containing protein 5,50746,120,1.08 [0.85-1.36],0.5247493786412989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNDC9,Thioredoxin domain-containing protein 9,43641,99,0.91 [0.63-1.33],0.6354122533992719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNL1,Thioredoxin-like protein 1,42245,94,0.82 [0.63-1.06],0.1267487793100847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",50317,118,1.23 [0.87-1.74],0.233891504911775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYMP,Thymidine phosphorylase,49971,117,1.12 [0.87-1.43],0.3817816240366081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYRO3,Tyrosine-protein kinase receptor TYRO3,50298,118,0.85 [0.48-1.52],0.5887974763196144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",42481,99,0.96 [0.71-1.30],0.8112475512149608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBAC1,Ubiquitin-associated domain-containing protein 1,50063,116,1.25 [0.78-1.99],0.3510985944318455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2B,Ubiquitin-conjugating enzyme E2 B,43536,100,0.63 [0.31-1.29],0.2097094459874484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,43744,99,1.18 [0.87-1.61],0.2813165037374396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,42481,99,0.79 [0.54-1.16],0.2373006507222733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBQLN3,Ubiquilin-3,42299,95,1.26 [0.92-1.70],0.1452572202435376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBXN1,UBX domain-containing protein 1,42800,100,1.02 [0.77-1.34],0.916602500099562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,43557,98,0.99 [0.87-1.14],0.938217423013737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UGDH,UDP-glucose 6-dehydrogenase,42299,95,0.94 [0.76-1.18],0.598074309564624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UHRF2,E3 ubiquitin-protein ligase UHRF2,42299,95,0.96 [0.53-1.72],0.8866555610761379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ULBP2,UL16-binding protein 2,49913,118,1.23 [0.82-1.84],0.3118828854822444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UMOD,Uromodulin,50758,116,0.68 [0.52-0.90],0.0072466427293782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNC5D,Netrin receptor UNC5D,42481,99,0.55 [0.25-1.20],0.1326888284372886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNC79,Protein unc-79 homolog,42186,96,0.69 [0.47-1.02],0.0659660091813492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UNG,Uracil-DNA glycosylase,43536,100,1.39 [0.88-2.22],0.1614860349175819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPB1,Beta-ureidopropionase,43744,99,1.21 [0.99-1.48],0.0604755783820042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPK3A,Uroplakin-3a,42326,94,1.13 [0.77-1.65],0.5357417430117606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPK3BL1,Uroplakin-3b-like protein 1,42868,99,1.01 [0.71-1.44],0.957565896044804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UROD,Uroporphyrinogen decarboxylase,42800,100,0.98 [0.74-1.30],0.8864219555122765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UROS,Uroporphyrinogen-III synthase,42549,97,0.93 [0.69-1.26],0.6336165912054847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USO1,General vesicular transport factor p115,50063,116,1.07 [0.89-1.29],0.4582181055032422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP25,Ubiquitin carboxyl-terminal hydrolase 25,43536,100,1.01 [0.77-1.32],0.9332041441076768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP28,Ubiquitin carboxyl-terminal hydrolase 28,43641,99,1.24 [0.78-1.96],0.3602300632160354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP47,Ubiquitin carboxyl-terminal hydrolase 47,42299,95,0.93 [0.73-1.19],0.589285464494471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,USP8,Ubiquitin carboxyl-terminal hydrolase 8,49383,114,1.04 [0.88-1.24],0.6370203063454782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UXS1,UDP-glucuronic acid decarboxylase 1,49115,114,0.93 [0.67-1.28],0.6418832863117092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAMP5,Vesicle-associated membrane protein 5,49383,114,1.34 [1.06-1.69],0.0158561914207663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAMP8,Vesicle-associated membrane protein 8,42481,99,0.98 [0.79-1.23],0.8907521633930106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASH1,Tubulinyl-Tyr carboxypeptidase 1,50225,119,1.01 [0.83-1.23],0.9452856877594172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASN,Vasorin,49515,116,1.10 [0.60-2.00],0.7568484348592855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VASP,Vasodilator-stimulated phosphoprotein,43781,100,0.99 [0.76-1.28],0.9282755534828032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,50063,116,0.47 [0.20-1.09],0.0793072011204428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAV3,Guanine nucleotide exchange factor VAV3,42326,94,0.95 [0.78-1.16],0.6248223280004424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAM1,Vascular cell adhesion protein 1,50417,119,1.98 [1.13-3.44],0.0161753125446971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAN,Versican core protein,50746,120,1.72 [1.04-2.85],0.0347974341221603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCPKMT,Protein-lysine methyltransferase METTL21D,42186,96,0.87 [0.67-1.14],0.3195175325190282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFA,Vascular endothelial growth factor A,50684,119,1.26 [0.97-1.63],0.0874798272210454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFB,Vascular endothelial growth factor B,42481,99,1.06 [0.55-2.06],0.8593717544899948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFC,Vascular endothelial growth factor C,50453,117,1.21 [0.91-1.62],0.1929573921774733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFD,Vascular endothelial growth factor D,50766,119,0.83 [0.54-1.27],0.3853451427489549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VGF,Neurosecretory protein VGF,43667,97,1.05 [0.56-1.96],0.8846620438443349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIM,Vimentin,49383,114,1.16 [0.99-1.35],0.0684489674400952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIPR1,Vasoactive intestinal polypeptide receptor 1,42584,98,0.87 [0.38-2.00],0.7458315598374878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIT,Vitrin,43744,99,1.14 [0.69-1.88],0.6142092095200682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VMO1,Vitelline membrane outer layer protein 1 homolog,50063,116,1.20 [0.93-1.55],0.1603235819930234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VNN1,Pantetheinase,43781,100,0.94 [0.72-1.21],0.6115910415432502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VNN2,Vascular non-inflammatory molecule 2,50063,116,1.49 [1.03-2.17],0.0337854937443482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS28,Vacuolar protein sorting-associated protein 28 homolog,42949,99,0.95 [0.70-1.28],0.7165512259067782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS37A,Vacuolar protein sorting-associated protein 37A,50063,116,0.98 [0.79-1.20],0.8205509851249864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS4B,Vacuolar protein sorting-associated protein 4B,43536,100,1.00 [0.82-1.23],0.9614006752984956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VPS53,Vacuolar protein sorting-associated protein 53 homolog,50063,116,1.01 [0.82-1.25],0.8934342601640965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG10,V-set and immunoglobulin domain-containing protein 10,43536,100,1.16 [0.71-1.92],0.5499139363097658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,42299,95,0.97 [0.53-1.78],0.9233708433425044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG2,V-set and immunoglobulin domain-containing protein 2,43536,100,1.25 [0.94-1.65],0.1214780989629851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIG4,V-set and immunoglobulin domain-containing protein 4,50249,118,1.26 [0.86-1.85],0.2291863110405654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,50221,118,1.11 [0.86-1.43],0.4439475302337549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSNL1,Visinin-like protein 1,43641,99,1.51 [1.01-2.28],0.0472620242624976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM1,V-set and transmembrane domain-containing protein 1,49125,114,0.94 [0.67-1.31],0.7079138326033332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM2B,V-set and transmembrane domain-containing protein 2B,42949,99,0.67 [0.37-1.22],0.1931596953417522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,49383,114,1.16 [0.90-1.50],0.2462151928615241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,50746,120,1.13 [0.90-1.41],0.2833118273364019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTCN1,V-set domain-containing T-cell activation inhibitor 1,49115,114,0.80 [0.47-1.37],0.4189681464162538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,42800,100,0.96 [0.68-1.34],0.7937745052741876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWA1,von Willebrand factor A domain-containing protein 1,50655,120,1.06 [0.73-1.56],0.749615976056261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWA5A,von Willebrand factor A domain-containing protein 5A,42186,96,0.99 [0.76-1.28],0.9187503065110736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWC2,Brorin,49748,118,1.17 [0.78-1.75],0.4446958167421203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWC2L,von Willebrand factor C domain-containing protein 2-like,43667,97,0.62 [0.35-1.10],0.104156887560577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWF,von Willebrand factor,50919,116,1.25 [1.00-1.55],0.0499995088333711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WARS,"Tryptophan--tRNA ligase, cytoplasmic",50317,118,1.62 [1.07-2.47],0.0234968860756888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WAS,Wiskott-Aldrich syndrome protein,49349,116,0.87 [0.67-1.12],0.2798166786224965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASF1,Wiskott-Aldrich syndrome protein family member 1,49383,114,0.96 [0.80-1.15],0.6714973597985734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASF3,Wiskott-Aldrich syndrome protein family member 3,49125,114,0.95 [0.78-1.15],0.5818860501857885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASHC3,WASH complex subunit 3,43641,99,0.87 [0.66-1.13],0.2922407288323135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WASL,Neural Wiskott-Aldrich syndrome protein,42481,99,0.98 [0.70-1.36],0.8866549114152007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WDR46,WD repeat-containing protein 46,43536,100,1.09 [0.66-1.80],0.7309447955292518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC1,WAP four-disulfide core domain protein 1,42652,96,0.89 [0.60-1.33],0.5786743178921803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC12,WAP four-disulfide core domain protein 12,50645,120,1.00 [0.78-1.29],0.9824100500702124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC2,WAP four-disulfide core domain protein 2,47743,113,1.50 [1.04-2.17],0.031991640878606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",49749,118,0.78 [0.52-1.15],0.2114965080786183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",50352,120,0.66 [0.42-1.06],0.0878859677461553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WIF1,Wnt inhibitory factor 1,50729,120,1.28 [0.81-2.03],0.2896515544098095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WNT9A,Protein Wnt-9a,49349,116,1.50 [0.89-2.55],0.129340580280773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,49913,118,1.08 [0.80-1.46],0.6249714288371548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XCL1,Lymphotactin,50729,120,1.26 [0.97-1.63],0.0803637372227413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XG,Glycoprotein Xg,50677,115,1.09 [0.66-1.79],0.7344330672551438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XIAP,E3 ubiquitin-protein ligase XIAP,42481,99,0.93 [0.66-1.31],0.6868267939905341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XPNPEP2,Xaa-Pro aminopeptidase 2,50453,117,0.95 [0.81-1.11],0.5104796077963717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,XRCC4,DNA repair protein XRCC4,49125,114,0.81 [0.50-1.29],0.3698664129337016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YAP1,Transcriptional coactivator YAP1,43641,99,1.78 [0.97-3.29],0.0644040314902873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",43557,98,1.04 [0.91-1.19],0.5624777676931753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YES1,Tyrosine-protein kinase Yes,50063,116,1.05 [0.91-1.22],0.4832698394203283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YJU2,Splicing factor YJU2,43536,100,0.88 [0.48-1.61],0.6844852629844407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YOD1,Ubiquitin thioesterase OTU1,42299,95,1.00 [0.73-1.36],0.9777183432190144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YTHDF3,YTH domain-containing family protein 3,49349,116,1.13 [0.94-1.37],0.2000667145608866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YWHAQ,14-3-3 protein theta,42800,100,1.06 [0.82-1.38],0.6351799052996137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,YY1,Transcriptional repressor protein YY1,42481,99,0.83 [0.41-1.67],0.5964444478014801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBP1,Z-DNA-binding protein 1,42481,99,1.04 [0.65-1.66],0.8822069800183201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBTB16,Zinc finger and BTB domain-containing protein 16,49115,114,0.92 [0.73-1.17],0.5064147515898383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBTB17,Zinc finger and BTB domain-containing protein 17,49383,114,1.46 [1.10-1.95],0.0094000992226285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZCCHC8,Zinc finger CCHC domain-containing protein 8,42299,95,0.90 [0.63-1.28],0.5488424355407462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZFYVE19,Abscission/NoCut checkpoint regulator,43557,98,0.99 [0.80-1.23],0.9365980171943402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZHX2,Zinc fingers and homeoboxes protein 2,43641,99,0.92 [0.50-1.69],0.7876425520361364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF174,Zinc finger protein 174,42481,99,1.01 [0.60-1.69],0.9819607073168372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF75D,Zinc finger protein 75D,42949,99,1.01 [0.74-1.38],0.9431926237563012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNF830,Zinc finger protein 830,43536,100,1.00 [0.78-1.28],0.9854652271787308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNRD2,Protein ZNRD2,43557,98,0.96 [0.73-1.27],0.7789536447708463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,43536,100,1.23 [0.89-1.69],0.219575546840282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZP3,Zona pellucida sperm-binding protein 3,42584,98,1.04 [0.97-1.13],0.2617116203726158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZP4,Zona pellucida sperm-binding protein 4,42186,96,0.66 [0.32-1.39],0.2739995190855077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZPR1,Zinc finger protein ZPR1,42326,94,1.19 [1.01-1.40],0.0390792710077328
